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ABSTRACT 
 
Stress during human pregnancy is associated with various adverse consequences for 
the physiological and psychological wellbeing of mother and child. A main focus for the 
research field of stress during pregnancy is to identify the underlying biological mechanism 
by which the maternal psychological stress is transferred to the developing foetus. 
Glucocorticoids, such as cortisol seem to play a pivotal role, since an overexposure of 
maternal cortisol, for example due to psychological stress is capable of crossing the placental 
barrier and thereby reaching the foetus. Heightened cortisol levels in the prenatal period have 
been associated with preterm birth and low birth weight. In animal studies, the placental 
enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) which converts active cortisol 
into its inactive metabolite cortisone, protects the developing foetus against an overexposure 
to maternal cortisol concentrations. This enzyme is also present in the adult salivary glands, 
where it exerts the same conversion of cortisol to cortisone. 
 The aim of the present thesis was to examine the psychological and physiological 
stress reactivity of pregnant women confronted with a standardized stressor and to 
concurrently investigate the conversion of cortisol to cortisone in the saliva and amniotic fluid 
of pregnant women. The empirical study results of the present thesis are divided into two 
parts. 
In part 1 (see chapter 7, page 63), the response of salivary cortisol, cortisone and the 
ratio between the two compounds, as an indicator of 11β-HSD2 activity in the salivary glands, 
were compared to the stress elicited by an amniocentesis with cortisol, cortisone and again the 
ratio between the two compounds in the amniotic fluid which served as an indicator of 11β-
HSD2 activity in the foetal system. This ratio was calculated by dividing cortisone (the end 
product of 11β-HSD2 activity) by the total sum of cortisone plus cortisol and has been 
adopted in previous studies to investigate the 11β-HSD2 activity.  
An aliquot of amniotic fluid and repeated saliva samples were collected from 34 
healthy pregnant women undergoing an amniocentesis for karyotyping. Mood alterations due 
to the intervention were surveyed using questionnaires. Subjects were re-examined in a 
 V 
 
control condition 2.7 weeks later after having been informed about the inconspicuous result of 
the amniocentesis. 
 The results revealed that subjects with a stronger acute stress response seem to have 
higher 11β-HSD2 activity levels in the foetal system as measured by the above mentioned 
ratio of cortisone to cortisol in the amniotic fluid.  
In part 2 (see chapter 8, page 80), we investigated the role of the maternal autonomic 
nervous system (ANS) in response to the stress of the amniocentesis and compared this stress 
response with amniotic fluid cortisol, cortisone and the conversion of cortisol to cortisone. 
Similar to the results in part 1, the amniocentesis revealed significant autonomic alterations 
compared to the control condition. Links between the ANS stress response and the ratio of 
cortisone to cortisol in the amniotic fluid were detected as well. 
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1. Introduction         
The assumption that maternal stressful experiences during pregnancy may have long 
lasting effects on the developing foetus is ancient (Schlotz & Phillips, 2009). Stress research 
has taken up this assumption in the middle of the last century and begun to investigate it more 
rigorously over the past 20 years. In the meantime, animal studies have long proven that 
maternal stress can adversely affect the offspring‟s development, enhancing the likelihood of 
poor pregnancy outcome (Brunton & Russell, 2011; Weinstock, 2008). Prenatal stress in 
animals has been associated with a wide range of problems for the offspring such as low birth 
weight, a deregulated hyperactive hypothalamic-pituitary-adrenal (HPA) axis, adult 
hypertension,  impaired cognitive and memory functioning as well as increased anxiety and 
depressive-like behaviour (Brunton & Russell, 2011; Seckl, 2004; Weinstock, 2005, 2008). 
Similar results are beginning to emerge from human studies (Glover, O'Connor, & O'Donnell, 
2010). Such consequences of prenatal stress have also been termed fetal programming effects 
(Barker, 1998; Drake, Tang, & Nyirenda, 2007). The concept of fetal programming states that 
there are critical periods during intrauterine development in which external stimuli or negative 
events may have a lifelong lasting impact on the foetus. However, the path by which maternal 
stress may reach the unborn still remains puzzling, since there are no neuronal connections 
between mother and foetus. How then can something that is not even material but rather 
psychological affect the unborn child? Different hypotheses exist and are subject of intense 
investigation. Nevertheless, before clear statements can be made a better understanding of the 
pregnant woman‟s stress experience, the manner in which she reacts psychologically as well 
as physiologically to stress is necessary. 
In this thesis the focus is laid on human pregnancy and therefore most reported 
findings are based on human studies unless otherwise indicated. The theoretical background 
(Part I) of the empirical studies (Part II) is presented in Chapter 1 in which a general overview 
on the psychobiology of stress, the definition of stress and its related concepts and the 
psychobiological stress response in the non-pregnant state is described. In this regard, two of 
the main stress responsive systems, namely the HPA axis and the autonomic nervous system 
(ANS) are introduced. The changes that these two stress systems undergo during pregnancy 
are discussed in Chapter 3. Chapter 4 briefly summarizes various stress settings that have 
been investigated by pregnancy research. Subsequently, findings on how pregnant woman 
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respond to stress in general are reviewed focusing on whether this differs from the non-
pregnant state and whether there are any periods during pregnancy which are especially 
vulnerable to stress. Finally, Chapter 5 is dedicated to the question of how maternal stress 
may arrive at and impact the unborn child. In this regard, the activity of a specific placental 
enzyme is highlighted, which has been proposed to play a vital role in protecting the foetus 
from excessive maternal stress hormones. 
After presenting the empirical study findings in Part II, the results are discussed in 
more detail in the general discussion in Part III. 
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PART I THEORETICAL BACKGROUND 
 
2. The Psychobiology of Stress 
Stress scientists have become increasingly aware of how psychological factors 
influence human health and disease. This is also the case during pregnancy except that for the 
duration of this condition stress not only may affect the mother but also the developing foetus. 
A growing body of research has found increased risk of pregnancy loss, preterm delivery and 
low birth weight to be associated with psychological stress (Dunkel Schetter, 2011; 
Madhappan et al., 2003; Mulder et al., 2002). Therefore, in order to protect the pregnant 
mother and her foetus from the detrimental effects of stress, it is essential to understand what 
stress is, which situations induce stress and whether all forms of stress are harmful.  
 
2.1 The Definition of Stress and Its Related Concepts 
In 1973, the endocrinologist Hans Selye stated that “everybody knows what stress is, 
and nobody knows what it is” (Selye, 1973, p. 692). Although knowledge has much increased 
since then through research, this statement is still relevant today. The phenomenon of stress in 
everyday life is of great interest to scientists from countless scientific fields, yet, consensus on 
a definition is lacking (Koolhaas et al., 2011). The Oxford Online Dictionary defines stress as  
“pressure or tension exerted on a material object” or “a state of mental or emotional strain 
or tension resulting from adverse or demanding circumstances” (Oxford Online Dictionary, 
2011). The term originates from the Latin verb, stringere, meaning to draw tight. 
Our understanding of stress has evolved greatly over past decades. The notions of 
equilibrium as a state of health, and imbalance as the source of disease dates back to the 
ancient Greeks and Romans (Chrousos & Gold, 1992). In the 19
th
 century this concept was 
developed further by the research of the French physiologist, Claude Bernard (Cooper, 2008; 
Goldstein & Kopin, 2007), who discovered, among other things, that the vascular blood flow 
is regulated by sympathetic nerves. His work led him to the concept of the milieu intérieur, 
meaning that the internal environment of the body made of fluids such as blood and lymph 
surround the body tissues and organs (Cannon, 1929). Bernard formulated the theory that, in 
response to disturbances from the external environment and in order to maintain physiological 
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equilibrium, the milieu intérieur is regulated dynamically by the nervous system (Chrousos & 
Gold, 1992; Cooper, 2008). This equilibrium is not a default condition but rather a result of 
continuous change and regulation.  
Inspired by Bernard, the American physiologist Walter B. Cannon espoused the idea 
of the milieu intérieur and coined the term homeostasis. Cannon (1929) explained that he 
chose the Greek-derived prefix homeo (meaning “like” or “similar”) instead of homo 
(meaning “same”) because the later would have implied something rigid and fixed. In animal 
studies, Cannon observed that emotions such as fear, rage and pain lead to rapid activation of 
the sympathetic nervous system and secretion of epinephrine from the adrenal medulla 
(Cannon, 1914). According to Cannon, these two important protagonists, the sympathetic 
nervous system and the adrenal medulla, operate as a unit to restore homeostasis. He referred 
to this system as the sympathico-adrenal system (Cannon, 1929; Goldstein & Kopin, 2007).  
Influenced by the British social psychologist, William McDougall, Cannon 
interpreted his findings as an emergency response of the nervous system induced by these 
strong emotions in order to supply the organism with enough energy to either fight or flee 
(Cannon, 1914; Cooper, 2008). This response of the sympathetic nervous system was 
therefore termed the fight-or-flight response (Iversen, Iversen, & Saper, 2000). Cannon‟s co-
workers later introduced the concept of negative feedback, a term originally derived from 
engineering that describes an important mechanism to safeguard homeostasis (Cooper, 2008; 
Rosenblueth, Wiener, & Bigelow, 1943). They defined negative feedback as corrective 
information acquired from the output or also response of a living organism (Rosenblueth et 
al., 1943).  
In 1936, the endocrinologist, Hans Selye, used the word stress which was derived 
from physics (Chrousos & Gold, 1992; Goldstein & Kopin, 2007) and defined it as “a 
nonspecific response of the body to any demand upon it” (Selye, 1973, p. 692). A stressor was 
defined as an agent that causes stress. Selye‟s concept of a “nonspecific response” was based 
on his observations that a variety of stressors such as cold, heat, burns, infections, fasting, 
trauma etc. each elicited the same physiological response pattern (Mason, 1971; Selye, 1973, 
1976).  
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 This response was termed the General Adaptation Syndrome (GAS) which develops 
in three stages: 1) alarm, 2) resistance, and 3) exhaustion (Selye, 1950). In the alarm stage the 
biological response is distress. In the resistance stage the body resists the imbalance and 
strives to adapt and regain a homeostatic equilibrium. With continued exposure to the stressor 
the organism enters the third stage of exhaustion that increases susceptibility to disease. 
Whilst Cannon‟s research put emphasis on the activation of the sympathoadrenal system in 
response to stress, Selye‟s work emphasized the activation of the hypothalamic-pituitary-
adrenal (HPA) axis. Selye also coined the term eustress from the Greek word, eu, meaning 
good (Chrousos & Gold, 1992; Lazarus, 1993). He thereby introduced the notion that stress is 
not always negative or harmful, but that mild forms can have positive effects such as 
enhanced emotional and intellectual development. Selye‟s concept of stress generated much 
interest but also controversy. Although Selye‟s assumption of nonspecificity has in the 
meantime been refuted (Mason, 1971; Pacak et al., 1998), his findings concerning stress and 
the related adverse effects on physical health have become a widely investigated field of 
research.  
Even though Selye acknowledged that psychological stimuli are capable of eliciting a 
stress response, his focus remained primarily on the impact of physical stimuli. However, the 
American psychiatrist and psychendocrinologist, John W. Mason, discovered in animal 
studies that stressors, such as cold, heat, fasting, etc. that were examined by Selye and 
postulated to cause a nonspecific physiological response, had powerful psychological 
components as well (Mason, 1971). When these psychological factors were taken into account 
and were investigated more closely, it became clear that they were the principle causes for the 
endocrine response of the HPA axis and not merely the physical factors. In Mason‟s research 
fasting caused an increased response of the HPA axis in monkeys – but only when the 
monkeys were surrounded by other monkeys that received feeding, and not when they were 
sheltered in small cubicles without social contact and the possibility of making social 
comparisons. Similarly, only a sudden rapid rise of room temperature elicited an HPA axis 
response in monkeys, but not a gradual one. Likewise, Cannon and his team had noticed that 
it was primarily the experience of fear that activated a physiological stress response (Cannon, 
1914). These findings suggest that stress mainly results from the way an individual perceives 
and appraises a stressor.  
 6 
 
From the 1950s on, the role of appraisal in the stress response was investigated 
extensively by the American psychologist, Richard Lazarus, and his colleagues (Lazarus, 
1993). For Lazarus (1993) appraisal was a mediating process between the demands of the 
environment and the beliefs and motivations of an individual. Therefore, individual 
differences in cognitive and motivational aspects became a primary focus of his 
investigations. He and his work group (Speisman, Lazarus, Mordkoff, & Davison, 1964) 
studied the reactions of study participants to a silent movie that showed a brutal coming of 
age ritual in an indigenous Australian tribe. Depending on the manner in which the narrator 
introduced the movie to the spectators, they exhibited either a stress response (when the 
brutality was emphasised) or not (when the film was introduced as an anthropological study 
and the brutality of the ritual was downplayed).  
In 1984, Lazarus and his assistant, Susan Folkman, published a Transactional Model 
of Stress – transactional because the model proposed that stress resulted from a transaction 
between an individual and his or her environment (Lazarus & Folkman, 1984). According to 
this model, individuals evaluate the situations they are confronted with according to relevance 
and stressfulness. There are generally three stages in this process. The first is called primary 
appraisal. A situation is appraised by an individual as stressful and relevant when it is 
perceived as either harmful (e.g., connected with an irrevocable loss), threatening (e.g., harm 
is impending or anticipated), or challenging (e.g., an individual feels he or she can manage a 
difficult situation by activating coping strategies). In a second stage termed secondary 
appraisal, an individual instantly analyses whether coping resources are available. Depending 
on this analysis, a stress response is initiated or not. In the third stage, an individual re-
appraises the situation based on the new experiences gained. 
A more recent concept of stress termed allostasis was introduced by the American 
neuroscientists, Peter Sterling and Joseph Eyer towards the end of the 20
th
 century (Goldstein 
& Kopin, 2007; Sterling & Eyer, 1988). The concept was further elaborated by Bruce 
McEwen and other researchers (Goldstein & McEwen, 2002; McEwen, 1998). Allostasis is 
defined as “the ability of the body to achieve stability through change” (Goldstein & 
McEwen, 2002; McEwen, 1998; Sterling & Eyer, 1988). The term is put together from the 
Greek prefix allo meaning change and stasis meaning stable (Schulkin, 2011). According to 
McEwen (1998) a stress response is triggered when an individual perceives a stressful 
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situation that involves the experience of threat and helplessness, for instance during a 
traumatic event. Stressors may also be related to the home, workplace or neighbourhood. 
They can be real or imagined (Goldstein & Kopin, 2007; McEwen, 1998). The individual‟s 
perception of stress depends on his or her genes, previous experiences and personal 
development (McEwen, 1998). In stressful situations physiological (e.g. activation of the 
HPA axis, ANS, etc.) and behavioural responses (e.g. fighting or fleeing, changing dieting 
habits, etc.) are triggered, leading to allostasis and adaptation.  
Chronic activation of the allostatic system, however, can result in allostatic load. 
McEwen (1998) differentiates between four types of allostatic load: 1) repeated stress “hits”, 
2) responses without adaptation resulting in prolonged exposure to the stressor, 3) the 
inability to shut the stress response down and recover, and 4) inadequate response. In contrast 
to homeostasis where the organism depends on negative feedback to maintain equilibrium, the 
concept of allostasis proposes that negative feedback alone does not suffice the needs of the 
organism and is too slow to regulate quick responses within the body. In order to effectively 
adapt to change, the anticipation of change is necessary (Schulkin, 2011; Sterling, 2011). 
Allostasis therefore depends on anticipatory and consequently feed-forward regulation. 
 The concept of stress has come a long way. But interest in the subject from 
innumerable scientific fields is still rapidly growing and, with it, our understanding of this 
important aspect of human life will surely grow in fast progress as well. The following 
chapter is dedicated to the psychobiological response to stress. 
 
2.2 The Psychobiological Stress Response 
One of the central structures of the brain involved in processing stress-relevant 
stimuli is the limbic system, which is composed of various brain structures such as the 
amygdala, the hippocampus and the prefrontal cortex (Gunnar & Quevedo, 2007; Kaltsas & 
Chrousos, 2007; Shekhar, Truitt, Rainnie, & Sajdyk, 2005). Further central structures 
responsible in orchestrating the stress response are the brain stem and the hypothalamus 
(Ulrich-Lai & Herman, 2009). In the body‟s periphery, the two major systems regulating the 
stress response are set into motion: the hypothalamic-pituitary-adrenocortical (HPA) axis and 
the autonomic nervous system (ANS) together with its two branches, the sympathetic nervous 
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system (SNS) and parasympathetic nervous system (PSNS). On closer inspection, information 
signalizing a threat (real or potential) is conveyed to the brain stem and/or limbic structures. 
Bottom-up signals from the brain stem reach the paraventricular nuclei (PVN; see Figure 1) of 
the hypothalamus through direct projections (Ulrich-Lai & Herman, 2009). The hypothalamus 
is located above the brain stem and composed of neuron clusters, such as the PVN 
(Snowdown & Ziegler, 2007). Distinct neurons within the PVN called parvocellular neurons 
are to a large extent responsible for coordinating the stress response of the HPA axis and ANS 
(Gunnar & Quevedo, 2007; Ulrich-Lai & Herman, 2009). The structures of the limbic system 
are indirectly connected with the PVN via top-down signalling and are not only involved in 
triggering the stress response but also in modulating its further course (Gunnar & Quevedo, 
2007; Shekhar et al., 2005). Therefore, these stress responsive systems do not exert their 
actions separately from each other but are interconnected, each influencing the activity of the 
other (De Kloet, Vreugdenhil, Oitzl, & Joels, 1998; Gunnar & Quevedo, 2007; Ulrich-Lai & 
Herman, 2009).  
The stress responses of the HPA axis and the ANS are geared towards mobilization 
of energy in order to deal efficiently with the threat and restore equilibrium. Increased blood 
flow and oxygen are redirected to the brain, heart and lungs, blood pressure rises, respiration 
and heart rate speed up, glucose mobilization from the liver increases while immune-mediated 
inflammation, reproductive hormones, pain sensitivity, bone and muscle growth are 
suppressed (Cannon, 1914; Ehlert, 2011; Herman et al., 2003; Kaltsas & Chrousos, 2007). 
Vigilance, alertness and other cognitive functions are enhanced and feeding and sexual 
behaviour are interrupted (Chrousos & Gold, 1992; Sapolsky, Romero, & Munck, 2000). The 
pathway of the HPA axis and the ANS activation will be discussed in detail in the following. 
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Figure 1.  Central structures that regulate the stress response of the HPA Axis and ANS. Brain structures 
that regulate the sympathetic action are in red and brain structures that regulate the 
parasympathetic action are in blue. (Adapted from Ulrich-Lai & Herman, 2009 and from 
Gunnar & Quevedo, 2007). 
 
 
2.2.1 The Hypothalamus-Pituitary-Adrenal Axis  
The activation of the HPA axis (see Figure 1) is triggered by the release of two 
peptides known as corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) 
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from the parvocellular neurons of the PVN within the hypothalamus (Kaltsas & Chrousos, 
2007). Both peptides appear to reciprocally enhance the secretion of each other and potentiate 
each other‟s effect (Lamberts, Verleun, Oosterom, de Jong, & Hackeng, 1984; Tsigos & 
Chrousos, 2002). CRH and AVP reach the anterior pituitary through the hypothalamic-
pituitary portal vessels
1
 where they induce a surge in the secretion of adrenocorticotropic 
hormone (ACTH). Subsequently, ACTH travels through the blood circulation and arrives at 
the inner cortex of the adrenal gland (zona fasciculate) where it initiates the production and 
secretion of glucocorticoids such as cortisol (Chrousos, 1995; Ehlert, 2011; Herman et al., 
2003). In humans, the cortisol response reaches a peak within 10 to 30 minutes after 
termination of a stressor (Kirschbaum, Pirke, & Hellhammer, 1993; Zoccola, Quas, & Yim, 
2010). It can take minutes to hours for the released cortisol to have an effect on its target 
organisms (Sapolsky et al., 2000).  
A large amount of the cortisol released into the blood is quickly bound to a 
glycoprotein called corticosteroid binding globulin (CBG; binding approximately 80% of 
cortisol) and to a much lesser extent (binding approximately 10-15% of cortisol) to the protein 
albumin (Hammond, Smith, & Underhill, 1991; Kirschbaum & Hellhammer, 1999). 
Therefore, only a small fraction of cortisol (5%) is circulating freely in the blood stream. This 
free fraction of cortisol is lipophilic and has a low molecular mass enabling it to pass through 
different physiological barriers such as the blood-brain barrier or the placental barrier as well 
as the cell membranes of various target cells throughout the body (Gunnar & Quevedo, 2007; 
Levine, Zagoory-Sharon, Feldman, Lewis, & Weller, 2007). Within the cell free cortisol binds 
to distinct receptors that are present within the cytoplasm and rapidly activates these 
(Sapolsky et al., 2000). In turn, these activated receptors enter the cell nucleus, locate and 
reach the gene they want to target and initiate gene transcription (e.g., suppressing the 
expression of anti-inflammatory proteins) (Rhen & Cidlowski, 2005). However, it seems that 
not only free but also bound cortisol may exert bioactive effects on certain target cells as well 
(Levine et al., 2007). The fact that glucocorticoids act to change gene transcription within the 
cells may explain why this stress system seems to react with a delay compared to the rapid 
                                                          
1  Blood vessels that link the hypothalamus with the anterior pituitary. 
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stress response of the ANS (Gunnar & Quevedo, 2007; Ulrich-Lai & Herman, 2009) as will 
be discussed below. 
In order to prevent sustained HPA activation and the resulting negative consequences 
of glucocorticoid excess (e.g., prolonged inhibitory effects on the reproductive and immune 
system), elevated cortisol levels cause an inhibition of further ACTH, CRH, and AVP release 
via negative feedback signals to the pituitary and hypothalamus (Dallman & Hellhammer, 
2011; Ehlert, 2011; Keenan, Licinio, & Veldhuis, 2001; Keller-Wood & Dallman, 1984). As a 
result, the system is shut down. Two types of receptors have been found to play an important 
role in this negative feedback signalling (Dallman & Hellhammer, 2011), namely the 
glucocorticoid receptor (GR) and mineralocorticoid receptor (MR)
2
,  
Moreover, it is through these two receptors, that cortisol exert its actions in the body 
(Ehlert, 2011; Funder, Pearce, Smith, & Smith, 1988; Sapolsky et al., 2000). They are 
presented in the following: 
1) Mineralocorticoid receptors (MRs, also known as type 1 receptors): 
Cortisol binds with high affinity to MRs (Gunnar & Quevedo, 2007; Gunnar & 
Vazquez, 2006). However, not only cortisol bind to MRs, but also so called 
mineralocorticoids. Mineralocorticoids are a group of steroid hormones and play a 
pivotal role in regulating the concentration of minerals such as sodium and potassium 
within the body. The main mineralocorticoid, aldosterone, stimulates the kidney to 
preserve sodium. This leads to a reduction of urine production and retention of water 
within the body (Breedlove, Watson, & Rosenzweig, 2010). When cortisol binds to 
MR it acts as a mineralocorticoid (Stewart & Mason, 1995). 
2) Glucocorticoid receptors (GRs, also known as type 2 receptors): 
Glucocorticoids bind with lower affinity to GR (Gunnar & Quevedo, 2007; Gunnar 
& Vazquez, 2006). The name glucocorticoid originates from the fact that this group 
of steroid hormones is involved in the metabolism of carbohydrates such as glucose 
(Breedlove et al., 2010; Sapolsky et al., 2000). The main glucocorticoid in humans is 
                                                          
2   Some findings suggest that only GRs are involved in the negative feedback signalling (Habib, Gold, & 
Chrousos, 2001). 
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cortisol (Snowdown & Ziegler, 2007) and aside from increasing the level of glucose 
in the blood, cortisol also plays an important role in anti-inflammatory processes 
(Rhen & Cidlowski, 2005; Sapolsky et al., 2000). 
 
MRs and GRs are crucial in regulating the cortisol effects on the organs. However, in 
order to prevent an over-activation of these receptors by cortisol, the enzyme 11β-
hydroxysteroid dehydrogenase type 2 (11β-HSD2) catalyses the conversion of active cortisol 
into its inactive metabolite cortisone (Edwards et al., 1988; Stewart, Murry, & Mason, 1994). 
Moreover, through the actions of 11β-HSD2, the binding of cortisol to the MR is regulated 
and receptor selectivity is conferred to aldosterone (Funder et al., 1988). 11β-HSD2 is 
therefore widely distributed in mineralocorticoid target tissues (Odermatt, Arnold, & Frey, 
2001). The other enzyme isoform, namely 11β-HSD1 mainly regenerates cortisol from 
cortisone and thereby enhances the glucocorticoid effect in glucocorticoid target tissues 
(Seckl & Walker, 2004). The function of 11β-HSD2 and 11β-HSD1 will be discussed in more 
detail in Chapter 5. 
 Free cortisol is able to pass rapidly through various bodily tissues and into fluids, 
such as saliva (Groschl, 2008; Hiramatsu, 1981). Consequently, salivary cortisol has become 
a widely used biomarker for non-invasive investigation of the mechanisms of the HPA axis 
under stressed or basal conditions, in the laboratory or under more natural circumstances 
(Hellhammer, Wust, & Kudielka, 2009; Kirschbaum & Hellhammer, 1999). Findings report 
high correlation coefficients between cortisol in the blood and saliva ranging from r =.71 to r 
= .96 (B. Harris et al., 1990; Kirschbaum & Hellhammer, 1994; McCracken & Poland, 1989; 
Perogamvros, Keevil, Ray, & Trainer, 2010; Umeda et al., 1981). Moreover, the 
concentration of cortisol in saliva is not dependent on the salivary flow rate, because it enters 
the saliva by passive diffusion (Kirschbaum & Hellhammer, 1994). Nevertheless, the enzyme 
11β-HSD2 is also present within the cells of the salivary glands, where it equally converts 
cortisol into its inactive metabolite cortisone (Smith et al., 1996). This has led researchers to 
suggest that salivary cortisone more accurately reflects levels of cortisol in the blood rather 
than salivary cortisol (Perogamvros et al., 2010). 
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In the subsequent paragraphs, factors that influence the HPA axis are discussed. For 
example, certain psychological characteristics of stress situations such as unpredictability, 
novelty, uncontrollability, anticipatory stress and the threat of being negatively evaluated by 
others (socio-evaluative threat) seem to be factors particularly capable of inducing strong 
cortisol responses (Dickerson & Kemeny, 2004; Kajantie & Phillips, 2006; Kirschbaum & 
Hellhammer, 1999). Chronic psychological stress, on the other hand, appears to be associated 
with a hypo-responsive HPA axis but findings in this regard are conflicting (Kudielka, 
Hellhammer, & Wust, 2009). Some researchers report attenuated cortisol responses while 
others describe elevated responses. 
In unstressed conditions, the HPA axis of healthy children and adults exhibits a 
circadian (Dickmeis, 2009; Hiramatsu, 1981) and ultradian rhythm (Walker, Terry, & 
Lightman, 2010; Young, Abelson, & Lightman, 2004). Over the 24 hours cycle, CRH, 
ACTH, and cortisol reach peak levels in the morning hours marked by a more or less steady 
decrease throughout the day and into the night with levels rising again shortly before the 
waking hours (Smyth et al., 1997; Umeda et al., 1981; Walker et al., 2010). With regard to the 
ultradian rhythm, cortisol is secreted from the adrenal gland in a pulsatile fashion over hours 
(Young et al., 2004). The frequency and amplitudes of these pulses change during the day and 
constitute the circadian rhythm. A similar but less distinct pulsatile release of ACTH seems to 
exist although the ultradian patterns of cortisol and ACTH do not appear to be associated but 
rather seem to be uncoupled (Dickmeis, 2009). CRH and AVP are also released in pulses of 
approximately one to three bursts per hour (Ixart et al., 1987; Tsigos & Chrousos, 2002). The 
circadian rhythm of the HPA axis and other endocrine systems is controlled by a small 
structure located within the anterior hypothalamus of the brain called the suprachiasmatic 
nucleus (SCN) which in turn is controlled by light (Dickmeis, 2009; Walker et al., 2010). 
Scientist have proposed that during acute stress the circadian secretion of the HPA axis 
hormones is interrupted and the pulse amplitudes and frequencies are increased (Chrousos, 
1995; Tsigos & Chrousos, 2002). Despite confirmatory findings from rat studies showing an 
increased frequency of corticosterone
3
 pulses in response to acute stress (Windle et al., 2001), 
more research is still needed to validate that such a response exists in humans as well (Young 
et al., 2004). 
                                                          
3
  Corticosterone is the main glucocorticoid in rats. In other words, it is the equivalent of cortisol in humans. 
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Further factors which have an influence on the HPA axis are amongst others genetic 
factors, age (children and young adults compared to elderly adults), gender, nicotine, coffee, 
alcohol and pregnancy and breast feeding (Kudielka et al., 2009). The effects of pregnancy on 
the HPA axis will be addressed below. 
 
2.2.2 The Autonomic Nervous System 
The ANS owes its name to the historic assumptions that, contrary to the somatic 
sensory and somatic motor system, the actions of the ANS are independent of conscious 
volition and therefore autonomic (Breedlove et al., 2010). In the meantime, it has become 
evident that the ANS can be brought under voluntary control as well (e.g., through 
biofeedback). The ANS is part of the peripheral nervous system and responsible for the 
control of the internal organs. Its three main branches include the SNS, the PSNS, and the 
enteric nervous system, the latter of which mediates digestive reflexes within the 
gastrointestinal system and represents a largely independent unit (Iversen et al., 2000). The 
following paragraphs will focus on the responses of the SNS and PSNS.  
The actions of the SNS and PSNS are often opposing in their effects and while the 
SNS has been regarded by Cannon and others as the responsive system for fight-or-flight 
situations, the PSNS has been suggested to be most active under conditions of rest and digest 
(Iversen et al., 2000; Porges, 1995). For example, sympathetic activation is related to 
excitatory effects on the heart leading to an increased heart rate, whereas parasympathetic 
actions are associated with an inhibitory effect mediated by the vagus nerve leading to a 
decreased heart rate in order to preserve energy (Porges, 1995; Thayer & Lane, 2009). 
However, these two branches do not act strictly autonomous and cooperate with each other 
under both stress and resting conditions.  
Unlike the somatic motor system where the motor neurons are situated within the 
brainstem and spinal cord and innervate the skeletal muscles directly, the neurons of the ANS 
termed preganglionic autonomic neurons lie outside the spinal cord. These preganglionic 
neurons receive projections from the neurons of the central nervous system and synapse with 
postganglionic neurons that innervate the target organs (Iversen et al., 2000). The 
preganglionic neurons of the SNS are located in the thoracic and lumbar segments of the 
 15 
 
spinal cord and project to the so-called sympathetic chain, a cord of autonomic ganglia
4
 
running parallel to the spinal column (Heim & Meinlschmid, 2003). Differently with regard to 
the PSNS where no such chain exists, the preganglionic neurons either project from the 
brainstem via long nerve connections such as the vagus nerve or directly from the sacral 
segments of the spinal cord to innervate postganglionic neurons situated mostly near or 
directly at the end organs (Heim & Meinlschmid, 2003). These preganglionic neurons of both 
the SNS and PSNS produce and secrete acetylcholine (ACh; Breedlove et al., 2010). For the 
most part, the SNS and PSNS innervate the same organs with a few exceptions such as the 
adrenal medulla and the sweat glands which receive input from the SNS only (Heim & 
Meinlschmid, 2003). The PSNS regulates the activity of the internal organs mainly through 
the vagus nerve - the tenth cranial nerve which arises from two nuclei within the brain stem: 
the dorsal motor nucleus and the nucleus ambiguus (Porges, 1995). The main neurotransmitter 
of the sympathetic postganglionic neurons is norepinephrine (NE), whereas for the PSNS it is 
ACh. In order to maintain and regain homeostasis, the balance between the activities of the 
SNS and PSNS are of importance (Iversen et al., 2000). 
Compared to the HPA axis, the stress response of the ANS is activated within 
seconds and rapidly terminated again due to the reflex arcs between the SNS and PSNS and 
the brain stem and spinal cord (Ulrich-Lai & Herman, 2009). The sympathetic stress response 
in the body‟s periphery results amongst others in activation of the sympatho-adrenomedullary 
(SAM) system. This means that besides the secretion of NE from the postganglionic neurons 
of the SNS, a secretion of NE (20%), and to a much larger extent epinephrine (EPI; 80%), is 
induced from distinct neuroendocrine cells within the adrenal medulla called chromaffin cells 
(Gunnar & Quevedo, 2007; Heim & Meinlschmid, 2003; Ulrich-Lai & Herman, 2009). These 
chromaffin cells have therefore also been suggested to be regarded as postganglionic neurons 
(Gunnar & Quevedo, 2007). Subsequently, the released NE and EPI from these chromaffin 
cells induce various fight-or-flight reactions such as increased heart rate and blood pressure 
(Iversen et al., 2000). Released EPI, moreover, causes blood glucose to rise, providing the 
body with sufficient energy (Rizza, Haymond, Cryer, & Gerich, 1979). The parasympathetic 
reaction to stress in the periphery leads to a withdrawal of „vagal tone‟ and to a greater 
activation of the sympathetic nervous system (Ulrich-Lai & Herman, 2009). Feedback is 
                                                          
4
   Autonomic ganglia are accumulations of nerve cell bodies (Breedlove et al., 2010). 
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dynamically regulated, since the vagus nerve is comprised of both afferent (i.e. carrying 
information to the brain, also known as sensory nerve fibres) as well as efferent nerve fibres 
(i.e. carrying information away from the brain, also known as motor or effector nerve fibres; 
Porges, 1995). 
The regulation of the ANS stress response within the central nervous system (CNS) 
is very complex and involves many different brain regions (Ulrich-Lai & Herman, 2009). The 
regulation of the ANS stress response within the central nervous system (CNS) is very 
complex and involves many different brain regions (Ulrich-Lai & Herman, 2009). In this 
regard, the locus coeruleus-norepinephrine (LC-NE) system has been proposed to be 
essentially involved in controlling and modulating the activities of the SNS and is composed 
of NE cell clusters within the medulla oblongata and the pons (Habib et al., 2001; Kaltsas & 
Chrousos, 2007). Both medulla oblongata and pons are components of the brain stem, the 
former being part of the lower and the latter part of the upper brain stem (Breedlove et al., 
2010). These NE cell clusters have widespread projections throughout the entire CNS such as 
into the amygdala and hypothalamus (Heim & Meinlschmid, 2003; Morilak et al., 2005). Due 
to its stimulatory effect on the amygdala in response to acute stress, the NE system in the 
brain has also been referred to as an alarm or emergency system (Habib et al., 2001). In line 
with this, NE seems to play an important role in arousal, vigilance, and anxiety mediated 
behaviour (Heim & Meinlschmid, 2003). Moreover, NE stimulates CRH and AVP secretion 
in the PVN of the hypothalamus and thereby reinforces the stress response of the ANS but 
also that of the HPA axis in the body‟s periphery (Habib et al., 2001). Conversely, CRH and 
AVP stimulate NE secretion from the brain stem resulting in positive feedback loops between 
the two systems (Chrousos & Gold, 1992) although negative feedback loops exist as well 
(Habib et al., 2001). Unlike glucocorticoids, NE and EPI released into the body‟s periphery 
are not able to cross the blood-brain barrier (Gunnar & Quevedo, 2007), but do pass through 
the placental barrier (Beard, 1962). A further important structure of the SNS as well as the 
PSNS (see below) is the nucleus of the solitary tract (NTS) located in the brain stem. This 
component receives input from the central nucleus of the amygdala and other limbic 
structures as well as from the PVN and projects to the LC and the medulla oblongata in order 
to control the SNS response (Iversen et al., 2000; Ulrich-Lai & Herman, 2009).  
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Analogous to the SNS, the central structures involved in governing the stress 
response of the PSNS are the PVN and NTS (Ulrich-Lai & Herman, 2009). In addition to this, 
a structure of the limbic forebrain termed the bed nucleus of the stria terminalis (BNST), 
plays an important role as well (Iversen et al., 2000). This structure receives projections from 
the amygdala and relays this input on to the PVN of the hypothalamus and the NTS of the 
brain stem. The nucleus ambiguus and the dorsal nucleus of the vagus nerve are additionally 
involved in mediating the PSNS stress response. Both structures are located in the medulla 
oblongata of the brain stem, receive projections from the NTS and exert inhibitory actions on 
the organs they innervate. For example, via the vagus nerve the nucleus ambiguus exerts a 
decrease in heart rate under non-stressed conditions (Purves et al., 2008; Ulrich-Lai & 
Herman, 2009).  
Further important central nervous structures in governing the autonomic stress 
response but also that of the HPA axis are the anterior cingulate cortex, the orbitofrontal 
cortex and the hippocampus. These structures seem to play an important role in negative 
feedback control and termination of the stress response (Gunnar & Quevedo, 2007; Ulrich-Lai 
& Herman, 2009).  
Chronic psychological stress has been associated with sympathetic over-activation 
and vagal withdrawal (Lucini, Di Fede, Parati, & Pagani, 2005). Further factors that have 
been found to affect ANS activity are: alcohol, nicotine, physical exercise, BMI, age and 
gender (Britton et al., 2007; Nater & Rohleder, 2009; Romanowicz, Schmidt, Bostwick, 
Mrazek, & Karpyak, 2011). Moreover, similar to the HPA axis, the ANS exhibits a circadian 
variation (Bonnemeier et al., 2003). 
Some of the most common investigated stress markers of the ANS are: electrodermal 
activity (EDA), heart rate (HR), heart rate variability (HRV), blood pressure, salivary alpha-
amylase (sAA), urinary and blood (plasma) NE and EPI (Berntson, Quigley, & Lozano, 2007; 
Bosch, Veerman, de Geus, & Proctor, 2011; Lundberg, 2011; Nater et al., 2006; Nater & 
Rohleder, 2009; Porges, 1995). In what follows is a brief presentation of HR, HRV, and sAA 
which are important markers that will be of particular significance in the chapters on the 
empirical studies: 
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Heart rate: 
Heart rate (HR) measures the number of consecutive heart beats usually in one 
minute (beats per min, bpm) whereas heart period measures the time between two 
consecutive heart beats in milliseconds (Berntson et al., 2007; Porges, 1995). In other 
words, heart period is the reciprocal of HR and vice versa and a decrease in heart 
period means faster heart rate. Since the heart is innervated by both the sympathetic 
and parasympathetic branch of the ANS, it is a marker for both sympathetic as well 
as parasympathetic activation (Berntson et al., 2007) or, more precisely, an increased 
heart rate reflects parasympathetic withdrawal and sympathetic activation, while a 
decreased heart rate mirrors a dominance of parasympathetic control over the heart 
(Berntson et al., 2007; Porges, 1995). 
 
Heart rate variability:  
The intervals between two consecutive heart beats vary as an individual inhales (HR 
increases) and exhales (HR decreases; Porges, 1995, see Figure 2 depicting beat to 
beat intervals in an electrocardiogram). This pattern has been termed respiratory 
sinus arrhythmia (RSA), given that the sinoatrial (SA) node situated in the right 
atrium of the heart regulates the normal heart rhythm. The SA node is also known as 
the „pacemaker‟ of the heart and is innervated by both the sympathetic and 
parasympathetic branch of the ANS. In this regard, NE induces an increase in the 
depolarisation rate of the SA node and ACh a decrease (Berntson et al., 1997). The 
RSA of an individual is influenced by his or her psychological state (Berntson et al., 
1997) and experience of stress (Marca et al., 2011).  
Heart rate variability (HRV) can be measured using time domain methods based, for 
example, on calculations of the standard deviation between normal consecutive beats 
(SDNN; see Figure 2) termed normal-to-normal (NN) intervals (or alternatively RR 
interval meaning the interval between two R spikes; Berntson et al., 2007). SDNN is 
one of the simplest time domain measures to calculate (Task force of the European 
Society of Cardiology and the North American Society of Pacing and 
Electrophysiology, 1996).  
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Figure 2.  The QRS complex and two beat to beat intervals in an electrocardiogram mirroring HRV. 
 
A further method for measuring HRV is based on power spectral analyses of heart 
rate variations (or heart period variations) termed frequency domain (spectral) 
methods (Akselrod et al., 1981; Berntson et al., 2007). This method is based on a 
mathematical approach called the Fourier theorem which enables to break down the 
time-varying waveforms of for example an electrocardiogram into its individual sine 
wave components (Berntson et al., 2007). In humans, the low frequency (LF) 
component ranges from 0.04 to 0.15 Hz and has in the past been proposed to mediate 
particularly sympathetic activity, but is now regarded as a marker reflecting both 
sympathetic and parasympathetic activity (Akselrod et al., 1981). The high frequency 
(HF) component ranges between 0.12 or 0.15 to 0.4 Hz, is mediated by 
parasympathetic activity and in general resembles RSA (Berntson et al., 1997; 
Berntson et al., 2007). As mentioned above, the balance between the sympathetic and 
parasympathetic branches of the ANS is of great importance and the ratio between 
the LF and HF component (LF/HF ratio) is a marker that reflects this balance and is 
termed sympatho-vagal balance. 
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Salivary alpha-amylase:  
Salivary alpha-amylase (sAA) is one of the most abundant enzymes in the saliva and 
initiates the process of starch digestion in the mouth by breaking it down into 
maltose and glucose (Bosch et al., 2011; Mandel, Peyrot des Gachons, Plank, 
Alarcon, & Breslin, 2010; Nater & Rohleder, 2009). Of the three major salivary 
glands, namely the parotid (situated in the upper back mouth area), the 
submandibular (between cheek and jaw in the lower sides of the mouth), and the 
sublingual glands (under the tongue), sAA is mainly produced by the parotid and 
submandibular glands (Beltzer et al., 2010). These glands are innervated by both the 
SNS and PSNS (Bosch et al., 2011). However, under stress-induced predominantly 
sympathetic activation the secretion of sAA increases; thus, sAA is mainly regarded 
as a marker for the stress response of the SNS (Ehlert, Erni, Hebisch, & Nater, 2006; 
Nater & Rohleder, 2009).  
 
2.3 Summary 
The understanding of stress and its related concepts have developed remarkably over 
the past decades. Yet, in science there still is no general consensus on its definition. The 
model of Lazarus and Folkman (1984) assumes that an individual‟s experience of stress is 
influenced by his or her appraisal of a situation. This depends on the extent to which a subject 
perceives a situation as threatening or not (primary appraisal) and to what extent he or she 
believes to cope with the resources at hand (secondary appraisal). Accordingly, psychological 
factors such as unpredictability, novelty and uncontrollability have been found capable of 
inducing strong physiological reactions. The HPA axis and the ANS are two major stress 
responsive systems. The perception of stress leads to a release of CRH and AVP from the 
hypothalamus. In turn, ACTH is released from the anterior pituitary, travels through the blood 
circulation and induces the production and secretion of cortisol from the adrenal cortex. 
Through negative feedback mechanisms, cortisol causes the stress response to shut down. 
Cortisol acts through GRs and MRs within cells and has amongst others immune-suppressive 
and anti-inflammatory effects. In order to prevent an over-activation of the GRs and MRs, the 
enzyme 11β-HSD2 inactivates cortisol into its inert metabolite cortisone.  
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The ANS is divided in two major branches: the SNS and the PSNS. These two 
divisions have opposing effects on the end organs they innervated, but they nevertheless 
cooperate with each other under stress as well as under baseline conditions. The SNS is also 
called the fight-and-flight system, while the PSNS is seen as the system mainly responsible 
for rest-and-digest. The ANS reacts to stress with vagal withdrawal and activation of the SNS 
system, the latter of which induces secretion of NE and EPI from the adrenal medulla. 
Cortisol in the blood or saliva is measured in order to examine the stress response of the HPA 
axis. Commonly investigated biomarkers of the ANS include HR, HRV and sAA. 
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3. Effects of Pregnancy on Physiological Stress Sensitive Systems 
The maternal body undergoes amazing anatomical and functional changes during 
pregnancy. This serves to further the development of the foetus and to prepare the pregnant 
woman‟s body for birth. The duration of human pregnancy usually lasts approximately 40 
weeks calculated from the first day of the pregnant woman‟s last menstrual cycle. This period 
can be divided into three equal phases of 13 to 14 weeks each called trimesters. These 
trimesters are considered important reference intervals in the progression of pregnancy and 
foetal development. How pregnancy affects the regulation of the HPA axis and the ANS is 
subject of the following paragraphs. 
 
3.1 The Hypothalamus-Pituitary-Adrenal Axis During Pregnancy 
3.1.1 Corticotropin-Releasing Hormone  
With progressing gestation, the activity of the maternal HPA axis intensifies (De 
Weerth & Buitelaar, 2005b; Lindsay & Nieman, 2005). In non-pregnant women CRH levels 
in the plasma are hardly detectably or very low, since hypothalamic CRH is largely diluted 
after passing through the hypothalamic-pituitary portal vessels (Fadalti et al., 2000; McLean 
& Smith, 1999; Riley & Challis, 1991). At approximately 8 weeks of gestation, the 
concentration of immunoreactive CRH in maternal plasma is also still low or merely 
detectable (Madhappan et al., 2003; Sorem et al., 1996) and not significantly different from 
non-pregnant women (Sasaki, Shinkawa, & Yoshinaga, 1989) as studies to date have shown. 
However, from approximately 16 to 20 weeks of gestation onward a gradual but continuous 
increase has been observed (Goland, Jozak, & Conwell, 1994; Goland, Wardlaw, Blum, 
Tropper, & Stark, 1988; Riley & Challis, 1991; Stalla et al., 1989) with an exponential rise at 
about 30 days before birth (McLean et al., 1995). This progressive increase, however, does 
not result in an overstimulation of the maternal HPA axis, because CHR is bound to the CHR-
binding protein (CRH-BP) thereby reducing its bioactivity (Ehlert, Sieber, & Hebisch, 2003). 
While maternal plasma concentrations keep rising with progressing gestation, approximately 
30 days before birth CRH-BP levels suddenly start to plunge by about 50% (Linton et al., 
1993; McLean et al., 1995). The result is an abundance of free bioactive CRH which triggers 
a cascade of reactions leading to the onset of birth (McLean & Smith, 1999). Maternal plasma 
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CRH levels reach a peak during labour and delivery (Fadalti et al., 2000; Sasaki et al., 1989) 
with concentrations up to a thousand-fold of the non-pregnant state (Mastorakos & Ilias, 
2003; Sasaki et al., 1989).  
The source of this drastic rise in maternal plasma CRH, seems not to be of 
hypothalamic origin but rather is induced by the placenta
5
, decidua
6
, amnion
7
 and chorion
8
, 
tissues which all produce CRH as well (Grino, Chrousos, & Margioris, 1987; McLean & 
Smith, 1999; Riley & Challis, 1991). Immunoreactive CRH has been identified in the 
syncytiotrophoblast
9
 from 9 weeks of gestation onward (Riley & Challis, 1991) and placental 
CRH mRNA has been detected from 7 to 40 weeks of gestation with a more than 20-fold 
increase during the last 5 gestational weeks before birth (Frim et al., 1988). Another finding 
substantiating a placental rather than a hypothalamic source of CRH increase comes from a 
study by Campbell and colleagues (1987), who found significant lower CRH levels in 
umbilical cord plasma than in the maternal circulation at term. Furthermore, CRH levels 
dropped back to normal within 15 hours after delivery and expulsion of the placenta 
(Campbell et al., 1987). Moreover, placental CRH and hypothalamic CRH are identical in 
structure, immunoreactivity, bioactivity and transcriptional sites (Ditzen & Beinder, 2011; 
Lindsay & Nieman, 2005; Magiakou, Mastorakos, Webster, & Chrousos, 1997). During 
pregnancy, CRH seem to be secreted in an ultradian fashion, however studies have not been 
able to detect a circadian rhythm (Lindsay & Nieman, 2005; Magiakou et al., 1997; 
Mastorakos & Ilias, 2003; Wadhwa, Sandman, Chicz-DeMet, & Porto, 1997) 
Since placental CHR is secreted into the maternal and foetal circulation systems 
(Campbell et al., 1987; Frim et al., 1988) it is assumed to activate both HPA axes by 
                                                          
5
  The placenta is a transient endocrine organ. Through it the foetus receives oxygen and nutrients from the 
mother and returns carbon dioxide and metabolic waste to the maternal system (Cunningham et al., 2010; 
Evain-Brion & Malassine, 2003). 
6
  The decidua is the hormonally changed lining (endothelium) of the uterus during pregnancy and during the 
end of the luteal phase of the menstrual cycle (Cunningham et al., 2010; Karumanchi & Yuan, 2007). 
7
  The amnion is the innermost, non-vascular membrane that surrounds the developing embryo or foetus. It is 
filled with amniotic fluid (Cunningham et al., 2010; Gruber, 2009). 
8
  The chorion is the outermost membrane that surrounds the developing embryo or foetus (Gruber, 2009). 
9
  The syncytiotrophoblast is comprised of multinucleated cells forming the outer layer of the placenta and 
representing the site of maternal-foetal exchange (Karumanchi & Yuan, 2007). 
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stimulating the release of ACTH from the maternal and foetal pituitary (Foyouzi, Frisbaek, & 
Norwitz, 2004; Goland et al., 1994; McLean & Smith, 1999). Moreover, McLean and 
colleagues (1995) discovered that the levels of plasma CRH at 16 to 20 weeks of gestation 
predict whether a pregnant woman will experience a preterm, term, or post-term birth of her 
child. These findings have been replicated and extended by Sandman and colleagues in 2006 
and have led researchers to propose that during pregnancy CRH functions as a “placental 
clock” timing the length of gestation and onset of labour (McLean et al., 1995; McLean & 
Smith, 1999). Moreover, in the more recent study of Sandman and colleagues (2006) the 
levels of plasma cortisol at 15 weeks of gestation were found to predict levels of placental 
CRH at 31 weeks (Sandman et al., 2006). This result along with those of other findings 
emphasize a potential role of the HPA axis in the association between prenatal stress and 
adverse pregnancy outcome. 
 
3.1.2 Adrenocorticotropin  
The maternal pituitary undergoes structural and functional alterations during 
pregnancy (Blackburn, 2010; Cunningham et al., 2010). It gains about 30% in weight and its 
volume doubles (Foyouzi et al., 2004). Over the course of gestation the release of ACTH from 
the pituitary increases but more slowly compared to plasma CRH  (Goland et al., 1994). A 
significant rise has been reported from 16 to 20 weeks onward reaching a maximum during 
birth (Carr, Parker, Madden, MacDonald, & Porter, 1981; McLean & Smith, 1999). Plasma 
ACTH levels in the umbilical cord at birth have been found to be lower than the levels in the 
maternal plasma (Carr et al., 1981).  
Despite the overall increase of plasma ACTH across pregnancy, contradicting 
findings have been found when basal ACTH levels were directly compared to those of healthy 
non-pregnant women (Lindsay & Nieman, 2005). While some findings have reported ACTH 
levels to be lower in comparison to healthy non-pregnant women (these levels were attributed 
to the suppressive effect of progesterones and oestrogens) (Carr et al., 1981), others have 
found increased levels that, nevertheless, remain within the non-pregnant range (De Weerth & 
Buitelaar, 2005b; Goland et al., 1994) Again others have found levels to be higher (De 
Weerth & Buitelaar, 2005b). The circadian rhythm of maternal ACTH is preserved during 
pregnancy (Carr et al., 1981; Lindsay & Nieman, 2005; Mastorakos & Ilias, 2003).  
 25 
 
Like CRH, ACTH is synthesized in the placenta as well and secreted into the 
maternal and foetal circulation (Cunningham et al., 2010). Its release is stimulated by 
placental CRH in a dose-dependent manner (Petraglia, Sawchenko, Rivier, & Vale, 1987). 
Though the physiological role of placental ACTH remains to be clarified (Cunningham et al., 
2010), it has been hypothesized to play an important role in stimulating the maternal and 
foetal HPA axes similarly to placental CRH and contributes to the augmented cortisol levels 
during pregnancy (Lindsay & Nieman, 2005; Waddell & Burton, 1993). Maternal ACTH, 
however, does not seem to be transferred to the foetus (Cunningham et al., 2010) 
 
3.1.3 Cortisol  
The increased release of ACTH from the maternal anterior pituitary stimulates the 
production and secretion of cortisol from the zona fasciculate of the adrenal glands (Wadhwa 
et al., 1997) and causes the glands to enlarge during gestation (Mastorakos & Ilias, 2003). 
Total plasma cortisol
10
 rises significantly above non-pregnant values from as early as 11 
weeks of gestation onwards (Demey-Ponsart, Foidart, Sulon, & Sodoyez, 1982), reaching a 
peak during the third trimester of pregnancy (Jung et al., 2011). Overall, total plasma cortisol 
levels during the second and third trimester of pregnancy have been found to be 2 to 3 times 
the values of non-pregnant women (Carr et al., 1981; Demey-Ponsart et al., 1982; Jung et al., 
2011). However, it has been suggested that it is not only an increase in the rate of cortisol 
secretion from the adrenal glands that is responsible for the hypercortisolism observed during 
pregnancy (Cunningham et al., 2010), but rather a reduced metabolic clearance of cortisol 
from the liver caused by an increased production of cortisol binding globulin (CBG) and 
thereby a doubling of the half-life of cortisol (Demey-Ponsart et al., 1982; Migeon, Bertrand, 
& Gemzell, 1961). The augmented production of CBG is a result of the placental induced 
increase in circulating oestrogens (Cunningham et al., 2010). Cross-sectional as well as 
longitudinal study designs, however, have shown that the concentration of free cortisol in the 
blood increases too, as does the concentration of urinary and salivary free cortisol (Jung et al., 
2011; Meulenberg & Hofman, 1990a). These findings therefore, point towards a general up-
regulation of the HPA axis and possibly also towards an increase in the rate of cortisol 
production (Jung et al., 2011). In line with the findings mentioned above, salivary free cortisol 
                                                          
10
  Total plasma cortisol is comprised of bound and unbound cortisol. 
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levels in third trimester pregnant women have been reported to be double as compared to non-
pregnant control women (Allolio et al., 1990).   
The circadian rhythm of cortisol is preserved during pregnancy (Allolio et al., 1990; 
Carr et al., 1981; Kivlighan, DiPietro, Costigan, & Laudenslager, 2008; Wadhwa et al., 1997) 
though it may possibly be dampened (Ditzen & Beinder, 2011; Lindsay & Nieman, 2005). 
As seen above, in the non-pregnant state, cortisol regulates the termination of the 
HPA axis response by a negative feedback mechanism. However during pregnancy, cortisol 
has a stimulating effect on the CRH production in the placenta (Jones & Challis, 1990; 
Robinson, Emanuel, Frim, & Majzoub, 1988) which leads to the establishment of a positive 
feedback loop (Ehlert, 2004). Yet, as also mentioned before, an overstimulation of the 
maternal HPA axis is prevented by the binding of CRH to CRH-BP. Furthermore, even 
though cortisol is capable of passing thought the placental barrier (Migeon et al., 1961), the 
foetus is to a certain extent protected from the increased levels of maternal glucocorticoids by 
the enzyme 11β-HSD2 present in the placenta that inactivates cortisol to cortisone (Edwards, 
Benediktsson, Lindsay, & Seckl, 1993; Giannopoulos, Jackson, & Tulchinsky, 1982; Seckl, 
2004; Seckl & Holmes, 2007).  
After birth the placenta is expelled from the body and the activity of the maternal 
HPA axis returns to its pre-pregnancy state (Mastorakos & Ilias, 2003). In a recent study, the 
total plasma cortisol and CBG levels remained elevated at 2 to 3 months postpartum 
compared to a non-pregnant control group whereas plasma free and urinary free 
concentrations returned to baseline levels (Jung et al., 2011). The authors suggested that this 
may be due to the presence of a pregnancy-specific form of CBG, the levels of which remain 
elevated up to 40 days after delivery either due to a prolonged biosynthesis (Strel'chyonok & 
Avvakumov, 1990) or due to its prolonged half-life (Sandberg, Woodruff, Rosenthal, 
Nienhouse, & Slaunwhite, 1964). 
Taken together, the levels of maternal CRH, ACTH and cortisol are increased during 
pregnancy due to the secretion of CRH from the placenta. No circadian variation of placental 
CRH has been detected to date, although it is released in a pulsatile fashion. Whether cortisol 
is increased because of the up-regulated HPA axis activity or because of its prolonged half-
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life (that is caused by an increase in CBG) is one of the questions future research needs to 
address.  
 
3.2 The Autonomic Nervous System During Pregnancy 
Many questions regarding the precise function of the ANS during pregnancy remain 
elusive (Fu & Levine, 2009). Early in pregnancy (approximately 5 to 6 weeks of gestation) 
vascular resistance decreases (Chapman et al., 1998; Cunningham et al., 2010; Fu & Levine, 
2009) possibly due to the vasodilatory effects of progesterone and oestrogen (De Weerth & 
Buitelaar, 2005b). As a result cardiac output increases between 30% to 50% (Fu & Levine, 
2009). Moreover, maternal blood volume increases progressively reaching levels of up to 45% 
above the pre-pregnant values at 32 to 34 weeks of gestation (Cunningham et al., 2010; 
Pritchard, 1965). This expansion in blood volume is termed hypervolemia and is the result of 
an increase in plasma and red blood cell volume. Pregnancy-induced hypervolemia serves the 
purpose of meeting the metabolic requirements of the enlarged uterus and of supplying the 
placenta and foetus with sufficient nutrients and micronutrients for growth, enabling blood to 
flow back to the heart when the mother is in a supine or erect position (protecting her from 
thromboembolic events) and safeguarding her from excessive blood loss at delivery 
(Cunningham et al., 2010; De Weerth & Buitelaar, 2005b).  
With regard to pregnancy-related alterations of the SAM system, results concerning 
NE and EPI are conflicting (De Weerth & Buitelaar, 2005b). One study found decreases in 
NE from approximately 13 weeks of gestation onwards whereas EPI levels did not change 
significantly (Wang, Zhang, & Zhao, 1999). Similarly, reduced NE levels were observed in 
near term pregnant women compared to their postpartum levels 41 weeks after delivery 
(Saisto, Kaaja, Helske, Ylikorkala, & Halmesmaki, 2004). By contrast, others found an 
increase in NE (Elenkov et al., 2001) and again others detected no significant changes in NE 
across the entire course of gestation (Chapman et al., 1998; Giannakoulopoulos, Teixeira, 
Fisk, & Glover, 1999).  
Arterial blood pressure falls gradually due to the decline in systemic vascular 
resistance. However, after reaching a nadir at 24 to 26 weeks of gestation, levels start to rise 
again until delivery (De Weerth & Buitelaar, 2005b; Hermida et al., 2000). In the following 
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paragraphs a short summary is given on the impact of pregnancy-induced alterations of the 
ANS on HR, HRV and sAA. 
 
3.2.1 Heart Rate 
The changes of the cardiovascular system become manifest from 6 to 8 weeks of 
gestation onwards although the development begins earlier (Cunningham et al., 2010; Stein et 
al., 1999). As the foetus grows and increasingly takes up space, the maternal diaphragm rises 
causing the heart to move towards the upper left side and rotate slightly on its long axis 
(Cunningham et al., 2010). HR begins to increase from 5 weeks of gestation onwards and as a 
result cardiac output
11
 begins to increase as well (Hunter & Robson, 1992). Between week 15 
to 18 HR values of about 79 beats per minute (bpm; SD = 16) have been reported (Moertl et 
al., 2009). At the end of pregnancy, cardiac output seems to reach a plateau and resting HR 
speeds up by 10 bpm or more and reaches values of approximately 88 to 96 bpm (Hunter & 
Robson, 1992; Moertl et al., 2009; Stein et al., 1999).  
In late pregnancy, the uterus pushes against the pelvic veins and the inferior vena 
cava, inhibiting venous return from the lower body (Cunningham et al., 2010). As a result 
heart rate, cardiac output, and also blood pressure are influenced by the position of the body 
(Cunningham et al., 2010; De Weerth & Buitelaar, 2005b). The cardiovascular system 
pursues a circadian rhythm during gestation (Koenen, Franx, Mulder, Bruinse, & Visser, 
2002; Stein et al., 1999). 
 
3.2.2 Heart Rate Variability 
Results concerning heart rate variability (HRV) are inconclusive although overall 
HRV appears to be attenuated during pregnancy (DiPietro, Costigan, & Gurewitsch, 2005; 
Ekholm & Erkkola, 1996; Ekholm, Piha, Antila, & Erkkola, 1993; Speranza, Verlato, & 
Albiero, 1998; Stein et al., 1999). The mean RR intervals and RR standard deviations have 
been found to be reduced in second trimester pregnant women compared to non-pregnant 
                                                          
11
  Cardiac output is defined as the quantity of blood (in litres) the heart is capable of pumping within one 
minute (particularly from the left ventricle into the aorta; Berntson et al., 2007). 
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women (Ekholm, Hartiala, & Huikuri, 1997; Ekholm et al., 1993). Moreover the high 
frequency (HF) component, which, as seen above, represents parasympathetic activity, seems 
to be decreased in comparison to the non-pregnant state (Ekholm et al., 1993; Tejera, Areias, 
Rodrigues, Nieto-Villar, & Rebelo, 2011; Voss et al., 2000). The low frequency (LF) 
component reflecting both sympathetic and parasympathetic modulation seems to be reduced 
as well with particular strong results for early and mid-pregnancy (Ekholm et al., 1997; Stein 
et al., 1999; Voss et al., 2000). But not all studies confirm this finding (Speranza et al., 1998; 
Tejera et al., 2011).  
As pregnancy progresses, HRV does not appear to change significantly (Moertl et al., 
2009; Speranza et al., 1998; Voss et al., 2000) although in a longitudinal study by DiPietro et 
al. (2005) a steady decline in RSA from 20 to 38 weeks of gestation was found. In addition to 
this, results of a cross-sectional study design report significant decreases in HF between 
second and third trimester pregnant women (Klinkenberg et al., 2009). Conflicting results also 
exist concerning changes in the balance between the sympathetic and parasympathetic (LF/HF 
ratio) branches during gestation. While some studies report no significant changes in the 
sympatho-vagal balance (Ekholm et al., 1997; Eneroth-Grimfors, Westgren, Ericson, Ihrman-
Sandahl, & Lindblad, 1994) others have found it to be reduced (Speranza et al., 1998). The 
circadian rhythm of HRV is preserved but may be reduced with regard to the HF component 
although findings in this respect are contradictory as well (Ekholm et al., 1997; Stein et al., 
1999).  
These conflicting results may be due to the great inter-individual differences in HRV 
(Stein et al., 1999) as well as to the many factors which have an impact on this marker such as 
BMI, prior food intake and smoking. Few studies have reported that they controlled for these 
factors. A further neglected factor in these studies is the psychological state of pregnant 
women, which has been shown to influence HRV. For example, a recent study demonstrated 
that women experiencing depression during pregnancy have reduced 24 hour SDNN levels of 
HRV as well as higher HR during sleeping hours (Shea et al., 2008). In addition to controlling 
for potential confounding variables, a more rigorous investigation of HRV across all 
gestational ages seems to be necessary.  
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3.2.3 Salivary Alpha-Amylase 
Few studies have investigated the activity of sAA during pregnancy. Previous 
findings from our workgroup (Nierop, Bratsikas, Klinkenberg et al., 2006a) found basal levels 
to be lowest in third trimester followed by the levels of second trimester pregnant women as 
compared to the non-pregnant state. Others, however, have detected no differences in sAA 
between late pregnant women (40 weeks of gestation) and a corresponding control group, 
even though sAA concentrations in early and mid-gestation were significantly increased 
(Salvolini, Di Giorgio, Curatola, Mazzanti, & Fratto, 1998). 
 
3.3 Summary 
The HPA axis during pregnancy is characterized by heightened activity due to the 
production of CRH in the placenta and secretion into the maternal blood. As a result, maternal 
plasma levels of CRH rise progressively from 8 weeks of gestation onward. It is believed that 
placental CRH stimulates the maternal (and foetal) HPA axis. Consequently, ACTH levels 
rise as well but whether they are increased in comparison to the non-pregnant state remains 
elusive. From 11 weeks of gestation plasma total cortisol levels increase as well. During the 
third trimester of pregnancy, salivary free cortisol concentrations are approximately twice the 
non-pregnant state. The foetus is protected from overexposure to maternal cortisol by the 
enzyme 11β-HSD2. In spite of this heightened functioning of the HPA axis, an over-
activation is curtailed by CRH-BP which bind to CRH and thereby diminishes its bioactivity. 
Then, at about 30 days prior to birth, CRH-BP levels drop by about 50% and the 
concentration of unbound CRH rises exponentially. Subsequently, the process of parturition is 
initiated. CRH has therefore been assumed the role of a placental clock which times the 
duration of pregnancy. Plasma CRH levels in second trimester pregnant women were found to 
be predictive of the onset of labour and delivery. As for the ANS, pregnancy seems to be 
associated with an increase in sympathetic activity (elevated HR) and a decrease in 
parasympathetic tone (reduced HRV). Findings with regard to sAA are limited and 
conflicting. The circadian rhythm of the HPA axis and ANS are preserved during gestation 
though possibly attenuated. 
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4. The Psychobiological Stress Response During Pregnancy 
After having discussed the changes the stress systems undergo during gestation the 
focus of the subsequent chapters will be on the dynamics of the psychobiological stress 
response in pregnant woman. Prior to this however, a brief overview will be given on the 
stressors that have been implemented by pregnancy research in order to examine stress. These 
stressors can be divided into naturalistic stressors that are investigated in everyday life or 
stressors that are examined in a standardized laboratory setting. 
 
4.1 Investigated Stressors During Pregnancy 
4.1.1 Natural Occurring Stressors 
Recently, Dunkel Schetter and Glynn (2011) conducted a review on the relationship 
between prenatal stress and different pregnancy outcome measures, such as gestational age, 
preterm birth, and low birth weight. The studies investigated this relationship under different 
naturalistic stress situations and the authors clustered these stressors according to the 
following four groups presented in Table 1. 
Most of the reviewed studies were able to show an association between these 
naturalistic stressors and adverse pregnancy outcome, but not all (Dunkel Schetter & Glynn, 
2011). For example, no study on daily hassles seemed to be significantly associated with 
gestational age at birth. However, what is more important with regard to psychobiological 
stress responses during pregnancy is that only a minority of the above mentioned studies 
included markers of the maternal HPA axis and the ANS when looking at pregnancy outcome. 
Besides, a potential naturalistic stressor that was not taken into account is the quality of the 
relationship between the pregnant woman and her partner. The investigation of partner 
relationship during pregnancy has generally been overlooked and systematic research is 
lacking (Dunkel Schetter, 2011) even more so with regard to its association with the maternal 
(and paternal) stress systems. 
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Table 1. Investigated Forms of Naturalistic Stressors During Pregnancy (Adapted from Dunkel-Schetter & Glynn, 2011) 
Episodic forms of stress - Major life events (e.g., loss of a loved one)  
- Catastrophic/traumatic events (e.g., exposure to the terrorist attacks 
on September 11, 2001, in New York City, or to the Chernobyl 
nuclear disaster) 
- Daily hassles 
Chronic forms of stress - Chronic strain (e.g., percentage/amount of time lived homeless, or 
household strain) 
- Appraised or perceived stress measured with the Perceived Stress 
Scale (S. Cohen, Kamarck, & Mermelstein, 1983) which is a non-
stressor specific questionnaire 
- Perceived racism 
- Neighbourhood- or community-level stress 
- Occupational stress 
Emotional stress - General or state anxiety (e.g., anxiety disorders during pregnancy, 
trait anxiety) 
- Depressed mood or symptoms of trauma (e.g., using questionnaires 
to measure depressive symptoms and symptoms of post traumatic 
stress disorder (PTSD)). 
- Other emotions/general distress (e.g., questionnaires on negative 
affect, worry, stress)  
Pregnancy-specific anxiety/stress This last cluster of stressors focused on distinct pregnancy related 
topics such as fear of labour. 
 
Since the above mentioned stressors were investigated with a main focus on 
pregnancy outcome rather than on the stress responsive systems, a summary is given in the 
following paragraphs on studies that have examined the impact of naturalistic stressors on the 
maternal HPA axis and ANS according to the clusters proposed by Dunkel Schetter and 
Glynn (2011).  
With regard to major life events, Obel et al. (2005) reported attenuated salivary 
morning cortisol levels in second trimester pregnant women confronted with stressful life 
events. Moreover, in late pregnancy, those pregnant women, who were more likely to be 
 33 
 
exposed to chronic stress because they had experienced more than one stressful life event, had 
higher salivary evening cortisol levels even though their morning cortisol levels remained 
inconspicuous (Obel et al., 2005). The authors suggested that these paradox findings might be 
attributed to alterations in the regulation of the HPA axis with progressing gestation.  
In the research of catastrophic/traumatic events during pregnancy, markers of the 
HPA axis or ANS have been little investigated in affected pregnant women, possibly due to 
the understandable ethical challenges related to such an investigation. Alternatively, several 
studies examined the HPA axis functioning in the children of affected pregnant women after 
they were born. For example, Yehuda et al. (2005) investigated one year old infants and their 
mothers who had directly experienced the World Trade Center collapse during pregnancy.  
The infants of mothers who had developed symptoms of PTSD 9 months after the 
traumatic experience had lower salivary cortisol levels than infants of mothers who had not 
developed symptoms of PTSD (Yehuda et al., 2005). This was especially so for infants of 
mothers, who were in their third trimester of pregnancy during the September 11 attacks. 
Similarly, Entringer and colleagues (2009) found that young adults whose mothers had 
experienced a severe life event (e.g., loss of a loved one, divorce) during pregnancy, showed 
dysregulated HPA axis responses to a psychosocial and pharmacological stress test compared 
to a control group. Serum cortisol baseline levels were elevated in the prenatally stressed 
group compared to the controls. In reaction to the psychosocial stress test, however, the 
prenatally stressed group exhibited a stronger increase of serum cortisol. Conversely, the 
cortisol response to the pharmacological stress test was lower in the prenatally stressed adults 
than in the controls. The circadian rhythm of cortisol however, did not differ significantly 
between the two groups (Entringer, Kumsta, Hellhammer, Wadhwa, & Wust, 2009). These 
findings imply that the maternal prenatal stress may have had programming effects on these 
young adults while they still were in their mother‟s womb. 
In association with chronic stress, a significant positive relationship was found 
between pregnant women‟s scores on the Perceived Stress Scale and the hair cortisol levels, a 
biomarker suggested for the use of measuring chronic stress (Kalra, Einarson, Karaskov, Van 
Uum, & Koren, 2007). Similar results have been reported by Wadhwa et al. (1999) for 
chronic stress and increased plasma ACTH concentrations at 28 weeks of gestation. With 
regard to occupational stress, urinary catecholamine levels, i.e. NE and EPI have been found 
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to be increased by 64% in third trimester pregnant women who were working under strenuous 
conditions compared to pregnant women who did not have such a stressful job (Katz, Jenkins, 
Haley, & Bowes, 1991). 
As for emotional stress and HPA axis or ANS dysregulations, Mancuso and her 
colleagues (2004) were able to show that plasma CHR levels between 28 and 30 weeks of 
gestation mediated the association between maternal prenatal anxiety and gestational age at 
birth (Mancuso, Schetter, Rini, Roesch, & Hobel, 2004). A study by Monk et al. (2011) 
revealed significantly higher HR baseline values in pregnant women diagnosed with an 
anxiety disorder compared to healthy pregnant control women. Furthermore, those pregnant 
women suffering from an anxiety disorder with a comorbid depression or comorbid PTSD 
showed higher cortisol baseline values. However, the groups did not differ with regard to 
blood pressure, respiration rate or HF-HRV (Monk et al., 2011). Moreover, Teixeira et al. 
(1999) reported that anxious pregnant women who were in their 32nd week of gestation had 
higher uterine artery resistance than non-anxious women (Teixeira, Fisk, & Glover, 1999). 
They suggested this to be indicative of an altered uteroplacental blood flow and possibly 
mediated by NE.  
Shea and colleagues (2007) observed no differences in the cortisol awakening 
response of pregnant women with depressed symptoms compared to healthy pregnant controls 
(Shea et al., 2007), but nevertheless significantly lower 24 hours HRV levels and increased 
HR during sleeping hours (Shea et al., 2008).  
Finally with regard to pregnancy-specific anxiety or stress, Saisto et al. (2004) found 
higher baseline levels of NE in 37 weeks pregnant women who suffered from fear of labour 
compared to pregnant women with no or only mild forms of fear. However, these findings 
were of only marginal statistical significance (Saisto et al., 2004). No significant differences 
between these two groups were observed regarding ACTH and cortisol baseline levels. 
The above listed studies of naturalistic stressors usually relied either on one-time 
measures of a certain biomarker, or examined its diurnal variation. This may be one reason for 
the partly conflicting results. However, valuable insight has been gained with these methods. 
Nevertheless, the psychobiological stress response cannot be captured this way. A naturalistic 
challenge with which the HPA axis stress reactivity can be measured, is the cortisol response 
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to awakening (CAR) which has also been examined during pregnancy (Buss et al., 2009; De 
Weerth & Buitelaar, 2005a; Entringer, Buss, Andersen, Chicz-Demet, & Wadhwa, 2011). 
Also, in order to measure the psychobiological stress response during pregnancy under real-
life conditions, researchers have investigated pregnant women‟s stress responses to medical 
examinations such as an amniocentesis
12
 (Glover, Bergman, Sarkar, & O'Connor, 2009; 
Sarkar, Bergman, Fisk, & Glover, 2006) or foetal blood transfusion (Gitau, Fisk, Teixeira, 
Cameron, & Glover, 2001). Findings with regard to the CAR and medical examinations 
during pregnancy will be presented in the chapters below. 
In conclusion, investigated naturalistic stressors seem to be associated with HPA axis 
and ANS dysregulations although only few studies to date have included the ANS in their 
research. The relationship seems to be especially evident with regard to major life events or 
catastrophic/traumatic events. Findings on emotional wellbeing during pregnancy are existent 
as well, but contradictory. More systematic research also across the different gestational ages 
is needed in order to interpret these findings accurately. Finally, to better understand how 
stress during pregnancy may lead to dysregulated physiological stress systems it is of central 
importance to examine the acute stress response during pregnancy under more controllable 
circumstances. For such an undertaking, standardized laboratory stress examinations are 
essential. 
 
4.1.2 Standardized Laboratory Stressors 
Standardized orthostatic challenges and physical exercise have been used to study the 
physiological reactivity during pregnancy such as cardiovascular reflexes (Ekholm & Erkkola, 
1996; Ekholm et al., 1993; Speranza et al., 1998). Though the findings from these studies 
have greatly furthered our insight in stress reactivity during pregnancy, psychobiological 
aspects have hardly been addressed therewith. Methods to investigate the psychological 
components of stress reactivity under standardized laboratory conditions are presented in the 
following paragraphs. 
                                                          
12
  An amniocentesis is an invasive medical procedure that tests whether the foetus has genetic defects or 
chromosomal abnormalities. A hollow needle is injected through a pregnant woman„s abdomen into the 
amniotic sac and a small amount of amniotic fluid is drawn. 
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In 2005, De Weerth and Buitelaar (2005) published a review on laboratory studies 
that had investigated the acute psychobiological stress response during pregnancy. The 
examined stressors focused on pain and discomfort, for instance by exposing pregnant women 
to white noise (Hartikainen-Sorri, Kirkinen, Sorri, Anttonen, & Tuimala, 1991), or the cold 
pressure test
13
 (Kammerer, Adams, Castelberg Bv, & Glover, 2002). Further investigated 
stressors included in the review were cognitive psychological stressors such as the mirror 
image tracing test
14
 (Matthews & Rodin, 1992) or the Stroop colour-word test
15
 (Monk, 
Myers, Sloan, Ellman, & Fifer, 2003; Nisell, Hjemdahl, Linde, Beskow, & Lunell, 1986). 
Some studies adapted the Stroop colour-word test combined with a mental arithmetic test (De 
Weerth & Buitelaar, 2005b; Monk et al., 2001). The most frequently measured biomarkers 
were blood pressure and heart rate and of the 15 reviewed studies, only 3 had investigated 
variables of the HPA axis. Furthermore, De Weerth and Buitelaar (2005) critically stated in 
their review that only few studies had included a non-pregnant control group. It also should be 
noted that the majority of studies compared the pregnant women‟s stress response during the 
third trimester and studies at earlier gestational ages are scarce. Moreover, few studies have 
assessed the HPA axis and ANS markers simultaneously in order to compare how the two 
stress systems react. Nevertheless, these studies have greatly contributed to a better 
understanding of the stress mechanisms during pregnancy.  
Six years have passed since De Weerth and Buitelaar (2005) published their review 
and more studies on the psychobiological stress response during pregnancy have emerged. 
Moreover, recent studies have begun to investigate pregnant women confronted with a 
standardized psychosocial stress provocation, such as the Trier Social Stress Test (TSST) 
(Kirschbaum et al., 1993). In this test situation, the participants are asked to give a 5 minute 
talk before an audience and perform a mental arithmetic task while being recorded on video. 
                                                          
13  The cold pressure test is a test where the participants have to immerse their hand or arm into an ice water 
container for usually one minute. 
14
  In the mirror image tracing test participants have to draw an outline of a figure while looking at it reversed 
through a mirror. 
15
  The Stroop colour-word test is a cognitively challenging test where colour words are printed in different 
colours than they read (for example, the word red is printed in blue; the word green is printed in yellow). 
These printed colour words are presented to the participants who have to read out load the words but not the 
colour print while under time pressure. 
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Using a wide range of standardized stress examinations is important, because different 
stressors seem to activate different stress systems (Dickerson & Kemeny, 2004; Kajantie & 
Phillips, 2006). The TSST, for example, is likely to evoke a strong response of the HPA axis 
and ANS, since it tends to elicit uncontrollability, ego involvement, and social-evaluative 
threat in the participants (Dickerson & Kemeny, 2004; Nierop, Bratsikas, Klinkenberg et al., 
2006a). On the other hand, the Stroop colour-word and the mirror image tracing test mainly 
stimulate the SAM system (Kajantie & Phillips, 2006). 
In the following two chapters an overview is given on the stress response of the HPA 
axis and ANS during pregnancy. 
 
4.2 Pregnant Women’s Stress Response and the Hypothalamus-Pituitary-Adrenal 
Axis  
As mentioned above, in their review De Weerth and Buitelaar (2005) found only few 
studies that measured HPA axis markers during pregnancy. In one study, pregnant women 
who were in their final weeks of gestation did not show any significant salivary cortisol 
increases in reaction to the cold pressure test, whereas non-pregnant control women did 
(Kammerer et al., 2002). This result points towards an attenuated HPA axis response during 
pregnancy. In the same way, no significant serum cortisol increases were found in response to 
the cold pressure test, however, neither in pregnant women at 37 weeks of gestation nor in 
non-pregnant control women (Saisto et al., 2004). Nevertheless and surprisingly, in the same 
study, significant ACTH increases were revealed compared to the control group contradicting 
the assumption of a stress-buffering effect during pregnancy and complicating a clear 
interpretation. Being exposed to white noise during late pregnancy did not induce any 
significant serum ACTH and cortisol reaction in a further study (Hartikainen-Sorri et al., 
1991) although no non-pregnant comparison group was included.  
Studies investigating the CAR during pregnancy found the response to be increased in 
comparison to the non-pregnant state due to increased baseline cortisol levels (De Weerth & 
Buitelaar, 2005a; Entringer et al., 2010). However, with advancing gestation the responses 
were more attenuated and less steep despite these higher cortisol baseline levels (Buss et al., 
2009; Entringer, Buss et al., 2011). Compared to the above mentioned controversial results, 
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these findings do suggest that the HPA axis response is dampened during pregnancy. 
Furthermore, a stronger increase in the CAR was associated with the length of gestation (Buss 
et al., 2009; Entringer, Buss et al., 2011), indicating a moderating role of the HPA axis in the 
association between prenatal stress and adverse pregnancy outcome. Further evidence for the 
impact of psychological stress on the physiological response during pregnancy comes from a 
study showing that pregnant women with higher scores on a childhood trauma questionnaire 
exhibited lower CAR (Shea et al., 2007).  
As for standardized psychosocial laboratory stressors such as the TSST, a summary 
of findings in this field is given in Table 1. In all studies, the stress situation induced 
significant psychological responses marked by an increase in state anxiety, psychological 
distress, and or a decrease in mood, thereby validating the effectiveness of the stressor 
(Entringer et al., 2010; Fink et al., 2010; Klinkenberg et al., 2009; Nierop, Bratsikas, 
Klinkenberg et al., 2006a; Nierop, Bratsikas, Zimmermann, & Ehlert, 2006b; Nierop, Wirtz, 
Bratsikas, Zimmermann, & Ehlert, 2008). Concerning the physiological stress response, a 
significant increase in cortisol was observed in second (Nierop, Bratsikas, Klinkenberg et al., 
2006a) and third trimester pregnant women (De Weerth, Wied, Jansen, & Buitelaar, 2007; 
Nierop, Bratsikas, Klinkenberg et al., 2006a). Higher cortisol responses in third compared to 
second trimester pregnant women were reported in one study due to the higher baseline levels 
of the third trimester pregnant women (Nierop, Bratsikas, Klinkenberg et al., 2006a) similar to 
the results on the CAR during pregnancy. Yet, the stress response in third trimester pregnant 
women was not blunted as compared to the second trimester, however the recovery from the 
stressor was prolonged in the second trimester group. This result may indicate that the second 
trimester is a particularly vulnerable period for stress during pregnancy (Nierop, Bratsikas, 
Klinkenberg et al., 2006a). In contrast to the above mentioned findings, Entringer et al. 
(2010), who adopted a longitudinal design, disclosed no significant cortisol responses to the 
TSST in pregnant women during the second trimester or the third trimester. There were also 
no significant responses in the control women. The authors attributed this result to their use of 
a modified version of the TSST protocol in which the participants were seated comfortably in 
a recumbent position and remained so during the entire study session (Entringer et al., 2010). 
This modification probably reduced the perception of stress in the participants and thereby the 
effect of the stressor. Similarly, Fink et al. (2010) found no significant serum cortisol 
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increases to a mental arithmetic test, but significant recovery reactions. This may possibly 
indicate anticipatory stress in the pregnant women, who as a consequence thereof arrived at 
the laboratory with cortisol concentrations already elevated. However, when the researchers 
divided the pregnant participants into responders and non-responders, they found that the 
responders tended to experience more work stress and also more stress in their personal lives 
(Fink et al., 2010).  
With regard to anticipating a medical procedure during pregnancy, findings for the 
HPA axis are limited and conflicting. In some studies, CRH and cortisol blood levels were not 
elevated in pregnant women who were either undergoing an amniocentesis, foetal blood 
sampling, or an intrauterine transfusion (Bartha, Martinez-del-Fresno, Romero-Carmona, 
Hunter, & Comino-Delgado, 2003; Gitau, Fisk, & Glover, 2004; Gitau et al., 2001). This may 
be due to the fact that most of the studies did not control for the psychological stress the 
women were experiencing, relied only on one-time measurements of glucocorticoids, and did 
not measure these biomarkers in control women or during a control condition. The point in 
time during gestation might play a role as well, as the following result indicates: Sarkar and 
colleagues (2006), found that elevated state anxiety levels were associated with elevated 
plasma cortisol levels, but only in pregnant women who were in the 17 week of gestation or 
earlier (Sarkar et al., 2006). No such relationship was found in pregnant women with more 
advanced gestational ages, indicating once more that the second trimester may be a vulnerable 
phase during pregnancy. But then again, Glover et al. (2009) observed a significant 
correlation between state anxiety and maternal plasma cortisol in pregnant women ranging 
from week 15 to 37 of gestation. Significant associations between plasma and amniotic fluid 
cortisol levels were apparent in the pregnant women‟s group that was most anxious. However, 
there were no direct associations between state anxiety and amniotic fluid cortisol (Glover et 
al., 2009). The authors suggested that the activity of the placental enzyme 11β-HSD2, which 
converts active cortisol into its inactive metabolite cortisone, may explain these findings 
(Glover et al., 2009). Animal studies have found that chronic prenatal stress may inhibit the 
activity of this enzyme, weakening the placental barrier and increasing the risk of maternal 
glucocorticoid overexposure to the developing foetus (Welberg, Thrivikraman, & Plotsky, 
2005). A parallel process has been hypothesised in human pregnancy and increased stress as 
well as anxiety may lead to a down-regulation in placental 11β-HSD2. 
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A further study that investigated how psychological aspect may influence the HPA 
axis response during pregnancy comes from our workgroup. Nierop et al. (2006b) found that 
women with more symptoms of a postnatal depression at 13 weeks postpartum, had already 
reacted with greater salivary cortisol increases to the TSST during pregnancy (Nierop, 
Bratsikas, Zimmermann et al., 2006b). Moreover, Nierop et al. (2008) observed a trend 
towards significance for greater self-efficacy in pregnant women to be associated with lower 
salivary cortisol responses (Nierop et al., 2008). This stress-buffering consequence of self-
efficacy seemed to be equally effective in both second as well as third trimester pregnant 
women. 
As a final point, baseline levels of the HPA axis markers as well as the stress 
response do not seem to be influenced by parity (Federenko et al., 2006). 
Overall, these findings, though conflicting, nevertheless point towards a blunted 
HPA axis response during pregnancy compared to the non-pregnant state. The second 
trimester may be a phase of increased vulnerability to the effects of the stress hormones. 
Obviously, further studies are needed in this field. Also, using the real-life stress experience 
of a medical examination may prove to be a valuable tool with which to investigate the HPA 
axis in pregnant women. In the next chapter, a short review on the stress response of the ANS 
during pregnancy is given. 
 
4.3 Pregnant Women’s Stress Response and the Autonomic Nervous System  
Compared to the HPA axis, autonomic changes in response to stress challenges 
during pregnancy have been more extensively investigated (De Weerth et al., 2007; DiPietro, 
Costigan, & Gurewitsch, 2003; DiPietro et al., 2005; Entringer et al., 2010; 
Giannakoulopoulos et al., 1999; Hatch et al., 2006; Klinkenberg et al., 2009; Matthews & 
Rodin, 1992; McCubbin et al., 1996; Monk et al., 2011; Monk et al., 2000; Monk et al., 2001; 
Monk et al., 2003; Monk et al., 2004; Nierop, Bratsikas, Klinkenberg et al., 2006a; Nierop et 
al., 2008; Nisell et al., 1986; Saisto et al., 2004). This is true in particular for HR and blood 
pressure whereas other biomarkers of the ANS such as HRV and sAA have been rather 
neglected.  
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Similar to the HPA axis, the question whether the stress response of the ANS is 
dampened during and possibly also with progressing pregnancy yields conflicting result. 
Certain findings point towards this direction despite overall increased baseline levels of the 
ANS markers (DiPietro et al., 2003, 2005; Entringer et al., 2010; Matthews & Rodin, 1992). 
For instance, Matthews and Rodin (1992) investigated women in response to a series of stress 
tasks before they became pregnant and then again during the second trimester of pregnancy. 
Their values were subsequently compared to a non-pregnant control group. The stress tasks 
consisted of a mental arithmetic task, a mirror image tracing task and an isometric handgrip 
exercise. After adjusting the data for baseline levels, the results revealed lower diastolic and 
systolic blood pressure responses, as well as lower HR responses compared to non-pregnant 
control women (Matthews & Rodin, 1992). Likewise in a longitudinal investigation, DiPietro 
and her team (2003) found maternal skin conductance
16
 and HR responses to the Stroop 
colour-word task to be diminished at 36 weeks of gestation compared to 24 weeks (DiPietro et 
al., 2003).  
Not all studies, however, have detected such an attenuation of the ANS reactivity 
across gestation (De Weerth et al., 2007; Klinkenberg et al., 2009; Nierop, Bratsikas, 
Klinkenberg et al., 2006a). These studies all used the TSST as stressor, which is why 
researchers suggested that the stressful nature of the TSST may be strong enough to provoke a 
response at all stages of pregnancy (De Weerth et al., 2007). In line with this hypothesis, 
Entringer and colleagues (2010) who used a milder variation of the TSST, indeed found HR 
responses in later pregnancy to be dampened compared to earlier stages (Entringer et al., 
2010). However, this hypothesis obviously needs further confirmation. The findings on the 
ANS responses to psychosocial stress are listed in Table 1.  
The only known study that investigated sAA levels to a psychosocial challenge 
during pregnancy was conducted by Nierop and colleagues (2006a). The stress response of 
sAA was blunted in both second and third trimester pregnant women compared to the non-
pregnant group. In line with the results mentioned above, no differences were apparent 
between the two trimesters (Nierop, Bratsikas, Klinkenberg et al., 2006a). Similar to the 
protective effect of psychological resources on the HPA axis reactivity, self-efficacy and also 
                                                          
16  In response to stress, the skin‟s ability to conduct electricity changes and these changes can be measured by 
applying electrodes to the skin (Dawson, Schell, & Filion, 2007). 
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daily uplifts had a stress-dampening effect on pregnant women‟s sAA responses to the TSST 
(Nierop et al., 2008) – a finding further emphasizing the importance of offering stress 
prevention programs to pregnant women. 
As with sAA, the investigation of HRV responses to psychological stress during 
pregnancy has been mostly neglected. Klinkenberg et al. (2008) observed in their study that 
HF power decreased in reaction to the TSST. This was more strongly so for third trimester 
pregnant women than for second and non-pregnant control women. At the same time, no 
significant changes were revealed for the LF component of HRV in pregnant or in non-
pregnant women and the LF/HF ratio increased, equally however in all groups (Klinkenberg 
et al., 2009).   
ANS responses in pregnant women undergoing a medical examination have to date 
hardly been investigated (see Table 2). In a study conducted by Giannakoulopoulos et al. 
(1999) NE levels in pregnant women between 18 and 37 weeks of gestation increased 
significantly in response to foetal blood sampling (Giannakoulopoulos et al., 1999). On the 
contrary, Bartha and colleagues (2003) found no significant NE or EPI differences between 
second trimester pregnant women anticipating an amniocentesis and pregnant control women 
(Bartha et al., 2003).  
Taken together, several studies indicated that the stress response of the ANS markers 
such as HR and blood pressure may be dampened during pregnancy, although contradictory 
findings exist as well. For example, the HR response has even been found to be higher in 
comparison to non-pregnant women. The reported attenuation of the ANS stress response 
during pregnancy may therefore, depend on the nature of the investigated stressor, as the 
findings with regard to the TSST suggest. Current data on HRV, sAA and catecholamine 
reactivity (NE and EPI) in pregnant women are insufficient for a precise interpretation of the 
stress response mechanisms during pregnancy. 
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Table 2. Maternal Psychosocial Stress Response During Pregnancy  
Study Subjects 
(stage of pregnancy) 
Stressor Main results: 
Psychological response 
  
 
Physiological response 
   Anxiety 
Stress response 
Stress 
Stress response 
Mood 
Stress response 
 HPA 
Stress response 
 
Baseline  
ANS 
Stress response 
 
Baseline 
Nierop 
et al. (2006a) 
 
 
 
 
EG1: n = 30 (13-18 weeks) 
EG2: n = 30 (26-31 weeks) 
CG:  n =  30  
TSST  
 
STAI-s↑: 
EG1 ≈ EG2 ≈ 
CG 
 
Perceived stressfulness↑: 
EG1 ≈ EG2 ≈ CG 
 
MDBF↓: 
EG1 ≈ EG2 ≈ 
CG 
 
 
SalF↑: 
EG2 > EG1, CG 
Recovery:  
EG2 > CG 
 
SalF: 
EG2 > EG1, CG 
 
HR↑:  
EG1 ≈ EG2 ≈ CG 
sAA↑: 
CG > EG1, EG2 
 
HR: 
EG2 > EG1, CG 
sAA: 
EG2 > EG1, CG 
 
Nierop  
et al. (2006b) 
 
 
 
 
 
 
n =57 (13-31 weeks): 
EG1: n = 16 high EPDS at 13 
weeks postpartum 
EG2: n =  41 low EPDS at 13 
weeks postpartum 
 
TSST  
 
STAI-s↑:  
EG1> EG2 
 
 MDBF↓: 
EG1< EG2 
 
 SalF ↑: 
EG1> EG2 
 
SalF: 
EG1 ≈ EG2 
 
  
De Weerth  
et al. (2007) 
EG: n =  120 (32.8 ± 1.1 weeks) 
CG: n =  31 
EG: Public speaking 
and mental 
arithmetic task  
CG: Public speaking 
only 
 
 
 
   SalF ↑: 
EG ≈ CG 
 HR↑: 
EG ≈ CG  
SBP↑; DBP↑ 
BP was not 
measured in the 
CG 
 
 
Nierop  
et al. (2008) 
 
 
 
 
 
 
 
 
 
 
 
 
EG1: n = 30 (13-17 weeks)  
EG2: n = 30 (26-31 weeks)  
TSST  STAI-s↑:  
EG1 ≈ EG2  
↑Self-efficacy  
↓STAI-s 
EG1 ≈ EG2  
 
 
Perceived stressfulness↑: 
EG1 ≈ EG2  
↑Self-efficacy 
↓Perceived stressfulness 
Trend: ↑Daily uplifts  
↓Perceived stress  
MDBF↓: 
EG1 ≈ EG2  
↑Self-efficacy  
↑MDBF 
EG1 ≈ EG2  
 
 SalF ↑:  
EG1 ≈ EG2  
Trend: ↑Self-
efficacy  
↓ SalF 
EG1 ≈ EG2  
 
 sAA↑: 
EG1 ≈ EG2  
↑Self-
efficacy↓AA 
reactivity 
EG1 ≈ EG2  
↑Daily 
uplifts↓AA 
reactivity  
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Table 2 (continued). 
 
Klinkenberg  
et al. (2009) 
EG1: n = 28 (13-18 weeks) 
EG2: n = 27 (26-31 weeks) 
CG:  n = 24 
TSST  
 
Perceived stressfulness↑: 
EG1 ≈ EG2 ≈ CG 
 
    
HR↑: 
EG1 ≈ EG2 ≈ CG 
HRV: 
HF↓: 
EG2 < EG1, CG 
LF→: 
Trend: EG2: LF↑; 
EG1: LF→; CG: 
LF↓ 
HR: 
EG2 > EG,  CG 
HRV: 
HF: 
EG2 < EG1, CG 
LF: 
EG2 < EG1, CG 
 
         LF/HF ratio↑: 
EG1 ≈ EG2 ≈ CG 
 
 
Entringer  
et al. (2010) 
n =148: 
T1 (17 weeks) vs. T2 (31 
weeks); 
CG: n = 36 
CGT1 vs. CGT2  
 
Modified TSST (at 17 
and again at 31 
weeks) 
 
 Psychological distress↑ : 
T1>T2 
CGT1 ≈ CGT2 
 
  SalF → : 
T1, T2 → 
CGT1, CGT2→ 
 
SalF: 
T1 < T2 
HR↑: 
T1 > T2 
CGT1 ≈ CGT2 
MAP↑: 
T1 > T2 
CGT1 ≈ CGT2 
 
HR : 
T1 < T2 
 
MAP : 
T1 ≈ T2 
Fink 
et al. (2010) 
EGtotal: n = 25 
(30 ± 1.4 weeks) 
EG1: n = 13 responders  
EG2: n = 12 non-responders 
Mental arithmetic task  Psychological distress↑  
EG1 ≈ EG2  
 
  Serum F:  
EG total→ 
Recovery↓  
EG1↑; EG2→ 
 
Plasma CRH: 
EG1 ≈ EG2  
 
 
 
 
  
Psychological response measures: EPDS = Edinburgh Postnatal Depression Scale; MDBF = Multidimensional Mood Questionnaire; MESA = Measure for Assessment of General Stress Susceptibility; STAI = State-Trait 
Anxiety Inventory (STAI-s = state anxiety; STAI-t = trait anxiety). 
Physiological reactivity measures: ANS = autonomic nervous system: sAA = salivary alpha-amylase, HR = heart rate; HRV = heart rate variability (HF = high frequency power, LF = low frequency power); SBP = systolic blood 
pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; HPA = hypothalamic-pituitary-adrenal-axis: SalF: salivary cortisol. 
↑ = significant increase in response to stress, ↓ = significant decrease in response to stress, → = no significant increases in response to stress; ≈ = no significant differences; > = significantly greater compared to; < = significantly 
lower compared to;  = significant effect on;  = no significant effect on; EG = experimental group, CG = control group, T = time. 
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Table 3. Psychobiological Effects in Pregnant Women Anticipating a Standardized Medical Procedure During Pregnancy 
Study Subjects 
(stage of pregnancy) 
Stressor Main results: 
Psychological 
response  
 
 
Physiological response 
Anxiety  HPA ANS Other 
Giannakoupoulos et 
al. (1999) 
 
N = 41 pregnant women 
(18-37 weeks) 
Foetal blood sampling 
   
NE↑  
 
Gitau et al. 
(2001) 
 
n = 51 pregnant women 
(22-35 weeks) 
Foetal blood 
sampling/ intrauterine 
transfusion 
  Plasma F→   
Bartha et al. 
 (2003) 
EG: n = 10  
(15 weeks)  
CG: n = 10 pregnant 
women 
(15 weeks) 
Amniocentesis STAI-s: 
EG > CG 
STAI-t: 
EG ≈ CG 
 
 Serum F: 
EG ≈ CG 
Serum ACTH: 
EG < CG 
NE; EPI; D 
EG ≈ CG 
 
Glucose; insulin; T3; T4; 
TSH: 
EG ≈ CG 
 
Gitau et al. 
(2004) 
 
n = 8 pregnant women 
(17-38 weeks) 
Foetal blood 
sampling/ intrauterine 
transfusion 
  Plasma CRH→   
Sarkar et al.  
(2006) 
 
EG: total n = 254 
(15-37 weeks) 
EG1: n = 174 (≤ 17weeks) 
EG2: n = 80 ( > 17 weeks) 
CG: n = 605 pregnant 
women  
(20.5± 1.1 weeks) 
 
Amniocentesis STAI-s: 
EG > CG 
STAI-t: 
EG ≈ CG 
 Plasma F not measured in CG 
Correlation between STAI-s and Plasma 
F: 
EG1: ↑STAI-s  ↑Plasma F 
EG2: ↑STAI-s  ↑ Plasma F 
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Table 3 (continued). 
Glover et al.  
(2009) 
262 pregnant women  
(15-37 weeks) 
STAI-s: 
EG1: n = 60 (least anxious) 
EG2: n = 71 (2nd quartile) 
EG3: n = 69 (3rd quartile) 
EG4: n = 62 (most anxious) 
STAI-t: 
EG1: n = 64 (least anxious) 
EG2: n = 64 (2nd quartile) 
EG3: n = 67 (3rd quartile) 
EG4: n = 67 (most anxious) 
Amniocentesis 
  
Results for STAI-s: 
Correlation between Plasma F and AFF: 
EG1: Plasma F  AFF 
EG4: Plasma F↑  AFF↑ 
EG1<  EG3, EG4 
Correlation between STAI-s and AFF: 
STAI-s  AFF 
Correlation between STAI-s and plasma 
F: 
STAI-s↑  pCort↑ 
 
Results for STAI-t: 
Correlation between Plasma F and AFF: 
EG1: plasma F  AFF 
EG2: plasma F ↑  AFF↑ 
EG3: plasma F ↑  AFF↑ 
EG4: plasma F ↑  AFF↑ 
EG1< EG4 
  
Psychological response measures: STAI = State-Trait Anxiety Inventory (STAI-s = state anxiety; STAI-t = trait anxiety). 
Physiological reactivity measures: ANS = autonomic nervous system: NE = norepinephrine, EPI = epinephrine, D = dopamine; HPA = hypothalamic-pituitary-adrenal-axis: CRH = corticotrophin 
releasing hormone; ACTH = adrenocorticotropic hormone; AF = amniotic fluid; F = cortisol; Other: T3 = triiodothyronine; T4 = thyroxine; TSH = thyroid-stimulating hormone. 
↑ = significant increase in response to stress, ↓ = significant decrease in response to stress, → = no significant increases in response to stress; ≈ = no significant differences;  
> = significantly greater compared to; < = significantly lower compared to;  = significant effect on;  = no significant effect on; EG = experimental group, CG = control group, T = time. 
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4.4 Summary 
A majority of studies that have examined whether prenatal stress is associated with a 
dysregulated HPA axis or ANS have focused on natural occurring stressors, ranging from 
episodic forms of stress such as major life events to chronic stress, emotional stress and 
pregnancy-specific anxiety. Though many but not all have found associations between 
maternal prenatal stress and evidences of HPA axis and ANS dysregulations, their results are 
largely based on one-time measurements or diurnal variations and not on the stress response 
per se. This fact may explain some of the conflicting results. The CAR and the stress response 
to medical examinations may provide more standardized research methods. Frequently 
examined psychological laboratory stressors include the cold pressure test, the Stroop colour-
word task, the mental arithmetic test and more recently psychosocial stress tasks, such as the 
TSST. Pregnant women‟s stress response has for the most part been investigated during the 
last weeks of gestation. Fewer studies have looked at earlier stages. Yet, findings indicate that 
these earlier stages may be more vulnerable to stress. Certain findings suggest that compared 
to non-pregnant women, the stress response of the HPA axis is dampened in pregnant women 
despite elevated baseline levels of these markers with progressing gestation. However, not all 
studies have been able to confirm such a dampening effect of pregnancy on the reactivity of 
the HPA axis and many questions remain as yet unanswered. Likewise, the ANS response to 
stress seems to be attenuated, but conflicting findings exist here as well. Though HR and 
blood pressure have been more extensively measured, studies on HRV and sAA are greatly 
lacking. Moreover, very few studies have examined how the reaction of the stress systems 
unfolds in pregnant women undergoing a medical examination.  
Investigating pregnant women under standardized conditions is important because it 
provides more accurate information about how the psychobiological stress response develops 
in general and is indicative of how pregnant women may commonly react to stress in every-
day life. Understanding the stress response during pregnancy is also a first essential step in the 
investigation of how maternal prenatal stress may reach the developing foetus. The recent 
finding of an association between human maternal plasma and amniotic fluid cortisol levels as 
a function of maternal anxiety (Glover et al., 2009) points in this direction. The role of the 
placental enzyme 11β-HSD2 in this association is discussed in the following chapter. 
 48 
 
5. The Role of 11β-Hydroxysteroid Dehydrogenase Type 2 During Human 
Pregnancy 
Cortisol and other glucocorticoids play a vital role during human pregnancy by: 
1. supporting the maternal hormonal and metabolic adaption to pregnancy-related 
physiological changes,  
2. furthering the development and maturation of foetal membranes, and by 
3. regulating the timing of delivery (Burton & Waddell, 1999; Ehlert et al., 2003; 
McLean & Smith, 1999).  
As discussed above, the maternal HPA axis undergoes extensive alterations with 
advancing gestation marked by an increase in cortisol levels (Ehlert et al., 2003; Lindsay & 
Nieman, 2005; Mastorakos & Ilias, 2003). The placenta contributes significantly to this up-
regulation as it also expresses CRH (Campbell et al., 1987; Grino et al., 1987; McLean & 
Smith, 1999). Despite the essentially favourable effect of glucocorticoids on mother and 
foetus, an overexposure, for example due to prenatal stress, has been linked to adverse foetal 
development, such as preterm delivery and reduced birth weight as seen above (Dunkel 
Schetter, 2011; Mancuso et al., 2004).  
Even though glucocorticoids are lipophilic and therefore able to cross the placental 
barrier (Seckl & Holmes, 2007), foetal cortisol concentrations have been found to be 8 to 28 
times lower than maternal cortisol values (Dormer & France, 1973; Gitau, Cameron, Fisk, & 
Glover, 1998; Sarkar, Bergman, Fisk, O'Connor, & Glover, 2007). This has been ascribed to 
the activity of the placental enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), 
which catalyses the rapid inactivation of cortisol into its inert metabolite, cortisone 
(Benediktsson, Calder, Edwards, & Seckl, 1997; Harris & Seckl, 2011; Holmes et al., 2006). 
This enzyme and its role in human pregnancy is presented in more detail in the subsequent 
paragraphs. 
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5.1 Characteristics, Biological  Function and Tissue Distribution of 11β-
Hydroxysteroid Dehydrogenase  
11β-Hydroxysteroid Dehydrogenase (11β-HSD; EC17 1.1.1.146) is a family of 
enzymes widely distributed in almost all organs of the body and located in the endoplasmic 
reticulum of the cell (Monder & White, 1993; Odermatt, Arnold, Stauffer, Frey, & Frey, 
1999). It was long believed that only one form of this enzyme existed. However, since then 
two isoforms have been detected and cloned in humans (Murphy, Smith, Giles, & Clifton, 
2006; Stewart, Whorwood, & Mason, 1995; Tannin, Agarwal, Monder, New, & White, 1991). 
These have been termed 11β-HSD1 and 11β-HSD2. The prior assumption of the existence of 
only one isoform caused somewhat of a confusion in the scientific community that was 
investigating the activity of 11β-HSD at that time. The characteristics and the biological 
functions that were attributed to the first isoform, later turned out to be the properties of the 
second isoform. In other words, both the activities of 11β-HSD1 and 11β-HSD2 were for a 
time being ascribed to 11β-HSD1.  
What follows in this chapter is a short description of the characteristics of the main 
11β-HSD family, an explanation of how the investigation of the enzyme in humans began 
and, finally, a presentation of the biological function and tissue distribution of both 11β-
HSD1 and 11β-HSD2. It is important to note, that the present thesis focuses mainly on the 
activity of the enzyme that is more relevant to the empirical studies, namely, 11β-HSD2. 
Nevertheless, in order to understand the enzyme fully the activity of 11β-HSD1 is described 
here as well. 
The 11β-HSD enzyme family belongs to the hydroxysteroid dehydrogenase (HSD) 
class of enzymes which are involved in the final phases of steroid biosynthesis and the 
regulation of the  quantity of steroid hormones that gain access to their particular receptors 
(Penning, 1997). The HSD class of enzymes, in turn, belongs to the short-chain 
dehydrogenase/reductase superfamily of proteins (Penning, 1997; Stewart, Whorwood et al., 
1995). The 11β-HSD family functions to catalyse the interconversion of active cortisol into 
hormonally inactive cortisone (Stewart, 1994; Stewart, Whorwood et al., 1995). Through this 
action it controls the access of cortisol to the glucocorticoid as well as to the 
                                                          
17
  EC = Enzyme commission number 
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mineralocorticoid receptors (Stewart et al., 1994). 11β-HSD has therefore also been referred 
to as a molecular gatekeeper (Michael, Thurston, & Rae, 2003; Williams, 1992).  
The investigation of the biological function of 11β-HSD in humans began with 
clinical observations in patients with an 11β-HSD2 deficiency, such as in the congenital 
syndrome of apparent mineralocorticoid excess (AME) or following excessive liquorice 
ingestion, which provokes an inhibition of the enzyme (Edwards et al., 1988; Stewart, 1994). 
Because it was assumed that only one isoform existed, it was, at first, believed that patients 
with AME were lacking 11β-HSD1 when essentially they were lacking 11β-HSD2. As 
discussed above, mineralocorticoids like aldosterone play an important role in the retention of 
salt by binding to the MRs. However, in mineralocorticoid target tissues, such as the kidney, 
parotid, and colon, MRs are non-selective receptors and bind with equal affinity to 
glucocorticoids as well as mineralocorticoids (Funder et al., 1988). This means that 
glucocorticoids, which are present in the circulation at concentrations 100 to 1000 times 
higher than aldosterone (Brown, Chapman, Edwards, & Seckl, 1993; Edwards et al., 1988; 
Funder et al., 1988), can easily access the MRs and thereby induce an overstimulation of salt 
retention (Figure 3). Such is the case in patients with AME. As a result, they are affected by 
increased water absorption, heightened blood pressure and decreased potassium levels 
(Michael et al., 2003; Stewart, 1994; Stewart, Corrie, Shackleton, & Edwards, 1988). Similar 
symptoms are induced by high doses of glycyrrhetinic acid, the main ingredient of liquorice, 
because it inhibits 11β-HSD2 activity18 (Stewart et al., 1987; Van Uum et al., 2002).  
 
 
 
 
 
 
                                                          
18  Glycyrrhetinic acid inhibits the activity of 11β-HSD1 as well (Morris, Latif, Hardy, & Brem, 2007). 
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Figure 3.  Regulation of the access of aldosterone to the mineralocorticoid receptor by 11β-HSD2 
(Adapted from Michael, Thurston, & Rae, 2003). 
 
11β-HSD1 is a dehydrogenase/oxoreductase, which means that it has bidirectional 
properties and is able to convert cortisol to cortisone and vice versa. For this action it is 
dependent on a molecule called nicotinamide adenine dinucleotide phosphate 
(NADPH/NADP
+
) as cofactor
19
 (Michael et al., 2003; Seckl & Walker, 2004). In spite of its 
bidirectional properties and unless cells are damaged, 11β-HSD1 mainly acts as an 
oxoreductase (11β-reduction) and converts cortisone to cortisol20 (product), due to its higher 
affinity for cortisone as compared to cortisol (Hundertmark et al., 2001; Murphy et al., 2006; 
Seckl & Walker, 2001; Stewart et al., 1994). 11β-HSD1 activity was first detected in rat liver 
(Agarwal, Monder, Eckstein, & White, 1989; Monder & White, 1993). Its primary role is to 
enhance the accessibility of glucocorticoids for the glucocorticoid receptor (GR) 
(Hundertmark et al., 2001; Murphy et al., 2006). 11β-HSD1 is therefore expressed in human 
glucocorticoid target tissues such as the liver, lung, adipose tissue, gonad, cerebellum, 
decidua, ovary (Ricketts et al., 1998; Stewart, Whorwood et al., 1995), chorion and amnion 
(Sun, Yang, & Challis, 1997b). 11β-HSD1 activity has been detected in certain cell layers of 
                                                          
19
  In order to be active an enzyme requires small molecules which are termed cofactors. These cofactors deliver 
the energy to drive biosynthetic processes (Insel, Ross, McMahon, & Bernstein, 2011). 
20
   In other words, the main product of 11β-HSD1 is cortisol. 
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the human placenta such as placental endothelial cells and the intermediate trophoblast
21
 
(Alfaidy, Gupta, DeMarco, Caniggia, & Challis, 2002; Alfaidy, Li, MacIntosh, Yang, & 
Challis, 2003; Sun, Yang, & Challis, 1997a). In addition, 11β-HSD1 seems to also be present 
in very small amounts in the syncytiotrophoblast of the placenta, the site of maternal-foetal 
interface. The activity of the second isoform, 11β-HSD2, predominates by approximately 14 
fold in these cells (Alfaidy et al., 2003; Arcuri et al., 1998). What is more, in a study where 
term placentas were perfused with cortisone, no conversion to cortisol was detected 
(Benediktsson et al., 1997). The human gene that encodes 11β-HSD1 is HSD22B1 which is 
located on chromosome 1 (Tannin et al., 1991; White, Mune, & Agarwal, 1997).  
 Until the point when 11β-HSD2 was detected, it was thought that the 11β-HSD1 
isoform was responsible for conferring specificity to the MR. However, different findings, 
such as a low affinity of 11β-HSD1 for cortisol (which is necessary for inactivating it), the 
fact that 11β-HSD1 principally catalyses cortisone into cortisol, and a lack of 11β-HSD1 gene 
mutations in patients with AME, led researchers to assume that a second isoform exists 
(Brown et al., 1993; White et al., 1997). 
11β-HSD2 was first detected and identified in rabbit kidney (Rusvai & Naray-Fejes-
Toth, 1993) as well as in human kidney and placenta showing high affinity for cortisol 
(Albiston, Obeyesekere, Smith, & Krozowski, 1994). It demonstrates unidirectional properties 
by exclusively catalysing the dehydrogenase reaction and converting active cortisol into 
inactive cortisone
22
 (Albiston et al., 1994; Rusvai & Naray-Fejes-Toth, 1993; Stewart et al., 
1994). In contrast to 11β-HSD1, which requires NADPH as an enzyme cofactor, 11β-HSD2 
requires nicotinamide adenine dinucleotide (NAD
+
) (Brown et al., 1993). 11β-HSD2 is 
encoded by the gene HSD11B2, located at chromosome 16 (Agarwal, Rogerson, Mune, & 
White, 1995), and shares only 14% identity with the gene that encodes 11β-HSD1 (Albiston 
et al., 1994). A comparison between 11β-HSD2 and 11β-HSD1 is presented in Table 4. 
 
 
                                                          
21
  The vasculature of the human placenta that contains maternal blood is lined by endothelial cells, which are of 
maternal origin and trophoblast cells which are of foetal origin. Maternal and foetal blood remain separate 
this way (Weiler & Sood, 2007).   
22
  This means that the main product of 11β-HSD2 activity is cortisone. 
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Table 4. Comparison of 11β-HSD2 and 11β-HSD1 (Adapted from Michael, Thurston, & Rae, 2003 and from 
Seckl, 1997) 
 11β-HSD2 11β-HSD1 
Gene HSD11B2 HSD22B1 
Chromosome 16 1 
Enzyme cofactor NAD
+
 only NADPH/NADP
+
 
Affinity to cortisol High Low 
Direction Unidirectional: 
11β-dehydrogenase only (inactivating) 
Bidirectional: 
11β-reduction > 11β-dehydrogenase  
(activating > inactivating) 
Tissue distribution Placental syncytiotrophoblast, kidney, 
adrenal, colon, pancreas, skin, salivary 
and sweat glands,  ovary, prostate and 
testis 
Liver, lung, adipose tissue, gonad, 
cerebellum, decidua, ovary, chorion, 
amnion, placental endothelial cells and 
intermediate trophoblast 
 
 
In the syncytiotrophoblast of the placenta, 11β-HSD2 protects the foetus from 
overexposure by maternal glucocorticoids (see Figure 4). As a consequence cortisol levels in 
the foetal system have been found to be 8 (cord blood) (Dormer & France, 1973), between 
11.4 and 13 (foetal blood) (Gitau et al., 1998; Gitau et al., 2004) and 28 times (amniotic fluid) 
(Sarkar et al., 2007) lower than maternal levels. The ability of placental 11β-HSD2 to 
metabolize cortisol is enormous. Cortisol levels in the maternal blood are greater compared to 
cortisone levels, but this ratio is reversed in the foetal system where cortisone predominates 
(Bro-Rasmussen, Buus, & Trolle, 1962). Benediktsson et al. (1997) reported a great inter-
individual variability in the placental ability to convert cortisol to cortisone with a minimum 
conversion of 50%  (Benediktsson et al., 1997). They conducted their analyses by obtaining 
term placentas after delivery, perfusing the maternal circuit with cortisol and analysing the 
foetal effluent. By use of a similar method, Dancis et al. (1978) found that approximately 85% 
of cortisol was converted to cortisone (Dancis, Jansen, Levitz, & Rosner, 1978). Beitins et al. 
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(1973) administered isotopically labelled cortisol and cortisone by continuous infusion to 
pregnant women before elective caesarean section and calculated the amount of cortisol and 
cortisone that had attained the foetus from the concentration of these compounds in the 
maternal plasma and umbilical cord. They found that 90% of the cortisone and only 25% of 
the cortisol in the foetus was of maternal origin (Beitins, Bayard, Ances, Kowarski, & 
Migeon, 1973). 
Placenta 11β-HSD2 activity has been detected from 5 to 6 weeks of gestation onward 
(Arcuri et al., 1998; Hirasawa et al., 2000; Krozowski et al., 1995). Whether its activity 
increases with progressing gestation is unclear (Murphy et al., 2006). Some have found a 
decrease from early to late gestation (Giannopoulos et al., 1982; Kajantie et al., 2003) with a 
simultaneous rise in 11β-HSD1 activity toward term (Murphy & Clifton, 2003). Yet again, 
others have found a general increase in 11β-HSD2 activity and mRNA quantity (Schoof et al., 
2001; Shams et al., 1998).  
 
 
Figure 4.  The maternal and foetal HPA axes and placental 11β-HSD2 activity (Adapted from Ehlert 
et al., 2003 and Drake et al., 2007). 
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From 8 weeks of gestation onwards 11β-HSD2 activity but not 11β-HSD1 activity 
has been detected in human foetal tissues as well (Condon et al., 1998; Pasqualini, Nguyen, 
Uhrich, Wiqvist, & Diczfalusy, 1970). These include the kidney, lung, gonad, liver, adrenal, 
and colon (Coulter et al., 1999; Murphy, 1981; Stewart et al., 1994; Stewart, Whorwood et al., 
1995). The ratio of cortisone to cortisol in the amniotic fluid has been found to increase from 
20 to 35 weeks of gestation indicating higher 11β-HSD2 activity in the foetal system with 
progressing gestation (Hundertmark et al., 2001). This result may imply that the foetus is 
more vulnerable to maternal stress in the earlier stages of pregnancy. 
 
5.2 Placental 11β-Hydroxysteroid Dehydrogenase Type 2 and Maternal Prenatal 
Stress  
As seen above, placenta 11β-HSD2 mainly functions as a barrier to control the 
amount of maternal cortisol passing through the placenta and reaching the foetus. Placental 
11β-HSD2 is therefore essential in the regulation of foetal growth (Murphy et al., 2006). 
Studies have found reduced 11β-HSD2 activity and mRNA levels but no genetic mutations of 
the enzyme in pregnancies complicated by intrauterine growth restriction (IUGR; Dy, Guan, 
Sampath-Kumar, Richardson, & Yang, 2008; McTernan et al., 2001; Shams et al., 1998). 
These findings indicate an involvement of non-genetic factors in this relationship. 
Furthermore, in pregnancies complicated by IUGR a decreased ratio of plasma cortisone to 
cortisol in the umbilical cord was revealed, indicative of decreased placental 11β-HSD2 
activity (Dy et al., 2008). Similarly, a positive association between low birth weight and 
reduced activity of 11β-HSD2 in placental tissues obtained after delivery was observed in 
pregnant women suffering from asthma. Foetal cortisol concentrations were increased in the 
asthmatic women as well (Murphy et al., 2002). In line with these findings, a reduced 11β-
HSD2 activity and reduced ratio of cortisone to cortisol in the umbilical cord vein were 
detected in small preterm infants (Kajantie et al., 2003).  
Taken together, in pregnancies complicated by IUGR, low birth weight, and preterm 
delivery, placental 11β-HSD2 activity appears to be attenuated. These findings seem to be 
independent of genetic factors. An interesting fact in this regard is that studies have found 
these pregnancy complications to be associated with prenatal maternal stress, anxiety, and 
depression (Dunkel Schetter, 2011; Grote et al., 2010). But, whether the activity of placental 
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11β-HSD2 is altered by the maternal experience of stress during human pregnancy has not yet 
been investigated. In rats, acute stress led to an up-regulation of 11β-HSD2 activity, whereas 
after chronic stress this up-regulation was impaired (Mairesse et al., 2007; Welberg et al., 
2005). 
 
5.3 The Regulation of Placental 11β-Hydroxysteroid Dehydrogenase Type 2 
Still little is known about the underlying mechanisms regulating placental 11β-HSD2 
(Seckl & Holmes, 2007). Just as stress seems to be capable of altering the enzyme activity in 
rats, incubation of human placental cells with the synthetic glucocorticoid, dexamethasone, 
led to an increase in 11β-HSD2 gene expression (Tzschoppe et al., 2011; van Beek, Guan, 
Julan, & Yang, 2004). Moreover, catecholamines, such as EPI and NE, which are also 
involved in the acute stress response, have shown to decrease placental 11β-HSD2 expression 
in human trophoblast cells (Sarkar et al., 2001). Lack of oxygen during foetal development 
has also been suggested to link prenatal stress with impaired birth outcome (Dunkel Schetter, 
2011). Interestingly, several studies have shown that hypoxia reduces 11β-HSD2 (Alfaidy et 
al., 2002; Homan, Guan, Hardy, Gratton, & Yang, 2006).  
Eight year old children, whose mothers had consumed greater amounts of liquorice 
during pregnancy (i.e. 500mg of glycyrrhetinic acid or more per week), exhibited higher 
CAR, higher baseline levels of cortisol and an increased cortisol response during the TSST 
(Raikkonen et al., 2010) indicating that liquorice inhibits the placental enzyme activity, 
leading to prenatal overexposure of glucocorticoids and long-lasting effects in the child.  
Finally, steroid hormones involved in pregnancy maintenance and foetal maturation 
such as estradiol, progesterone (Sun, Yang, & Challis, 1998) and prostaglandins (in the 
baboon; Pepe & Albrecht, 1984) have been found to inhibit 11β-HSD2 activity as well. Other 
factors that have shown to be involved in the regulation of 11β-HSD2 are nitric oxide (Sun et 
al., 1997b), calcium (Hardy, Dixon, Narayanan, & Yang, 2001), zinc (Niu & Yang, 2002), 
proinflammatory cytokines (Kossintseva et al., 2006) and maternal protein restriction (in rats; 
Bertram, Trowern, Copin, Jackson, & Whorwood, 2001). These products all cause a decrease 
of 11β-HSD2.  
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5.4 11β-Hydroxysteroid Dehydrogenase Type 2 in the Salivary Glands and The 
Maternal Stress Response  
In blood plasma and serum, cortisol concentrations generally exceed cortisone 
concentrations whereas the opposite is true in the saliva. This is due to the activity of 11β-
HSD2 in the salivary glands which has been localized in the human parotid and 
submandibular glands (Smith et al., 1996). As seen above, cortisol enters the saliva through 
passive diffusion. On its way through the salivary glands, approximately 50% is converted 
into cortisone (Meulenberg, Ross, Swinkels, & Benraad, 1987). To date, the investigation of 
the exact biological purpose of 11β-HSD2 in the salivary glands has been neglected (Groschl, 
2009) and neither in the non-pregnant nor in the pregnant state much is known about its 
response to stress. Greaves and West (1963) investigated the ratio of salivary cortisol (active) 
to cortisone (inactive) in third trimester pregnant women compared to non-pregnant women 
and found it to decrease from 1:4 in the non-pregnant state to 1:5 during pregnancy (Greaves 
& West, 1963). This indicates a general augmentation of salivary cortisone during pregnancy 
in relation to salivary cortisol and may either originate from an increase in plasma cortisone or 
from a higher metabolism of cortisol to cortisone by salivary 11β-HSD2 (Meulenberg & 
Hofman, 1990a). Likewise, Meulenberg and Hofman (1990a, 1990b) observed a greater 
increase in cortisone compared to cortisol in pregnant women than in non-pregnant controls 
(Meulenberg & Hofman, 1990a, 1990b). Unfortunately, neither Greaves and West (1963) nor 
Meulenberg and Hofman (1990a, 1990b) tested whether this observation reached statistical 
significance. However, Beitins et al. (1973) found a significantly lower blood plasma ratio of 
cortisol to cortisone in pregnant woman near term compared to non-pregnant women, again 
indicating an up-regulated metabolic clearance of cortisone relative to cortisol (Beitins et al., 
1973).   
No study to date has investigated how 11β-HSD2 in the salivary glands reacts to 
psychological stress. It also remains unclear whether salivary 11β-HSD2 mRNA activity is 
up-regulated or not. A few studies however have examined the enzyme reaction indirectly 
through the ratio of salivary cortisol to cortisone in response to pharmacological provocation 
tests in non-pregnant subjects (Kalra et al., 2007; Katz & Shannon, 1969; Perogamvros et al., 
2010; Perogamvros et al., 2009). Baseline levels of salivary cortisone were significantly 
higher than baseline levels of salivary cortisol, however after ACTH administration this 
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relationship was reversed, in all probability due to a saturation of 11β-HSD2 by the surge in 
salivary cortisol (Katz & Shannon, 1969; Perogamvros et al., 2009). A similar increase of the 
cortisol/cortisone ratio was observed after administration of glycyrrhetinic acid (Van Uum et 
al., 2002). 
Finally, Meulenberg and Hofman (1990b) investigated the CAR in pregnant and non-
pregnant women and found that the increase in cortisone exceeded the increase in cortisol 3-
fold and that the peak time of both hormones was delayed by approximately 2 hours 
(Meulenberg & Hofman, 1990b). This latter result of a shifted CAR peak, however, is in 
contradiction to more recent findings (Buss et al., 2009; Entringer et al., 2010), although they 
did not take cortisone into account. Moreover, the ratio of cortisol to cortisone in the saliva 
seems to vary across the day with 4 times higher cortisone than cortisol concentrations in the 
morning hours (6:00-7:00 AM) and 9 times higher cortisone than cortisol concentrations in 
the evening (4:30-5:30 PM; Lee et al., 2010). 
In brief, little is known about the activity of 11β-HSD2 in the salivary glands during 
the non-pregnant and pregnant states and further research with special regard to its response 
to stress is needed. 
 
5.5  Summary 
11β-HSD is an enzyme family responsible for regulating the amount of cortisol that 
is able to access the GR and MR. Two enzyme isoforms exist, namely 11β-HSD1 and 11β-
HSD2. These isoforms are widely distributed throughout the body. The first isoform has 
bidirectional properties but mainly converts cortisone to cortisol. The second isoform 
exclusively catalyses active cortisol into its inactive metabolite, cortisone. Through this 
activity 11β-HSD2 prevents an over-activation of the MR and GR. During pregnancy, cortisol 
and other glucocorticoids can cross the placenta. To a certain degree this is beneficial to the 
development of the foetal organs but an excess has been related to pregnancy complications. 
In this regard 11β-HSD2 plays a pivotal role in shielding the developing foetus from 
excessive exposure to maternal cortisol. Placental 11β-HSD2 ensures that cortisol 
concentrations in the foetal compartment remain low. As a result most of the cortisone in the 
foetal system is of maternal origin. Moreover, from 8 weeks of gestation on, the foetus 
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produces 11β-HSD2 itself. The activity of the enzyme varies and is altered by maternal stress 
in animals. In particular, chronic maternal stress seems to impair the enzyme activity. 
Whether this is also the case in humans is subject to further investigation.  
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6. Summary of the Theoretical Background, Study Ideas and Hypotheses 
Based on animals studies the hypothesis has been put forth that stress during 
pregnancy is causally associated with pregnancy complications and that this may have long 
lasting effects on the offspring (Brunton & Russell, 2011; Drake et al., 2007; Seckl, 2004). 
Such effects have been termed foetal programming effects (Barker, 1998). During the last 
twenty years an abundance of studies have emerged showing that prenatal stress in pregnant 
women has a similar impact (Glover et al., 2009; Mulder et al., 2002). However, the 
underlying biological processes in this relationship remain elusive.  
In rats, the placental enzyme 11β-HSD2 seems to play an important role. This 
enzyme is present in the human placenta as well (Albiston et al., 1994; Arcuri et al., 1998; 
Brown et al., 1993; Krozowski et al., 1995). No human study to date has investigated the 
potential effect maternal stress may have on the activity of this enzyme. In a first step, 
however it is necessary to understand the psychobiological processes in pregnant women 
experiencing stress. Though prenatal stress has been associated with a dysregulation of the 
maternal HPA axis and ANS, many questions remain unanswered. Studies indicate that the 
second trimester of pregnancy may be a more vulnerable period. Moreover, different maternal 
stress markers, such as sAA and HRV have seldom been examined concerning stress 
responses during pregnancy and little is known about the reaction of salivary 11β-HSD2 to 
stress.   
Therefore, the aim of this thesis was to investigate the maternal stress response of the 
HPA axis and the ANS to a standardized real-life stress situation and to compare the maternal 
stress reactivity with indicators of 11β-HSD2 activity in the foetal system. We investigated 
second trimester pregnant women undergoing an amniocentesis and invited them to 
participate in a later control condition. A surplus of 2ml of amniotic fluid was drawn for 
research purposes. During this period of foetal development, the content of amniotic fluid 
largely corresponds to that of foetal plasma (Underwood, Gilbert, & Sherman, 2005). 
In part 1 (Chapter 7), we set out to test the stress reactivity of the HPA axis by 
measuring salivary cortisol (SalF), cortisone (SalE) and the SalE/(E+F) ratio as a marker for 
the 11β-HSD2 activity in the salivary glands. We compared the responses of these markers 
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with the same ones in the amniotic fluid. The E/(E+F) ratio in the amniotic fluid serves as an 
indicator for 11β-HSD2 activity in the placenta and foetal system.  
In part  2 (Chapter 8), we aimed at investigating the maternal HR, sAA and HRV 
reactions to the stress of the amniocentesis and examined whether these ANS markers were 
associated with amniotic fluid F, E, and the E/(E+F) ratio. 
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PART II  EMPIRICAL STUDIES 
 
7. Salivary Cortisol to Cortisone Conversion as a Marker of the Stress Response 
During Amniocentesis Corresponds With the Conversion of Cortisol to 
Cortisone in the Amniotic Fluid 
 
7.1 Introduction 
A growing body of literature on animal and human studies indicates that maternal 
psychological factors such as stress can affect the developing foetus (Glover et al., 2010). 
However, the underlying mechanisms remain to be elucidated. Current findings suggest that 
the hypothalamic-pituitary-adrenal (HPA) axis and enzymatic processes in the placenta may 
play an important role in this mechanism. While glucocorticoids are vital for foetal organ 
development, excessive exposure has been associated with reduced birth weight, higher blood 
pressure, and distractibility in adolescence (Harris & Seckl, 2011). Being lipophilic, maternal 
cortisol (F) can easily cross the placental barrier (Harris & Seckl, 2011; Migeon et al., 1961).  
Levels of maternal plasma F have been found to be related to levels of F in foetal plasma 
(Gitau et al., 1998) and amniotic fluid (Murphy, Patrick, & Denton, 1975; Sarkar et al., 2007). 
Nevertheless, at the maternal-foetal interface, the syncytiotrophoblast of the placenta 
(Krozowski et al., 1995), most of maternal F (80-90%; Beitins et al., 1973) is converted into 
its inactive metabolite, cortisone (E) by the placental enzyme 11-hydroxysteroid 
dehydrogenase type 2 (11-HSD2; Benediktsson et al., 1997). This enzyme regulates the 
amount of glucocorticoid that passes through, leading to approximately 13-28 times lower 
levels of F in the foetal system compared to the levels in the mother (Gitau et al., 2001; Sarkar 
et al., 2007). However, this also implies that minor increases of maternal F concentrations or 
an impairment of placental 11-HSD2 activity might have a significant impact on foetal F 
concentrations (Gitau et al., 1998; Harris & Seckl, 2011).  
Prenatal stress has been found to alter placental 11-HSD2 activity in pregnant rats, 
leading to an up-regulation in the face of acute maternal stress (Welberg et al., 2005), but 
under chronic stress exposure this up-regulation seems to be diminished (Mairesse et al., 
2007; Welberg et al., 2005). Whether a similar process exists in humans remains elusive, 
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though recent findings supporting such an assumption are beginning to emerge. For example, 
studies have shown that in vitro, glucocorticoids increase human placental 11-HSD2 activity 
and mRNA expression (Tzschoppe et al., 2011; van Beek et al., 2004). Also, the relationship 
between maternal plasma F and amniotic fluid F was found to depend on the state and trait 
anxiety levels of pregnant women as a significant association between these physiological 
parameters was observed in the group of most anxious pregnant women, but not in the non-
anxious group (Glover et al., 2009). Though enormously valuable, these findings are 
nonetheless still too indirect to confirm a link between prenatal stress and placental 11-
HSD2 activity in human pregnancy.  
Interestingly, aside from the placenta, 11β-HSD2 has also been localized in the adult 
parotid and submandibular glands (Edwards et al., 1988; Smith et al., 1996). The relationship 
between SalF, salivary cortisone (SalE) and the SalF/SalE ratio has been investigated in 
response to adrenocorticotropin (ACTH) stimulation tests in earlier studies and an increase of 
SalF to SalE was found (Katz & Shannon, 1969; Perogamvros et al., 2009). The response to 
psychological stress has not yet been examined. 
To date research on the psychological stress response of the HPA axis during 
pregnancy is sparse. By investigating the stress response of pregnant women in a standardized 
manner a better understanding of the psychobiological mechanisms involved in stress 
processing during pregnancy can be achieved. Our workgroup and others have shown that 
SalF increases in pregnant women when confronted with a psychosocial laboratory stressor 
(De Weerth et al., 2007; Nierop, Bratsikas, Klinkenberg et al., 2006a). Previous studies have 
also investigated the maternal endocrine stress reaction in pregnant women awaiting an 
amniocentesis (Glover et al., 2009; Sarkar et al., 2007). However, these studies have mainly 
relied on single measurements of stress hormones, and no study to date has evaluated the 
entire stress response elicited by this medical procedure. 
The objective of the current study was to investigate the stress response of SalF, 
SalE, and the SalE/(SalE+SalF) ratio as a marker for 11β-HSD2 activity in the salivary glands 
in second trimester pregnant women prior, during and after an amniocentesis (i.e. the stress 
condition) as compared to a control condition. Moreover, we were seeking to examine the 
relationship between the salivary stress response and F and E in the amniotic fluid, as well as 
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the E/(E+F) ratio as a marker for 11β-HSD2 activity in the foetal system. Building on 
previous findings in this field, we hypothesized that a higher salivary stress response in the 
pregnant women would be associated with higher amniotic fluid levels of F and E as well as 
greater E/(E+F) ratio. 
 
7.2 Methods 
7.2.1 Study Participants  
Pregnant women, who were scheduled at various Swiss Hospitals (see below) for 
undergoing an amniocentesis for karyotyping during the second trimester of pregnancy were 
informed in detail about the ongoing study and asked whether they would be interested in 
participating. Exclusion criteria were artificial insemination, multiple gestation, known 
maternal or foetal medical complications (e.g., hypertension, diabetes mellitus, hyperemesis 
gravidarum, foetal growth restriction etc.), maternal psychiatric disorders, protein restricted 
diet, alcohol intake of more than one glass of wine or beer per week, current use of 
psychotropic substances or medication (e.g., glucocorticoids, diuretics, antihypertensives, 
vasodilators).  
Of the 90 women contacted, 40 met the requirements for participation in the study 
(Figure 5). This led to a final sample size of 34 participants. However, the amniotic fluid 
sample of one participant was contaminated with blood and could therefore not be included in 
the statistical analysis for testing the hypotheses concerning amniotic fluid. A further subject 
showed a surge in salivary parameters during the rest condition of more than 2 standard 
deviations, and therefore her control data were defined as an outlier.  
In addition to the exclusion criteria, the remaining participants were instructed to 
refrain from heavy physical exercise, caffeine, chewing gum and alcohol intake 24 hours prior 
to the appointment. They were also asked to abstain from eating 2 hours and from tooth 
brushing 1 hour beforehand. 
The study was conducted in accordance with the Declaration of Helsinki and 
approved by the cantonal ethics committees of Zurich, Schaffhausen, and Lucerne. 
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Figure 5.  Flow diagram depicting the recruitment process of the study. 
 
7.2.2 Study Design and Procedure 
The study was conducted at the University Hospital Zurich from April 2009 until 
January 2011 and is part of a larger prospective research project to examine the 
psychobiology of stress during pregnancy. To facilitate the recruitment of participants, 
cooperations with different local hospitals and private practices in the Cantons of Zurich, 
Schaffhausen and Lucerne were established, namely with the Hospitals of Buelach, Uster, and 
Wetzikon, with two private practices, one in Winterthur and one in Zurich, and with the 
Cantonal Hospitals of Schaffhausen and Lucerne.  
Due to the respective hospital logistics and procedures, all amniocenteses were 
conducted in the morning. Participants arrived at the hospital and provided written informed 
consent 50 minutes prior to the scheduled amniocentesis. Saliva samples were collected 
repeatedly and mood questionnaires were filled in regularly. Subsequent to the amniocentesis, 
 66 
 
participants were monitored for a further 60 minutes in order to measure recovery from the 
stress of the amniocentesis, before leaving the hospital.  
After the participants had received the amniocentesis test results they were re-
examined during a control condition 2.7 weeks later (SD = 1.0). This examination was also 
scheduled in the morning, in order to control for circadian variations in SalF and SalE (Smyth 
et al., 1997). At this appointment, anamnestic data of the participants were assessed and all 
participants underwent a structured clinical interview, DIA-X/M-CIDI (Wittchen & Pfister, 
1997) in order to screen for psychiatric disorders. Participants were also screened for liquorice 
ingestion, because its main ingredient, glycyrrhetinic acid, is known to inhibit 11β-HSD2 
activity (Stewart et al., 1987). None of the participants suffered from a psychiatric disorder at 
the time of the testing and none consumed liquorice. 
  
7.2.3 Outcome Measures 
Psychological Measures  
State anxiety, mood and perceived stressfulness were assessed at -40, -10, +20, +50 
min of the study protocol by self-report measures. An additional assessment of perceived 
stressfulness was obtained at -1min prior to the amniocentesis.  
Perceived stressfulness was assessed by means of a visual analogue scale (VAS) 
(Klinkenberg et al., 2009). State anxiety was measured with the validated German version of 
the state subtest of the State-Trait Anxiety Inventory (STAI-s; Laux, Glanzmann, Schaffner, 
& Spielberger, 1981), and mood was measured using the original German version of the 
Multidimensional Mood State Questionnaire (Steyer, Schwenkmezger, Notz, & Eid, 1997). 
The latter consists of three subscales: “good mood – bad mood”, “calmness – nervousness”, 
and “wakefulness – tiredness” with higher scores signifying good mood, calmness, and 
wakefulness. These psychometric measures are commonly used and well known for their high 
internal consistency and validity (Nierop, Bratsikas, Klinkenberg et al., 2006a). 
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Biochemical Measures 
Saliva was collected repeatedly using cotton rolls (Salivette, Sarstedt, Sevelen, 
Switzerland) at the following time points: 1 min prior to and +10, +20, +30, +45, and +60 min 
after the amniocentesis. After collection, the saliva samples were stored at -25 ºC until 
biochemical analysis took place at the end of the study. SalF and SalE were measured using a 
highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method 
(Perogamvros et al., 2009) in order to avoid the problem of cross-reactivity when assessing 
such highly similar substrates as F and E in the saliva.  
Missing values due to insufficient saliva (dry cotton swab) were replaced following 
the method of Jönsson et al. (2010) using estimated values by calculating the mean quotient 
(slope) between the missing and subsequent values of all participants (Jönsson et al., 2010). 
All in all, missing values of three participants at -1, +10, and +20min were replaced with this 
method. 
During the amniocentesis, a surplus of 2ml of amniotic fluid was obtained and stored 
at -80 ºC. Amniotic fluid was analysed using a reversed-phase HPLC system with UV 
detector. 
The 11β-HSD2 activity of the salivary gland and foetal system was calculated in 
percentage by adapting the subsequent formula (Benediktsson et al., 1997; Kajantie et al., 
2003; Murphy, 1981): The E level (product) was divided by the sum of E plus F, and 
multiplied by 100 (E/(E+F)*100. For brevity‟s sake results are reported as E/(E+F).  
 
7.2.4 Data Analyses 
Prior to the analyses all data were tested for normal distribution, and skewed 
biological variables were naturally log transformed (cf. Entringer et al., 2010). This was the 
case for: SalF (i.e. ln(SalF+1)), the SalE (i.e. lnSalE), and amniotic fluid E (i.e. lnE). With 
regard to the psychological outcome measures, the “good mood-bad mood” subscale of the 
MDBF and the perceived stressfulness item of the VAS were skewed as well. For these 
variables non-parametric tests were conducted. 
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Analyses of the psychological outcome measures were calculated using two-way 
repeated-measures ANOVAs. Post hoc tests were conducted by using subsequent repeated-
measures ANOVAs for each condition, as well as Bonferroni‟s test for comparisons between 
the different time points. Non-normal distributed psychological data was analysed using 
Friedman‟s ANOVA in order to disclose possible effects across time for each condition 
separately. Due to the nature of this non-parametric test, it was not possible to calculate 
potential interaction effects. However, the Wilcoxon signed-rank test was applied to compare 
the individual time points between the two conditions and the effect size was calculated using 
r. 
Analyses of salivary parameters were performed in the following manner. Two-way 
analyses of variance (ANOVAs) for repeated measures were used to assess possible 
interaction effects between condition and time. Where the sphericity assumption was violated, 
results were corrected by the Greenhouse-Geisser procedure. As post hoc tests, subsequent 
ANOVAs with repeated measures were conducted for both conditions separately. The area 
under the curve with respect to increase (AUCi) was computed with a slightly modified 
trapezoid formula (Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003) in order to 
take the decline of the salivary parameters in the morning hours into account. Briefly, the 
formula is derived by subtracting the askew area under the curve with respect to ground for 
the connection between the first and last measure. Paired Student‟s t-tests were computed for 
comparisons of the AUCs between the conditions. To assess the association between the 
salivary stress responses and the amniotic fluid parameters, bivariate and partial correlations 
were calculated between the deltas of the respective salivary parameters (difference between 
the highest stress and lowest pre-stress measure, cf. De Weerth et al., 2007) and the respective 
amniotic fluid parameter.  
Effect sizes were determined using partial η2 for interactions between time and 
condition of the two-way repeated-measures ANOVAs and using r for comparisons between 
the conditions of the paired Student‟s t-tests. Effect sizes were interpreted according to Cohen 
(1992) indicating r = .10 for small (explaining 1% of the total variance), r = .30  for medium 
(explaining 9% of the total variance), and r = .50 for large effects (explaining 25% of  total 
variance). The level of significance was set at p < 0.05 for all analyses. All analyses were 
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two-tailed except for the hypothesis testing the relationship between the salivary and amniotic 
fluid parameters, where based on prior findings formal predictions were made. 
 
7.3 Results 
7.3.1 Sample Characteristics 
Sample characteristics are presented in Table 1.  
 
Table 5. Characteristics of the Study Population 
 
 
 
 
 
 
 
 
 
Note. Data are expressed as mean (SD). 
 
 
 
 
Maternal age (years)  37.36 (3.93) 
Gestation (weeks)
 
 15.93 (0.70) 
Body mass index at the 15
th
 gestational week 22.66 (2.13) 
Time between stress and rest condition (weeks)  2.74 (1.00) 
Amniotic fluid F (nmol/l)  15.51 (5.32) 
Amniotic fluid E (nmol/l)  48.76 (11.09) 
Amniotic fluid E/(E+F) (%) 
 
 75.90 (5.6) 
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7.3.2 Effect of the Amniocentesis 
Psychological Stress Response 
A significant interaction between time and condition was revealed for state anxiety 
(F(2,62) = 4.86, p < .05, η2 = .14) and for the “calmness - nervousness” scale of the MDBF 
(F(2,64) = 3.47, p < .05, partial η2 = .10). No significant interaction between time and 
condition was attained for the “wakefulness – tiredness” subscale of the MDBF (p = n.s.)  
With regard to the “good mood – bad mood” subscale of the MDBF, results obtained 
by Friedman‟s ANOVA marginally failed to reach a statistical significant effect of time 
during the amniocentesis condition (χ2(2) = 5.36, p = .07). Moreover, Friedman‟s ANOVA 
indicated a significant effect of time for perceived stressfulness during the amniocentesis 
condition (χ2(3) = 46.01, p > .001) but not during the rest condition (p = n.s.).  
 
Biological Stress Response of SalF, SalE, and SalE/(E+F) Ratio 
A significant interaction between time and condition was observed for SalF 
(F(3.56,106.67) = 4.41, p < .01, partial η2 = .13). The AUCi showed a significant increase in 
SalF in the amniocentesis condition (M = 3.96, SE = 1.35) compared to the control condition 
(M = -1.42, SE = 0.90, t(30) = 3.30,  p < .01, r = .52). Post hoc ANOVA revealed a significant 
effect of time in the amniocentesis (F(2.80,83.93) = 9.93, p < .001, partial η2 = .25) but in the 
control condition as well (F(3.40,105.44) = 19.69, p < .001, partial η2 = .39).  
For SalE, a trend towards a significant interaction between time and condition was 
revealed (F(3.93,88.00) = 2.26, p = .09, partial η2 = .07), however, the AUCi disclosed a 
significant increase in SalE during the amniocentesis condition (M = 2.43, SE = .09) 
compared to the control condition (M = -.67, SE = 0.70, t(30) = 2.93, p < .01, r = .47). 
Because of the circadian course of E, the post hoc ANOVA again revealed a significant effect 
of time for both conditions (amniocentesis: F(3.10,99.24) = 7.81, p < .001, partial η2 = .20; 
control: F(3.04,94.23) = 6.63, p < .001, partial η2 = .18). 
Referring to the SalE/(E+F) ratio, a significant interaction between time and 
condition was found (F(5,150) = 3.15, p < .05 partial η2 = .10). The AUCi values disclosed a 
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significant decrease of SalE/(E+F) in the amniocentesis condition (M = -38.77, SE = 17.24) 
compared to the control condition (M = 16.23, SE = 15.0, t(30) = -3.0,  p < .01, r = .48). 
Figure 6 presents the box plots of the AUCis for the amniocentesis and control condition. 
 
A   B 
   
 
C 
 
 
 
 
 
 
 
Figure 6.   Mean increase in the AUCi for salivary cortisol (SalF; ln+1), salivary cortisone (SalE; ln) and the 
SalE/(E+F) ratio (%) during the amniocentesis and rest condition; **, p < .01. 
 72 
 
Control Variables for Testing the Associations Between Salivary and Amniotic 
Fluid Parameters 
Prior to analyses, the control variables were determined. Bivariate correlations 
between maternal age, gestational age, BMI and salivary and amniotic fluid parameters 
revealed a significant correlation between gestational age and amniotic fluid F (r = .36, p < 
.05) only. Therefore, gestational age was included as a control variable in the subsequent 
analyses wherever amniotic fluid F was of interest. 
Between amniotic fluid F and E no significant association was found (p = n.s.). 
However, amniotic fluid F was significantly and inversely correlated with the amniotic fluid 
E/(E+F) ratio (r = -.79, p < .001). Finally, amniotic fluid E was positively correlated with the 
amniotic fluid E/(E+F) ratio (r = .38, p < .05). 
 
Association Between Salivary and Amniotic Fluid Parameters 
No significant association was obtained for the delta increase in SalF and any 
amniotic fluid parameter. However, the delta increase in SalE was significantly and positively 
related to the level of amniotic fluid F (r = .40, p < .05, one-tailed), but not with amniotic 
fluid E or the E/(E+F) ratio (both p = n.s.).  
Moreover, for the delta increase in the SalE/(E+F) ratio, a significant positive 
association with the ratio in the amniotic fluid was obtained (r = .40, p < .05, one-tailed; see 
Figure 7). Again, no other association with the salivary ratio achieved statistical significance. 
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Figure 7.   Bivariate correlations between the delta increase in SalE/(E+F) in % and the amniotic 
fluid E/(E+F) ratio in % (p < .05). 
 
7.4 Discussion 
In the current study, we aimed at examining the stress response of SalF, SalE, and 
the SalE/(E+F) ratio in healthy, second trimester pregnant women undergoing amniocentesis. 
A further objective was to examine the association between the salivary stress response and F 
and E in the amniotic fluid as well as the E/(E+F) ratio as marker for the 11-HSD2 activity 
in the foetal system. 
Our findings revealed a significant stress effect of the amniocentesis on state anxiety, 
mood, and perceived stressfulness. In the same way, a significant increase in SalE, SalF, and a 
simultaneous decrease in the SalE/(E+F) ratio in response to the stress of the amniocentesis 
was observed. In addition, we found an association between the salivary glucocorticoid 
parameters and levels of these same parameters in the amniotic fluid. In particular, a 
significant positive association was discovered between the stress-induced increase in SalE 
and amniotic fluid F. Above all, a positive association was found between the stress response 
of the E/(E+F) ratio in the saliva and the ratio in the amniotic fluid. 
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The increase in SalF in response to this real life stressor is in line with previous 
findings of our workgroup and others who investigated the stress response in second (Nierop, 
Bratsikas, Klinkenberg et al., 2006a) and third trimester (De Weerth et al., 2007; Nierop, 
Bratsikas, Klinkenberg et al., 2006a) pregnant woman to a standardized laboratory-based 
psychosocial stressor. These studies showed an increase in SalF in response to the stressor. 
Although amniocenteses have been applied as a standardized condition to investigate the 
psychobiological stress responses during pregnancy in earlier studies (e.g., Sarkar et al., 
2007), the above described findings are the first to report the course of these stress hormone 
responses, including the stress-induced increase and the subsequent recovery.  
While the increase of SalF levels is attributable to the increase in the secretion of 
glucocorticoids by the adrenal glands, the increase in SalE represents to a great extent the 
fraction of SalF that was converted by 11-HSD2 in the parotid glands. In the un-stimulated 
state, unbound F usually exceeds the level of unbound E in the serum (Perogamvros et al., 
2010) and plasma (Katz & Shannon, 1969). However, the greatly reversed ratio of F to E in 
the saliva can predominantly be attributed to the 11-HSD2 activity in the salivary glands 
(Katz & Shannon, 1969; Perogamvros et al., 2010), despite the fact that a fraction of 
circulating unbound serum E also contributes to the amount of SalE by means of passive 
diffusion (Perogamvros et al., 2010).  
In contrary to the general increase of SalF and SalE, the salivary ratio of E/(E+F) 
decreased significantly in response to the stress of the amniocentesis. This decrease may 
indicate a transitional flooding of the 11-HSD2 enzyme by the rapid surge of plasma F 
reaching the salivary glands (Katz & Shannon, 1969). Thus, the enzyme might not be able to 
meet the increased demands of catalysing the increased amount of F into E. Our results are in 
line with stimulation studies using ACTH and intravenous hydrocortisone to stimulate the 
adrenal glands in men (Katz & Shannon, 1969), and non-pregnant women (Perogamvros et 
al., 2010; Perogamvros et al., 2009) to examine the subsequent 11-HSD2 activity in the 
salivary glands. Besides increased SalF and SalE levels, these studies found an excess of SalF 
over SalE indicating a saturation of 11-HSD2 activity. In addition, the activity of parotid 
11-HSD2 has also been examined following administration of glycyrrhetinic acid (Van Uum 
et al., 2002), a constituent of liquorice which inhibits the activity of this enzyme 
(Benediktsson et al., 1997). Similar to the stimulation studies, a surge of SalF following the 
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11-HSD2 inhibition by glycyrrhetinic acid was revealed. However, the effect of stress on 
parotid 11-HSD2 activity has not been investigated before and our results contribute to a 
broadened understanding of the enzyme activity.  
What exactly happens with the 11-HSD2 enzyme in the salivary glands when faced 
with stress is not exactly known. 11-HSD2 activity in the placenta is up-regulated by acute 
stress in pregnant rats (Welberg et al., 2005). Similarly, the synthetic glucocorticoid 
dexamethasone has been shown to cause an increase in placental 11-HSD2 activity and 
mRNA expression in cultured human placental trophoblast cells (van Beek et al., 2004). To 
what extent this applies to the activity of the enzyme in the parotid glands must still be 
elucidated. In our study, the duration of the stressor may be too short to cause changes in 
mRNA expression, therefore we assume that a short-term flooding of the enzymatic capacity 
was induced. 
However, taking 11-HSD2 into account when examining the effects of SalF 
reactivity is important, because it provides a clearer understanding of how the HPA axis 
responds to stress. This enables stress researchers to gain a clearer picture of the mind-body 
interactions. SalF is regarded as a reliable indicator for the amount of F released from the 
adrenal cortex and a marker for the activity of the HPA axis in response to stress 
(Perogamvros et al., 2010). Nevertheless, the concentration of SalF is composed of only 
approximately 50-60% of the free plasma F concentrations due to the conversion of F to E by 
parotid 11-HSD2 (Meulenberg & Hofman, 1990a). In accordance with this, a recent study 
showed that SalE more strongly mirrored free plasma F than did SalF (Perogamvros et al., 
2010).  
Clearly, more accurate tools such as the use of LC-MS/MS are needed for the 
measurements of such structurally close related compounds as F and E. Commonly utilized 
immunoassays tend to be affected by cross-reactivity and might therefore, to a certain extent, 
be measuring F and E together rather than F alone (Perogamvros et al., 2010; Perogamvros et 
al., 2009).  
Activity of 11-HSD2 has been detected in the placenta from 5 to 6 weeks of 
gestation onward (Arcuri et al., 1998; Giannopoulos et al., 1982; Hirasawa et al., 2000; 
Krozowski et al., 1995). From this time on, enzyme activity has also been found in human 
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foetal tissues, such as the kidney, adrenal, skin, gut, muscles, lung, liver, and gonads (Condon 
et al., 1998; Murphy, 1981; Stewart et al., 1994), where it is assumed to regulate the balance 
between the beneficial effects of glucocorticoids and protection from overexposure. 
Since direct measurement of placental 11-HSD2 activity in vivo is difficult, the 
amount of conversion from F to E expressed as a ratio between the two substrates in the 
umbilical cord blood is a commonly used marker for the placental activity of the enzyme 
(Huh et al., 2008). In prior studies, amniotic fluid (obtained from amniocenteses at a range of 
15 to 38 weeks of gestation) has been used to examine the amount of glucocorticoid exposure 
to the foetus (Glover et al., 2009; Sarkar et al., 2007). The amniotic fluid ratio between F and 
E has also been determined to measure 11-HSD2 activity in the foetal kidney (Hundertmark 
et al., 2001). Moreover, during the period between 10 to 20 weeks of gestation the consistency 
of amniotic fluid is similar to that of foetal plasma (Underwood et al., 2005). 
The lack of association between amniotic fluid F and amniotic fluid E is surprising, 
but might reflect the fact that these compounds are of different sources in the foetal system. 
Approximately 90% of E found in the foetus is derived from the mother, in contrast to only 
20-50% of F in the foetus (Beitins et al., 1973), indicating that a substantial conversion of F to 
E takes place in the placenta. In line with the hypothesis, that placental 11-HSD2 converts F 
to E, we found amniotic fluid F to be significantly and inversely correlated with the amniotic 
fluid E/(E+F) ratio and amniotic fluid E positively correlated. 
As for the association between salivary and amniotic fluid parameters, SalF was 
unrelated to the amniotic fluid glucocorticoids in our study, which is in contrast to the 
discovered positive association between F in the amniotic fluid and in the maternal blood 
(plasma and serum; Murphy et al., 1975; Sarkar et al., 2007), as well as foetal plasma and 
maternal plasma F (Gitau et al., 1998), and also in contrast to the strong association between 
plasma and salivary levels of F (Perogamvros et al., 2010). However, this lack of association 
might, in part, be attributable to the dehydrogenase reaction of 11-HSD2 in the parotid gland 
and the placenta, representing therefore two sources of transformation with possibly different 
catalysing characteristics. It might again, be ascribed to the source of F, which in the case of 
saliva and plasma is the maternal adrenal cortex, while amniotic fluid F is of both maternal 
and foetal origin. Moreover, the association between maternal plasma and amniotic fluid F 
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has shown to increase with gestational age (Sarkar et al., 2007), which also might be a reason 
for the lack of association found in our study, since we investigated pregnant women at 15 to 
17 weeks of gestation.   
In this regard, it is of interest to note that the amniotic fluid E concentrations were 
higher than the amniotic fluid F concentrations, a finding in line with other studies as well 
(Beitins et al., 1973). This again can be attributable to placental 11-HSD2. A greater 
increase in maternal SalE levels in response to stress was associated with higher levels of F in 
the amniotic fluid. This may be in line with the recent finding that SalE reflected serum free F 
more closely than did SalF due to the conversion of F to E by 11-HSD2 in the salivary 
glands (Perogamvros et al., 2010). 
Last but not least, the SalE/(E+F) ratio was positively associated with the stress 
response of the E/(E+F) ratio in the amniotic fluid, and therefore, also reflected greater 11-
HSD2 activity in the foetal system. Pregnant women with a stronger acute stress response, 
and thus, probably also a stronger manner to react to acute stress situations in general, seem to 
have greater 11-HSD2 activity as well. It seems that indeed, 11-HSD2 acts as a shield to 
protect the foetus from acute psychological stress of the mother. Clearly, this finding needs to 
be replicated and confirmed with direct measurement of the enzyme activity in the placenta. 
Nonetheless, this result parallels findings in rats of an up-regulation of the enzyme activity 
due to acute stress (Welberg et al., 2005). It further substantiates the hypothesis that the 11-
HSD2 enzyme plays a vital role in the association between prenatal stress and foetal 
development. Whether and to what extent chronic stress impairs the enzyme activity in human 
pregnancy, still needs to be investigated.  
Beside these new insights in the psychobiology of stress during pregnancy, our 
findings also reveal some limitations. For instance, the time it takes for maternal F to cross the 
placenta is poorly understood, much less in an acute psychological stress situation (Glover et 
al., 2009). However, in pregnant women undergoing an abortion between 12 and 23 weeks of 
gestation the radioactive cortisol (4-C14) that was intravenously injected 20 to 72 minutes 
prior to the procedure was subsequently detectable in the foetal plasma (Migeon et al., 1961).  
The extent to which the second isoform of the 11-HSD enzyme, namely 11-
hydroxysteroid dehydrogenase type 1 (11-HSD1) that primarily converts E into F, 
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contributes to the levels of F and E in the foetal system, is not known (Kajantie et al., 2003). 
11-HSD1 activity has not been detected in midgestation foetal tissues (16-19 weeks; 
Murphy, 1981; Stewart et al., 1994) and its activity is mainly found in the human deciduas 
and chorion and only at minor levels in the placenta (Giannopoulos et al., 1982; Murphy, 
1981). 
Due to the fact that all amniocentesis were conducted in the morning, the effect of 
the stressor on the salivary parameters might have been obscured by the decline of the 
glucocorticoids in the morning hours. A stronger effect might have been obtained, if the 
amniocentesis had been scheduled in the afternoon (cf. Sarkar et al., 2006). However, this was 
not possible due to hospital procedure. For obvious reasons, it was also not possible to study 
the course of the amniotic fluid glucocorticoids over the period of the acute stress response as 
it was possible to do with salivary glucocorticoids, therefore limiting the interpretation of the 
effects of acute and chronic stress especially on the amniotic fluid markers.   
In conclusion, the psychological stress of an amniocentesis during the second-
trimester of pregnancy elicits an increase in SalF, SalE and a decrease of the SalE/(E+F) ratio. 
The latter response is possibly due to the sudden surge of F from the blood circulation 
reaching the salivary glands. The ratio of F to E in the amniotic fluid during a stressful event 
has not been studied before. Our findings indicate that 11-HSD2 activity in the human foetal 
system may be increased in pregnant woman who tend to react stronger when confronted with 
acute psychological stress, and it therefore seems to act as a shield that safeguards the foetus 
from overexposure to maternal F. 
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8. The Association Between the Acute Autonomic Stress Response and Amniotic 
Fluid Cortisol and Cortisone During the Second Trimester of Human 
Pregnancy 
 
8.1 Introduction 
Research on the underlying biological mechanisms by which prenatal maternal stress 
may affect the developing foetus has greatly focused on the hypothalamic-pituitary-adrenal 
(HPA) axis and the detrimental effects of glucocorticoid overexposure to the foetus. To date, 
little attention has been paid to the potential role of the autonomic nervous system (ANS), 
which like the HPA axis is activated by stress. Studies of our workgroup and others 
examining the ANS responses to stress during human pregnancy have found increased 
salivary alpha-amylase levels (sAA), increased heart rate (HR), and decreased heart rate 
variability (HRV) in women undergoing laboratory based psychological stress tests (DiPietro 
et al., 2003; Entringer et al., 2010; Klinkenberg et al., 2009; Monk et al., 2011; Nierop, 
Bratsikas, Klinkenberg et al., 2006a; Nisell et al., 1986). Most studies, however, have focused 
on the third trimester of pregnancy.  Furthermore, in comparison to HR, the responses of sAA 
and HRV to psychological stress have been little investigated.  
One path by which maternal prenatal stress may reach the foetus is by impaired 
activity of the placental enzyme 11β-hydroxysteroid dehydrogenase Type 2 (11β-HSD2). By 
converting active cortisol (F) into its inactive metabolite cortisone (E), 11β-HSD2 shields the 
developing foetus from glucocorticoid overexposure (Benediktsson et al., 1997; Burton & 
Waddell, 1999; Murphy, 1979). From rodent research it is known that acute maternal stress 
induces an up-regulation of placental 11β-HSD2 activity, while chronic stress impairs the 
enzyme function (Mairesse et al., 2007; Welberg et al., 2005). A parallel process has been 
proposed to exist in humans as well, since 11β-HSD2 is also present in the 
syncytiotrophoblast of the human placenta, the site of maternal-foetal exchange (Arcuri et al., 
1998; Krozowski et al., 1995). There it exerts the same oxidase activity by converting F to E 
(Arcuri et al., 1998). Reduced placental 11β-HSD2 functioning has been found in pregnancies 
complicated by intrauterine growth restriction (Dy et al., 2008; McTernan et al., 2001), in 
small preterm infants, and in infants affected by decreased birth weight (Kajantie et al., 2003; 
Stewart, Rogerson, & Mason, 1995). These pregnancy complications have, in turn, been 
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associated with maternal prenatal stress, anxiety, and depression (Dunkel Schetter & Glynn, 
2011; Grote et al., 2010).  
Since in vitro 11β-HSD2 activity is inhibited by norepinephrine and epinephrine 
(Sarkar et al., 2001) the potentially important role of the ANS in the interaction of maternal 
stress and foetal development has been assumed (Glover et al., 2009). An additional ANS 
effect following stress induction has been shown in animal research since stress-induced 
increases of norepinephrine reduced the utero-placental blood flow (Shnider et al., 1979). 
Likewise in humans, maternal prenatal anxiety (Sjostrom, Valentin, Thelin, & Marsal, 1997; 
Teixeira et al., 1999) and psychological distress (Vythilingum et al., 2010) has been reported 
to be positively associated with impaired placental blood flow.  
Taken together, these findings emphasize the importance of investigating the ANS 
during pregnancy and its possible link with the foetal environment in utero. In the current 
study, we examined sAA, HR, and HRV in second trimester pregnant women prior to, during 
and following an amniocentesis. Since the composition of amniotic fluid during the second 
trimester of pregnancy resembles foetal plasma (Underwood et al., 2005), in a further step we 
compared these ANS markers with cortisol (F), cortisone (E), and the E/(E+F) ratio in the 
amniotic fluid, the latter of which is a marker for 11β-HSD2 activity in the foetal system.  
 
8.2 Methods 
8.2.1 Study Participants 
Thirty-four healthy second trimester pregnant women with a singleton intrauterine 
pregnancy were examined while undergoing an amniocentesis. This medical intervention was 
conducted in order to identify any genetic abnormalities, such as chromosomal trisomies. The 
participants were recruited at different Swiss Hospitals after they had registered for the 
amniocentesis procedure. Neither the participants nor their foetuses showed medical 
complications or illnesses. Pregnancies via artificial insemination, current mental disorders, 
medication intake, smoking or obesity were defined as exclusion criteria. Ethical approval of 
the study was obtained and all participants gave informed written consent. 
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8.2.2 Study Design and Procedure 
The study design and procedure is presented in Figure 8. Due to the hospital 
proceedings, all amniocenteses were conducted during the morning hours. The participants 
arrived approximately 50 minutes prior to the medical examination, filled in study 
administrative questionnaires and were subsequently asked to put on an ambulatory 
electrocardiographic device, before the participants were seated in a semi-recumbent chair. 
Cardiac activity was continuously measured and repeated saliva samples and psychological 
measurements were obtained. Prior to the amniocentesis, the pregnant women were examined 
by ultrasound and their gestational age was determined by foetal ultrasound biometry. During 
60 minutes following the amniocentesis participants were still monitored. To enable precise 
statements on the stress reactivity of the second trimester pregnant women, we invited them to 
participate in a control condition after they had received the results of the amniocentesis (M = 
2.74 weeks later, SD = 1.00). Aside from the medical intervention, the procedure of the 
control examination was identical to the experimental condition. In order to control for 
circadian fluctuations (Smyth et al., 1997) the control condition was scheduled at the same 
time of the morning as the amniocentesis. 
 
 
Figure 8.   Study design and procedure. 
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8.2.3 Outcome Measures 
Psychological Measures 
The psychological measures were repeatedly assessed prior to and after the 
amniocentesis at -40, -10, and +20 minutes (see Figure 8) and at equivalent points during the 
rest condition. 
State anxiety levels were determined using the validated 20 item German version of 
the state subtest of the State Trait Anxiety Inventory (STAI-s: (Laux et al., 1981); Cronbach‟s 
α = .90 - .94). Respondents are asked to rate the intensity at which they are experiencing the 
presence or absence of anxiety symptoms at the time of testing, ranging from 1 (not at all) to 4 
(very much so). The items consist of self-descriptive adjectives (e.g., „I feel worried‟). 
State mood was assessed with the original German version of the Multidimensional 
Mood State Questionnaire (Multidimensionaler Befindlichkeitsfragebogen, MDBF; Steyer et 
al., 1997; Cronbach‟s α = .86 - .96). This scale is composed of 24 items that fall within three 
subscales („good-bad mood‟, „calmness-nervousness‟, „wakefulness-tiredness‟). Participants 
indicate on a scale of 1 (not at all) to 5 (very much so) to what extent they, feel „happy, 
„tense‟, „exhausted‟ etc. at the time of filling in the questionnaire. Depending on participants‟ 
current mood state, the sum of the scores may range from 24 to 120 with higher scores 
reflecting good mood, calmness, and wakefulness. 
Perceived stressfulness was examined by using a visual analogue scale (VAS, 
(Klinkenberg et al., 2009) at the same points in time mentioned above and additionally at 1 
minute prior to the amniocentesis.  
 
Biochemical Measures 
Salivary alpha-amylase: Saliva samples were collected with Salivettes (Sarstedt, 
Sevelen, Switzerland) and participants were instructed to gently chew on the cotton roll for 2 
minutes at the following points: -30, -20, -10, -1, +1, +10, +20, +30, +45, and +60 minutes. 
The saliva samples were stored at -20°C until biochemical analysis. After thawing, the sAA 
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activity was analysed with the automatic analyser Cobas Mira and assay kits from Roche 
(Nater et al., 2006). 
 
Marker of 11β-HSD2 Activity 
Amniotic fluid parameters:  A surplus of 2ml of amniotic fluid was obtained during 
the amniocentesis and stored at -80 ºC. In order to separate F and E levels, the amniotic fluid 
parameters were analysed using a reversed-phase HPLC system with UV detector. 
The activity of 11β-HSD2 in the foetal system was determined by dividing E 
(product of 11β-HSD2) by the sum of E + F in the amniotic fluid. For conversion reasons into 
percentage the ratio was subsequently multiplied by 100 (c.f. Benediktsson et al., 1997; 
Kajantie et al., 2003; Murphy, 1981). In the following, this variable is reported as E/(E+F) for 
the sake of simplicity.  
 
Electrophysiological Measures 
Cardiac activity was measured using the LifeShirt system 200 (Vivometrics, 
Ventura, CA, USA; Heilman & Porges, 2007). Five-minute intervals of raw data were edited 
manually and corrected for ectopic beats and arrhythmias by applying linear interpolations. 
These selected 5 minute intervals began at the following points in time: -32.5, -17.5, -5, 
+12.5, +32.5, and +47.5 minutes. The corrected inter-beat-intervals were subsequently 
analysed for heart rate (HR) and frequency domain measures, i.e. low frequency (LF) and 
high frequency (HF) heart rate variability (HRV) and the ratio between the two (LF/HF) after 
applying a Fast Fourier Transformation (FFT).  
 
8.2.4 Data Analyses 
Prior to analyses, missing values due to insufficient saliva were replaced by 
estimated values according to the method described by Jönsson et al. (2010). The slope 
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between the missing and the subsequent value was calculated across all participants and 
multiplied by the value of the individual participant preceding the missing one. 
Data was tested for normality of distribution, whereupon sAA, HF, LF, the LF/HF 
ratio and amniotic fluid E were log transformed (ln) due to skewness. Two-way repeated-
measures analyses of variance (ANOVAs) were computed in order to disclose possible 
interaction effects between the two conditions for the physiological as well as the 
psychological stress responses. Wherever the assumption of sphericity was violated, results 
underwent Greenhouse-Geisser correction. Values for the area under the curve with respect to 
increase (AUCi) were computed using the trapezoid formula (Pruessner et al., 2003) while 
taking the individual baseline (last measurement point of the study protocol) into account. 
Comparisons between the two conditions were analysed with paired Student‟s t-tests. For post 
hoc testing ANOVAs were conducted for each condition separately as well as Bonferroni‟s 
tests for possible differences between the individual points in time. 
Non-parametric tests were used for the non-normally distributed psychological 
outcome measures (i.e. „good mood - bad mood‟ subscale of the MDBF and the perceived 
stressfulness VAS). Using Friedman‟s ANOVA possible time effects were tested, but 
interaction effects could not be assessed due to the nature of this statistical test. Nevertheless, 
potential differences between the two conditions were analysed using the Wilcoxon signed-
rank test. Bivariate and partial correlations between the AUCis of the ANS markers and the 
amniotic fluid parameters were conducted in order to assess whether any associations existed 
between the two. Effect sizes were computed either using η2 or r. All analyses were two-tailed 
and the level of significance was set at p < .05. 
 
8.3 Results 
8.3.1 Sample Characteristics 
The pregnant women‟s mean age was M = 37.36 (SD = 3.93; range 27-45) and their 
BMI was within a normal scope for pregnant women of this particular age group (19.6 – 27.3, 
M = 22.66, SD = 2.14). Gestational age was confirmed by ultrasound and ranged from 15.00 
to 17.86 weeks (M = 15.93, SD = 0.70).  
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8.3.2 Effects of the Amniocentesis 
Psychological Stress Response 
The amniocentesis condition induced greater state anxiety (STAI-s) as compared to 
the control condition (interaction condition by time: F(2,62) = 4.86, p < .05, η2 = .14), which 
was confirmed by the separate post hoc ANOVAs revealing a significant main effect of time 
for the amniocentesis condition (F(1.63,53.80) = 8.96, p < .01, η2 = .21), but not for the 
control condition. Results obtained by the Bonferroni post hoc test showed that pregnant 
women were significantly more anxious at -40 minutes (p < .05) and -10 minutes (p < .01) 
prior to the amniocentesis than +20 minutes later. 
Similarly, changes in pregnant women‟s feeling of nervousness (MDBF, „calmness – 
nervousness‟) was caused by the amniocentesis compared to the control condition (interaction 
condition by time: F(2,64) = 3.47, p < .05, η2 = .10) as the separate post hoc ANOVAs 
disclosed a significant result for the amniocentesis (F(2,68) = 7.29, p < .01, η2 = .18) but not 
for the control condition. Results of the Bonferroni post hoc test revealed that during the 
amniocentesis condition pregnant women were more nervous at -40 minutes (p < .05) and -10 
minutes (p < .01) compared to 20 minutes after the amniocentesis. Friedman‟s ANOVA for 
the „good mood – bad mood‟ subscale (MDBF) revealed a trend towards a significant 
alteration in mood over time in the amniocentesis condition (χ2(2) = 5.36, p = .07). No 
significant effect over time was present for the control condition. Comparing the „good mood-
bad mood‟ state between the two conditions disclosed that at -40 minutes (z = -2.72, N-Ties = 
29, p < .01, r = -0.33) and -10 minutes (z = -4.40, N-Ties = 33, p < .001, r = -0.54) of the 
amniocentesis condition, the pregnant women were in a poorer mood than during the control 
condition. No significant interaction between condition and time was found for the 
„wakefulness – tiredness‟ subscale. 
Results obtained by Friedman‟s ANOVA for perceived stressfulness (VAS) indicated 
significant alterations over time during the amniocentesis condition (χ2(3) = 46.0, p < .001) 
but not during the control condition. Post hoc analyses revealed that pregnant women 
perceived the situation to be more stressful at -40, -10 minutes, and -1 minute compared to 
+20 minutes (-40 compared to +20 minutes: z = -3.31, N-Ties = 31, p < .01, r = -0.41; -10 
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compared to +20 minutes: z = -3.69, N-Ties = 31, p < .001, r = -0.46; -1 minute compared to 
+20 minutes: z = -4.72, N-Ties = 32, p < .001, r = -0.58). 
 
Salivary Alpha-Amylase Response 
Due to an insufficient amount of saliva, there was a total of eight missing values 
from seven different participants which were replaced following Jönsson et al. (2010; see 
data analyses). 
The amniocentesis led to a significant increase of sAA levels over time compared to 
the control condition (interaction condition by time: F(5.05,156.63) = 6.80, p < .0001, 
η2=.18, see Figure 9). The AUCi of the amniocentesis condition (M = 23.54, SE = 7.46) was 
significantly larger in comparison to the control condition (M = -6.55, SE = 6.01, t(31) = 
3.02, p < .01, r = .48). The post hoc ANOVAs revealed a significant effect of time across the 
amniocentesis condition (F(5.06, 161.86) = 7.68, p < .0001, η2=.19), but also for the control 
condition (F(4.33,138.59) = 3.15, p < .05, η2= .09). Bonferroni post hoc test revealed that the 
participants‟ sAA levels had increased during the control condition from -1 to +45 minutes (p 
< .05) as well.  
 
Electrophysiological Measures 
HR increased significantly during the amniocentesis condition compared to the rest 
condition (interaction condition by time: F(3.46,110.81) = 13.37, p < .001, η2= .30, see 
Figure 9). This finding was confirmed by the differences between the conditions in their 
AUCis (amniocentesis condition: M = 474.00, SE = 51.39; control condition M = 285.69, SE 
= 78.52, t(32) = 2.20, p < .05, r = .36). From the post hoc ANOVAs, a significant effect of 
time was obtained for the amniocentesis condition (F(3.41,119.25) = 37.56, p < .0001, η2= 
.52), but also for the control condition (F(3.01,96.23) = 4.72, p < .01, η2= .13). The 
Bonferroni post hoc test disclosed that in the control condition a significant decrease in HR 
took place from -30 to +50 minutes (p <.01). 
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HF results revealed a significant increase during the amniocentesis condition 
compared to the control condition (interaction condition by time: F(5,155) = 4.24, p < .01, 
η2=.12, see Figure 9). This result was further substantiated by the differences of the AUCis 
between the two conditions (amniocentesis condition: M = -12.99, SE = 6.00; control 
condition M = -35.02, SE = 6.38, t(31) = 2.59, p < .05, r = .42). The results obtained by the 
post hoc ANOVAs disclosed significant effects over time for both conditions (amniocentesis: 
F(3.51,119.31) = 9.10, p < .001, η2= .21; control condition: F(3.78,117.29) = 6.57, p < .001, 
η2= .18). The Bonferroni post hoc test revealed that during the control condition a significant 
increase had taken place from -30 to +50 minutes (p < .01), as well from -5 to +50 minutes (p 
< .001). 
LF findings did neither disclose a significant increase during the amniocentesis 
condition compared to the control condition nor a significant difference between their AUCis 
(all p=n.s.).  
The LF/HF ratio decreased significantly during the amniocentesis condition 
compared to the control condition (F(5,155) = 6.00, p < .001, η2=.16, see Figure 9). There 
was no significant difference between the two conditions in their AUCis (p = n.s.). The post 
hoc ANOVAs revealed a significant effect over time in both conditions (amniocentesis 
condition: F(5,170) = 6.95, p < .001, η2=.17; control condition: (F(5,155) = 3.80, p < .01, 
η2=.11) due to the significant decrease from +30 to +50 minutes (p < .05) during the control 
condition as revealed by the Bonferroni post hoc test. 
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Figure 9.  Stress response (mean and SEM) of salivary alpha-amylase (A), heart rate (B), high frequency power (C), low 
frequency power (D) and the LF/HF ratio (E) during the amniocentesis condition compared to the control 
condition. Levels of significance are marked as follows: *, p < .05, **, p < .01, ***, p < .001. 
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Association Between the ANS and the Amniotic Fluid Parameters 
Potential Control Variables 
 In order to determine the control variables, bivariate correlations were conducted 
between maternal age, gestational age, BMI, and the ANS and amniotic fluid parameters. 
With regard to baseline values, gestational age was significantly related with HR (r = .42, p < 
.05), HF (r = -.48, p < .01) and the LF/HF ratio (r = .42, p < .05) baselines. Gestational age 
was therefore controlled for in the subsequent analyses. 
As for the stress response, gestational age was significantly related to the sAA 
reactivity (r = .54, p < .01) and amniotic fluid F (r = .36, p < .05), whereas BMI was 
significantly related to the HR AUCi (r = .36, p < .05). No association between maternal age 
and any of the physiological parameters was found. Therefore, gestational age was included 
into the calculations where sAA and amniotic fluid F were of interest and BMI was controlled 
for with regard to the HR stress response. 
  
The Association Between the ANS Baseline Levels and Amniotic Fluid F, E and 
the E/(E+F) Ratio 
No significant associations were found between sAA, HR, and HF baseline values 
and any of the amniotic fluid parameters. However, the LF baseline was negatively related to 
the E/(E+F) ratio in the amniotic fluid (r = -.41, p < .05). Also, a trend towards a significant 
result was obtained for a positive association between LF baseline and amniotic fluid F (r = 
.35, p = .054). Moreover, a significant negative relationship was disclosed between LF/HF 
ratio baseline values and E/(E+F) in the amniotic fluid (r = -.53, p < .01, see Figure 10), and a 
significant positive relationship was found between the LF/HF ratio baseline and amniotic 
fluid F (r = .55, p < .01). 
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Figure 10.  Bivariate correlations between the baseline levels of the ln transformed LF/HF ratio and 
the amniotic fluid E/(E+F) ratio in % (p < .05). 
 
 
The ANS Stress Response and Amniotic Fluid F, E and the E/(E+F) Ratio 
 While a trend towards significance was apparent for a positive relationship between 
the AUCi of sAA and amniotic fluid E/(E+F) (r = .36, p = .055), the correlation between the 
HR AUCi and amniotic fluid E attained statistical significance (r = .37, p < .05). The 
association between the HF AUCi and the amniotic fluid ratio also revealed a trend towards a 
significant negative correlation (r = -.33, p = .06). No significant association was found 
between the LF AUCi and amniotic fluid E or E/(E+F), but a trend towards significance was 
apparent for a negative relationship with amniotic fluid F (r = -.31, p = .09). However, the 
stress response of the LF/HF ratio (AUCi) was positively and significantly related to amniotic 
fluid E/(E+F) (r = .44, p < .05, see Figure 11) and negatively related to amniotic fluid F (r = -
.37, p < .05). 
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Figure 11. Bivariate correlations between the AUCi of the ln transformed LF/HF ratio and the 
amniotic fluid E/(E+F) ratio in % (p < .05). 
 
 
8.4 Discussion 
To the best of our knowledge, this is the first study to investigate the association 
between the stress responses of different ANS markers during pregnancy and amniotic fluid 
parameters. The amniocentesis induced an anticipatory stress reaction with heightened 
feelings of anxiety, nervousness, and stress in second trimester pregnant women as well as a 
surge in sAA and HR over time compared to the control condition. HF levels were decreased 
prior to the amniocentesis and started to rise again whereas the opposite was true for the 
LF/HF ratio. No significant interaction between the amniocentesis and the control 
examination was apparent for the LF component of HRV. With regard to associations 
between the ANS markers and amniotic fluid parameters, LF and the LF/HF ratio baseline 
values were negatively related to 11β-HSD2 activity in the foetal system. In addition, the 
LF/HF ratio baseline was positively associated with amniotic fluid F. As for the acute stress 
response, the LF/HF ratio indicated a significant positive association with amniotic fluid 
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E/(E+F). A significant association was in turn found between the LF/HF ratio and amniotic 
fluid F, whereas a negative relationship was revealed for LF and amniotic F.  
The finding that the pregnant women experienced the situation as highly stressful 
already 40 minutes prior to the amniocentesis confirmed our hypothesis that the medical 
intervention induced a profound psychological anticipatory stress response. 
Up to now, the investigation of sAA in the face of acute psychological stress during 
pregnancy is limited. Our findings of a surge of sAA during the amniocentesis condition 
indicate an increased sympathetic nervous system activity as revealed by our workgroup for 
non-pregnant healthy subjects (Ehlert et al., 2006; Nater et al., 2006). The present findings 
are also in line with our previous results revealing an increase of sAA levels in second and 
third trimester pregnant women who participated in a laboratory-based psychosocial stress 
task (Nierop, Bratsikas, Klinkenberg et al., 2006a).  
Compared to sAA, HR reactivity during pregnancy has been investigated more 
extensively (De Weerth & Buitelaar, 2005b). Increased HR, an index of overall autonomic 
activity, has been found during the third trimester of pregnancy in response to the cold 
pressor test (Greenwood, Stoker, Walker, & Mary, 1998; Saisto et al., 2004), the Stroop 
colour-word test (Monk et al., 2011; Monk et al., 2003; Monk et al., 2004; Nisell et al., 
1986), and to both tests combined (Hatch et al., 2006). Moreover, laboratory stressors using 
psychosocial evaluation such as public speaking combined with a mental arithmetic task 
show an increase in HR at 32 gestational weeks (De Weerth et al., 2007). Similarly, the Trier 
Social Stress Test (Kirschbaum et al., 1993) induced significant HR rises during second as 
well as third trimester of pregnancy (Entringer et al., 2010; Klinkenberg et al., 2009; Nierop, 
Bratsikas, Klinkenberg et al., 2006a). Few studies have investigated HR reactivity in earlier 
or mid-pregnancy and our result of an increased HR response in anticipation of a medical 
examination in second trimester pregnant women contributes to the literature. Most studies to 
date found that HR values increased significantly from baseline in reaction to the stress task 
and decreased again after recovery. In our case, the pregnant women arrived with HR values 
already raised even though we began monitoring their cardiac activity with sufficient resting 
time prior to the amniocentesis. These findings correspond to the pregnant women‟s 
psychological experience of an affective anticipatory stress response prior to the 
amniocentesis. 
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Few studies have investigated the effect of a standardized psychological stress task 
on pregnant women‟s HRV response (DiPietro, Costigan, Nelson, Gurewitsch, & 
Laudenslager, 2008; Klinkenberg et al., 2009; Monk et al., 2011). In the present study, the 
interaction between condition and time was statistically significant with regard to HF. At the 
beginning and the end of both conditions HF values were comparable in the pregnant women, 
but HF levels differed at times in between. Twenty minutes prior to the amniocentesis, HF 
was decreased compared to the control condition and began to rise again after the medical 
procedure. This post-stress vagal rebound (Mezzacappa, Kelsey, Katkin, & Sloan, 2001) 
reached significance 30 minutes after the amniocentesis with higher values in the 
amniocentesis condition before decreasing again to control levels. Moreover, and in line with 
previous results from our work group (Klinkenberg et al., 2009), we found no significant LF 
changes over time in the current study, although LF was higher during the entire 
amniocentesis condition compared to the control condition. Based on our result that vagal 
activity (i.e. HF power) in the amniocentesis condition did not differ from vagal activity in 
the control condition at most time points (except at +30 minutes), the observed higher LF 
values during the amniocentesis might refer to an increased sympathetic tone across the 
entire condition. Nevertheless, because LF power is influenced by both vagal and 
sympathetic activity (Akselrod et al., 1985; Akselrod et al., 1981; Stein & Kleiger, 1999), the 
validity of this interpretation remains uncertain. Concerning the LF/HF ratio, the interaction 
between condition and time was significant with a higher LF/HF ratio at the beginning of the 
amniocentesis condition which approached the lower levels of the control condition over 
time. Similarly, Klinkenberg et al. (2009) found higher responses in the LF/HF ratio to 
psychosocial stress in second and third trimester pregnant women compared to non-pregnant 
women. Again, the higher sympatho-vagal balance prior to the amniocentesis may be 
indicative of an anticipatory stress response accompanied by sympathetic predominance. 
Surprisingly, in the control condition, sAA and HF increased significantly over time 
while HR and the LF/HF ratio declined significantly. An increase in HRV (i.e. RSA) during a 
control condition over time has been reported previously (La Marca, Nedeljkovic, Yuan, 
Maercker, & Ehlert, 2010). This finding was interpreted as a result of habituation and 
relaxation due to the lack of activity. Relaxation in pregnant women (DiPietro et al., 2008) as 
well as boredom in non-pregnant subjects (Keller, Bless, Blonmann, & Kleinböhl, 2011) 
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have been associated with higher HRV levels. Moreover, relaxation has been found to induce 
an increase in sAA in non-pregnant subjects (Morse, Schacterle, Furst, Esposito, & 
Zaydenburg, 1983) since sAA is influenced by sympathetic as well as parasympathetic 
activity. Likewise, our findings may indicate that the pregnant women were experiencing an 
increase in relaxation or even boredom during the control condition and therefore, an 
increased parasympathetic activation. Relaxation has also shown to cause HR to decrease in 
third trimester pregnant participants (DiPietro et al., 2008; Teixeira, Martin, Prendiville, & 
Glover, 2005). 
The investigation of the ANS during pregnancy may also contribute to a better 
understanding of how prenatal maternal stress may reach the foetus. In vitro findings have 
shown that 11β-HSD2 mRNA is down-regulated by norepinephrine and epinephrine (Sarkar 
et al., 2001) which leads to the assumption that chronic activation of the maternal ANS due to 
prenatal stress may cause a decrease in 11β-HSD2 activity and its barrier function and, as a 
result, may lead to an over-exposure of the foetus to glucocorticoids. We therefore, aimed to 
test whether increased ANS baseline levels as well as the acute ANS stress response in second 
trimester pregnant women were associated with amniotic fluid F and E and the E/(E+F) ratio 
as a marker for 11β-HSD2 activity in the foetal system. Indeed, our results revealed a 
significant association between LF as well as LF/HF ratio baseline values and E/(E+F) in the 
amniotic fluid. Moreover, LF/HF ratio baseline values were positively associated with 
amniotic fluid F. Because increased baseline levels of stress markers have been found to 
reflect chronic stress exposure (Lucini et al., 2005), our findings resemble the results of an 
impaired capacity of 11β-HSD2 to convert F to E in chronic stressed rats (Welberg et al., 
2005). In the study at hand, we observed the following relation: the higher the LF/HF 
baseline, the lower was the amniotic fluid E/(E+F) level and the higher the amniotic fluid F 
level. The capacity of norepinephrine and epinephrine to decrease 11β-HSD2 mRNA 
expression in vitro has been found in first trimester as well as in term placental trophoblasts 
(Sarkar et al., 2001). Interestingly, in healthy non-pregnant subjects the LF/HF ratio seems to 
be positively related to urinary norepinephrine and epinephrine in response to a psychological 
stressor (Laskar, Iwamoto, Nakamoto, Koshiyama, & Harada, 2004) and positively to plasma 
norepinephrine during a handgrip exercise (Kurita et al., 1999). HF has also been reported to 
negatively correlate with plasma norepinephrine (Kurita et al., 1999) though not all studies 
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have been able to replicate this finding (Laskar et al., 2004). Likewise, it has been suggested 
that LF may reflect norepinephrine levels. Although such associations have been found 
(Kurita et al., 1999; Laskar et al., 2004), the data remains conflicting (Grassi & Esler, 1999; 
Sloan et al., 1996). This might be due to the fact that LF mirrors sympathetic as well as 
parasympathetic influences on the heart (Akselrod et al., 1985; Akselrod et al., 1981).  
With regard to the acute stress reaction, a trend towards significance was found in 
which an increased sAA stress response was related to a higher E/(E+F) ratio and a higher HF 
stress response  was related to a lower E/(E+F) ratio in the amniotic fluid. The extent to which 
sAA reflects plasma norepinephrine and epinephrine is a matter of controversy as well (Bosch 
et al., 2011; Chatterton, Vogelsong, Lu, Ellman, & Hudgens, 1996; Nater et al., 2006). 
Nevertheless, this salivary marker is regarded as indicative of sympathetic activation although 
parasympathetic activity may play a role in its secretion as well (Bosch et al., 2011; Nater & 
Rohleder, 2009). As mentioned above, our findings of increased sAA levels during the control 
condition may mirror the parasympathetic influence on sAA.  
The significant relationship between the LF/HF ratio and the amniotic fluid ratio may 
indicate that a higher sympatho-vagal balance in response to stress might be associated with 
an increased 11β-HSD2 activity in the foetal system. In line with this, an increased stress 
response of the LF/HF ratio was associated with lower levels of amniotic fluid F.  
Moreover, the HR stress response was positively related with amniotic fluid E, which 
is regarded as the inactive metabolite of F. Up to 90% of foetal E is of maternal origin 
because of the conversion of maternal F to E by 11β-HSD2 in the placenta (Beitins et al., 
1973). In  brief, these findings point to a possible up-regulation of 11β-HSD2 activity in the 
foetal system in response to acute stress of the maternal ANS and are similar to the findings of 
an increased activation of 11β-HSD2 in acute stressed pregnant rats (Welberg et al., 2005). 
The manner in which the participants reacted to this pregnancy-related stressor may reflect the 
general manner in which they react to stressors during pregnancy.  
Our study has a few limitations. We were not able to assign the participants to the 
amniocentesis and control condition in a randomized manner. Most women received the 
appointment for the amniocentesis at short notice. From this point on, they were in a state of 
increased anxiety due to the uncertainty related to the outcome of the amniocentesis. The 
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control condition could therefore only be set after they had received the confirmation that 
their child was not afflicted by chromosomal abnormalities.  
For obvious reasons, it was not possible to monitor the amniotic fluid parameters as 
the maternal stress response unfolded over time. Therefore, no clear statements can be made 
about the foetal stress response. Continuous infusion of norepinephrine and epinephrine in 
pregnant rabbits and guinea pigs caused a reduction in placental blood flow leading, therefore, 
to a fall in foetal HR within 20 to 60 seconds after the infusion had started (Dornhorst & 
Young, 1952). Similarly in humans, within one minute after a single injection of 
norepinephrine to the mother a decrease in foetal heart rate was observed (Beard, 1962).  
Moreover, we did not measure placental 11β-HSD2 activity directly. We measured 
the E/(E+F) ratio as a marker for 11β-HSD2 activity in the foetal system. 11β-HSD2 activity 
has been found in the foetal adrenal, kidney, lungs, gonads, liver, colon and skin from as early 
as 8 weeks of gestation onward (Condon et al., 1998; Coulter et al., 1999; Murphy, 1981; 
Stewart et al., 1994). However, placental 11β-HSD mRNA activity has been detected at this 
early stage of pregnancy as well (Arcuri et al., 1998). 
Whether and to what degree our results are influenced by the activity of 11β-
hydroxysteroid dehydrogenase type 1 (11β-HSD1), which mainly catalyses the opposite 
reaction as 11β-HSD2, namely the conversion of E to F, is unclear. 11β-HSD1 is present in 
the decidua, the chorion, and the endothelium of the placental villous tissue and umbilical 
cord (Stewart, Rogerson et al., 1995; Stewart, Whorwood et al., 1995; Sun et al., 1997a). But 
its activity has not been detected in the foetal membranes between 16 to 19 weeks of gestation 
(Murphy, 1981; Stewart et al., 1994; Stewart, Whorwood et al., 1995). Moreover, 11β-HSD2 
activity strongly predominates over 11β-HSD1 activity in the human placenta (Arcuri et al., 
1998).  
The strengths of the study at hand include the examination of the physiological and 
psychological stress response in pregnant woman confronted with a real-life stressor, the 
assessment of different parameters of ANS activity and the comparison of these with F, E, and 
the E/(E+F) ratio in the amniotic fluid. The findings indicate that the ANS and its potential 
association with 11β-HSD2 in the foetal system is an important path for future research in 
understanding the underlying mechanisms of how prenatal maternal stress affects foetal 
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environment and possibly impairs healthy development in the womb. The knowledge gained 
by such studies may contribute to strengthening maternal stress coping during pregnancy, 
enhance psychological well-being and prevent adverse birth outcome. 
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PART III  GENERAL DISCUSSION 
 
9. Summary and Discussion of the Empirical Studies 
Numerous studies have reported an increased risk of pregnancy complications to be 
associated with psychological stress during pregnancy. A primary mechanism by which this 
occurs, appears to involve the activation of the maternal HPA axis and the ANS. However, 
many questions persist and the exact process by which maternal stress is transmitted to the 
foetus remains yet unclear. The objectives of this thesis were therefore to obtain a broader 
understanding of the psychobiological mechanism in the stress response of pregnant women 
by measuring a variety of HPA axis and ANS parameters and to investigate the extent to 
which these parameters are associated with stress markers within the foetal amniotic fluid. 
This final chapter provides a brief summary of the main empirical findings, followed 
by a discussion and integration of the results within the current literature, and subsequently 
addresses the methodological limitations and strengths of the studies. Finally, the relevance of 
our findings and implications for future research are considered. 
 
9.1 Salivary Cortisol to Cortisone Conversion as a Marker of the Stress Response 
during Amniocentesis Corresponds with the Conversion of Cortisol to Cortisone 
in the Amniotic Fluid 
In part 1 of our empirical study results, we investigated stress-induced changes of 
SalF, SalE and the SalE/(E+F) ratio in second trimester pregnant women that underwent an 
amniocentesis for karyotyping. Questionnaires measuring state anxiety, perceived 
stressfulness, and mood were filled in by the participants over the entire course of the medical 
examination, in order to validate the psychological stress experience of the amniocentesis. A 
surplus of amniotic fluid was taken for the study to compare whether the maternal salivary 
stress markers were associated with the same markers in the amniotic fluid. This served 
indirectly to investigate the activity of 11β-HSD2 in the placenta and foetal compartments. 
The participants were asked to return for a control condition after they received notification 
that the amniocentesis test results were normal. On average this was 2.7 weeks after the test.  
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The amniocentesis proved to be a potent standardized and also naturalistic stressor. 
Compared to the control condition significant alterations in participants‟ mood accompanied 
by significant increases in SalF and SalE were induced. Simultaneously the ratio of 
SalE/(E+F) declined significantly. Moreover, the stress response of SalE was positively 
correlated with amniotic fluid F while the stress response in the SalE/(E+F) ratio was 
positively related to the E/(E+F) ratio in the amniotic fluid. 
 
9.2 The Effect of the Autonomic Stress Response on Amniotic Fluid Cortisol and 
Cortisone in the Second Trimester of Human Pregnancy 
In order to test the hypothesis that in addition to the HPA axis the ANS is also 
involved in mediating the stress response of a pregnant woman to the foetus, we compared the 
ANS reactivity elicited by an amniocentesis to levels of amniotic fluid F, E, and E/(E+F). 
With the use of an ambulatory monitoring vest, measures of HR and HRV were acquired 
including HF-HRV, LF-HRF and the LF/HF ratio. Repeated saliva samples were obtained to 
determine the activity of sAA. The responses of the ANS parameters were additionally 
examined during a control condition. The statistical analyses disclosed significant autonomic 
changes over time compared to the control condition for sAA, HR, HF, and the LF/HF ratio, 
yet not for LF. LF levels were generally higher during the amniocentesis compared to the 
control condition. More importantly, higher LF/HF baseline levels, indicative of chronic 
stress exposure, were negatively related to E/(E+F) and positively with F in the amniotic 
fluid. Conversely, a stronger stress response of the LF/HF ratio was positively associated with 
the amniotic fluid E/(E+F) ratio and negatively with amniotic F. 
 
9.3 Integration of the Current Findings 
The empirical study at hand is innovative and leading in meticulously monitoring the 
stress response of various HPA axis and ANS markers in pregnant women undergoing an 
invasive medical examination and in investigating how these responses are linked to an 
indicator of 11β-HSD2 activity in the amniotic fluid. These findings show that the 
amniocentesis elicited significant responses in both stress systems. A small number of studies 
have previously adopted pregnancy-relevant medical examinations in order to assess the 
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maternal stress reaction (see Table 3 in Chapter 4; Bartha et al., 2003; Giannakoulopoulos et 
al., 1999; Gitau et al., 2004; Gitau et al., 2001; Glover et al., 2009; Sarkar et al., 2006). None 
of them have however, grasped the entire stress response. Out of these only three have 
measured maternal responses directly prior to and again within 5 to 20 minutes after the 
invasive medical examination (Giannakoulopoulos et al., 1999; Gitau et al., 2004; Gitau et al., 
2001). However, this means that these studies measured the increase of the stress markers but 
not the return to baseline levels. Whereas Giannakoulopoulos and colleagues (1999) found a 
significant rise of NE in pregnant women undergoing foetal blood sampling, Gitau et al. 
(2001) and Gitau et al. (2004) did not find significant increases of maternal plasma F and 
CRH in response to the same invasive medical procedure. This may be due to the lack of 
repeated sampling over the entire course of the stress reaction and possibly also to the lack of 
a control condition. As these studies relied on taking maternal blood, which is invasive and 
involves a degree of discomfort and pain, it is understandable that no short term repeated 
sampling was conducted, as was the case in the present two studies. We used saliva samples 
with the advantage that this method allows stress-free, non-painful, and real-time repeated 
sampling.  
Part 2 of our empirical study results pioneered measuring the stress responses of HR, 
HRV and sAA in reaction to a medical procedure during pregnancy. And though the peak 
levels of these markers remained within the normal range, they differed significantly from the 
responses during the control condition emphasizing the effect of the psychological stress.  
Overall, our findings suggest that a medical procedure such as an amniocentesis may 
serve as a useful tool in order to study the stress response during pregnancy under 
standardized but nevertheless real-life conditions. Since the amniocentesis constitutes a 
pregnancy-relevant situation, the stress reactions may also mirror how women in general react 
to stress during pregnancy. The increase in SalF observed in the first part of the empirical 
study results of this thesis parallels previous findings from our workgroup (Nierop, Bratsikas, 
Klinkenberg et al., 2006a) in which a surge of SalF in pregnant women confronted with the 
TSST was revealed. However, contrary to these results, Entringer et al. (2010) did not observe 
a stress-elicited rise in SalF by the TSST during pregnancy. This may be explained by the fact 
that Entringer et al. (2010) used a modified version of this laboratory based stress task, which 
appeared to diminish the experience of stress and uncontrollability. Our findings are also in 
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line with the results of others (Buss et al., 2009) who reported that pregnant women showed a 
significant CAR during the second trimester of pregnancy. 
The systematic investigation of F responses to stress during pregnancy is of 
importance because of the mediating role the HPA axis seems to play between maternal 
psychological stress and pregnancy outcome (Entringer, Buss et al., 2011; Entringer et al., 
2009; Glover et al., 2009; Mancuso et al., 2004). Moreover, previous findings from our work 
group have reported that an increased SalF stress reaction during pregnancy was predictive of 
the development of depressive symptoms in the postpartum period (Nierop, Bratsikas, 
Zimmermann et al., 2006b). Pregnant women who experienced depressive symptoms after 
birth had reacted with a greater SalF stress response to the TSST already during pregnancy 
than pregnant women with no such symptoms. Interestingly, the two groups did not differ 
with regard to SalF baseline levels. Altogether, these and other findings point towards an 
underlying role of the SalF reactivity in various psychological and physiological 
complications related to pregnancy and the postpartum period. 
Few studies have taken SalE into account when investigating the HPA axis during 
pregnancy. Our results revealed significant SalE increases in response to the stress of the 
amniocentesis compared to the control condition. These results are in line with Meulenberg 
and colleagues (1990b) who observed a substantial surge in the SalE in pregnant women‟s 
responses on awakening. Other studies investigating SalE reactivity to a stressor during 
pregnancy do not seem to exist. This would be necessary, since compared to the non-pregnant 
state basal SalE levels have shown to increase threefold whereas SalF levels were doubled 
(Greaves & West, 1963). This finding points either toward elevated plasma E concentrations 
during pregnancy or toward an augmentation of 11β-HSD2 activity in the salivary glands 
(Meulenberg & Hofman, 1990a).  
Due to the activity of 11β-HSD2 in the salivary glands, the consideration of SalE 
when examining the stress response of the HPA axis is of central importance. Though SalF 
correlates highly with F in the blood, it has been proposed that SalE reflects serum F activity 
more precisely than SalF (Perogamvros et al., 2010). Moreover, F and E are closely related 
compounds, a fact that calls for more sensitive methods of measuring (i.e. liquid 
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chromatography-tandem mass spectrometry; LC-MS/MS
23
) than are commonly applied in 
order to assess SalF and SalE activity accurately, since otherwise the activity of both 
glucocorticoids may erroneously be measured together. This may be one explanation for 
certain conflicting findings in the literature with regard to the assessment of SalF (Groschl, 
2008). Moreover, the simultaneous measurement of both SalF and SalE offers the possibility 
of assessing 11β-HSD2 activity in the salivary glands (Perogamvros et al., 2009). 
Although SalE has received little attention in pregnancy research, it has been 
examined in non-pregnant subjects after ACTH provocation tests and has exhibited an 
increase (Katz & Shannon, 1969; Perogamvros et al., 2010; Perogamvros et al., 2009). The 
response of SalE has also been examined in infants several days after delivery. Schäffer et al. 
(2009) assessed the HPA axis functioning in 4 days old healthy neonates who had received 
prenatal betamethasone
24
 compared to a control group of neonates who had not received 
prenatal glucocorticoid treatment (Schaffer, Luzi, Burkhardt, Rauh, & Beinder, 2009). The 
infants in the control group responded with increased SalE and SalF levels to the heel prick 
test whereas the SalE and SalF responses of infants exposed to prenatal betamethasone did not 
alter significantly. Similarly, significant SalE and SalF reactivity to the heel prick test was 
apparent in infants appropriate for gestational age but not present in infants small for 
gestational age (Schaffer et al., 2009). Glucocorticoid treatment of human placental tissue has 
shown to increase 11β-HSD2 activity (van Beek et al., 2004). However, since the authors 
found SalE and SalF to be correlated, it was assumed that their results were not mediated by 
an increased conversion of F to E in the infants. Yet, the authors did not calculate and 
compare the ratio of F to E in both groups. Nevertheless, these findings emphasize the 
importance of measuring both E and F in the stress response and suggest that foetal 
programming effects of the HPA axis have occurred in these infants.  
To the best of the author‟s knowledge, the first empirical study results of this thesis is 
seminal in indirectly measuring the reaction of salivary 11β-HSD2 to psychological stress by 
                                                          
23
  LC_MS/MS is a powerful analytical technique utilized in chemistry to detect and identify chemical 
compounds in the presence of similar other compounds (Meyer & Scribner, 2009). 
24
  Betamethasone and also dexamethasone are synthetic glucocorticoids, which are administered to pregnant 
women who are at risk of preterm delivery (i.e. birth prior to 37 weeks of gestation). The administration of 
these glucocorticoids furthers fetal lung maturation and thereby reduces the risk of infant mortality and 
morbidity (Bloom, Sheffield, McIntire, & Leveno, 2001; Dalziel et al., 2005). 
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calculating the ratio of SalE/(E+F). This ratio has been used in previous studies to assess 11β-
HSD2 activity in the placenta and foetal system based on cord vein blood samples, foetal 
tissue, and the foetal effluent of perfused placentas (Benediktsson et al., 1997; Kajantie et al., 
2003; Murphy, 1981). Others have used either the F/E ratio (Huh et al., 2008; Hundertmark et 
al., 2001; Perogamvros et al., 2010; Van Uum et al., 2002) or the E/F ratio (Dy et al., 2008) as 
markers for 11β-HSD2 activity. Though these different ratios correlate highly (Huh et al., 
2008), we nevertheless chose the E/(E+F) calculation method as it shows more clearly that it 
is the end product of 11β-HSD2 activity, namely E, that is of interest, and because it assesses 
the activity of E in relation to both E and F. Our findings indicate that in response to the 
psychological stress of the amniocentesis the SalE/(E+F) ratio decreased significantly 
suggesting that 11β-HSD2 was not able to convert the increased amount of F into E 
sufficiently rapidly. This is in line with studies that found SalE to exceed SalF during baseline 
levels but a reversed ratio of SalE to SalF after ACTH stimulation (Katz & Shannon, 1969; 
Perogamvros et al., 2010; Perogamvros et al., 2009) and after inhibition of the enzyme 
activity by glycyrrhetinic acid (Van Uum et al., 2002). Katz and Shannon (1969) suggested 
that the enzyme activity may be temporarily flooded by the sudden surge of SalF. The 
velocity by which the enzyme recovers from this flooding may potentially reflect a more 
healthy stress reaction within individuals.  
Future studies should attempt to investigate the functioning of 11β-HSD2 activity in 
the salivary glands more directly. For example, it has been established that in vitro placental 
11β-HSD2 mRNA activity increases after treatment of placental tissues with glucocorticoids 
(van Beek et al., 2004). Whether a similar process takes place in the salivary glands due to a 
stress-induced rise in F is unclear. 
As for the response of the different ANS markers to the stress of the amniocentesis, 
the findings presented in part 2 of the empirical studies help to contribute to a better 
understanding of acute stress responses during pregnancy. The significant stress induced 
increase in sAA confirms previous results from our workgroup that examined second and 
third trimester pregnant women (Nierop, Bratsikas, Klinkenberg et al., 2006a), as do the 
unchanged LF values and the increase of the LF/HF ratio in response to stress (Klinkenberg et 
al., 2009).  
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Only a handful of studies have investigated sAA and HRV responses to stress during 
pregnancy. In addition to the HPA axis the ANS may however be an important mediator in 
the association between prenatal stress and adverse pregnancy outcome as the following 
results indicate. Decreased 24 hours HRV levels and increased HR during sleeping hours have 
been found in pregnant women experiencing symptoms of depression (Shea et al., 2008). 
Pregnant woman exposed to strenuous work conditions exhibited increased urinary 
catecholamine levels (Katz et al., 1991). Furthermore, pregnant woman, who scored higher on 
both the state and trait versions of the STAI had higher mean artery uterine resistance and 
therefore impaired utero-placental blood flow – a factor involved in intrauterine growth 
restriction (Teixeira et al., 1999). Moreover, increased diastolic blood pressure reactivity 
during pregnancy appears to predict gestational age at birth (Hatch et al., 2006; McCubbin et 
al., 1996). 
The placental 11β-HSD2 enzyme regulates the amount of maternal glucocorticoids 
reaching the unborn and is up-regulated by acute stress and impaired by chronic stress in 
rodents (Mairesse et al., 2007; Welberg et al., 2005). It has therefore been assumed to play an 
essential role in mediating the relationship between maternal stress and adverse foetal 
development and pregnancy outcome. Our findings investigating human pregnancy show that 
higher levels of the E/(E+F) ratio in the amniotic fluid as a marker for the 11β-HSD2 in the 
placenta and foetal environment are associated with a higher stress response of the 
SalE/(E+F) ratio in pregnant women. Though our analyses were restricted to the one-time 
measurement of amniotic fluid levels of F, E, and the E/(E+F) ratio, the results nevertheless 
demonstrate that the maternal and foetal systems are linked during the experience of acute 
stress. Pregnant women with stronger SalE/(E+F) responses may in parallel demonstrate a 
stronger conversion of F to E in the placenta or foetal system. Furthermore, higher levels of 
amniotic fluid F were related to higher stress-induced increases in SalE. This finding may 
reflect a different process than the result regarding the SalE/(E+F) ratio because it may mirror 
the above mentioned findings of other research groups indicating that SalE more accurately 
reflects plasma F levels (Perogamvros et al., 2010; Perogamvros et al., 2009). Maternal 
plasma F levels are associated with levels of F in the umbilical cord, foetal blood and 
amniotic fluid (Dormer & France, 1973; Gitau et al., 1998; Sarkar et al., 2007). The present 
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study is the first to show that the acute stress response of the pregnant mother correlates with 
amniotic fluid parameters. 
Moreover, in the second study within this thesis we found a stronger maternal 
cardiac sympatho-vagal stress response (i.e. LF/HF ratio) to correspond with elevated levels 
of E/(E+F) and decreased levels of F in the amniotic fluid. This may indicate an essential 
contribution of the maternal ANS in regulating the conversion of F to E in the placental and 
foetal system. This interpretation is further substantiated by the significant association of 
increased LF/HF ratio levels at baseline with a decreased ratio of E/(E+F), and increased 
levels of F in the amniotic fluid. High resting levels of the LF/HF ratio have been found to be 
an indicator of chronic stress exposure (Lucini et al., 2005). 
 
10. Limitations and Strengths of the Empirical Studies 
In both studies the activity of 11β-HSD2 in the salivary glands as well as in the 
placenta and foetal system was measured indirectly by calculating the ratio of E/(E+F). 
Although this ratio has been used in previous studies to assess 11β-HSD2 activity in various 
tissues, a clearer understanding of the enzyme activity could be gained by more direct 
measurement methods, for instance by use of isotopically labelled cortisol (Andrew, Smith, 
Jones, & Walker, 2002). However, this method cannot be administered to pregnant women. In 
our results it remains unclear whether the E/(E+F) ratio in the amniotic fluid is a result of 
placental 11β-HSD2 activity, foetal 11β-HSD2 activity or both combined. During the second 
trimester of pregnancy, the enzyme is active in both the placenta and foetal tissues (Murphy, 
1981; Stewart et al., 1994; Stewart, Whorwood et al., 1995). However, probably, as the 
placenta has a larger capacity for metabolizing cortisol than the foetus (Murphy, 1981), a 
huge fraction of the E/(E+F) ratio may be a result of placental 11β-HSD2 conversion of F to 
E. An alternative way of examining 11β-HSD2 might have been to compare the amniotic 
fluid parameters of F, E, and E/(E+F) with the direct measurement of the enzyme activity in 
the placentas obtained after the delivery of our study participants. Although this additional 
analysis would certainly have been advantageous for the present study, it was beyond the 
scope but should be examined in future studies. 
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In a recent study, a further major steroid in the foetal system was investigated to 
assess exposure to prenatal maternal stress, namely dehydroepiandrosterone (DHEA). This 
was  analysed in nail cuttings of infants after birth (Tegethoff et al., 2011). The authors found 
a significant relationship between DHEA in the infants‟ nails and stressful life events of the 
mother during pregnancy. The use of DHEA may have been beneficial in our study, but this 
parameter measures chronic stress exposure rather than acute stress.  
Moreover, the placenta, deciduas, amnion and chorion express activity of the 11β-
HSD1 isoform which catalyses the conversion of E to F (Alfaidy et al., 2002; Ricketts et al., 
1998; Sun et al., 1997a). This fact further complicates the interpretation of the present 
findings, because it remains unclear as to what extent 11β-HSD1 activity may have 
contributed to our results. It seems, however, that 11β-HSD2 activity predominates over 11β-
HSD1 activity in the placenta by approximately 14 times (Arcuri et al., 1998). Moreover, in 
mid-gestational foetal tissues no 11β-HSD1 activity has been detected (Murphy et al., 2006). 
In order to test whether the association between the maternal LF/HF ratio and the 
E/(E+F) ratio in the amniotic fluid might have been mediated by maternal NE and EPI levels, 
measurements of plasma or urinary maternal NE and EPI could have proven beneficial. In 
non-pregnant individuals the LF/HF ratio has been reported to be positively associated with 
plasma and urinary NE and EPI (Kurita et al., 1999; Laskar et al., 2004). NE and EPI appear 
to inhibit placental 11β-HSD2 mRNA activity (Sarkar et al., 2001). 
In the present study sample, foetal female and male sex was not equally distributed in 
order to examine sex differences in amniotic fluid 11β-HSD2 activity. However, findings 
have reported a reduced activity of placental 11β-HSD2 activity in female infants born small 
for gestational age compared to male infants, but no such association was found in infants 
born appropriate for gestational age (Mericq et al., 2009). Similarly, reduced placental 11β-
HSD2 activity was observed in female foetuses of mothers affected by asthma during 
pregnancy but not in mothers without asthma (Murphy et al., 2003). Glover et al. (2009) 
found no effect of foetal sex on amniotic fluid F.  
11β-HSD2 activity in the parotid and submandibular glands was similarly assessed 
in an indirect manner by use of the SalE/(SalE+SalF) ratio. Here too more direct measurement 
methods would have been favourable.  
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Due to hospital proceedings all measurements were conducted in the morning during 
the circadian fall of SalF and SalE, which may have to some degree obscured the stress-
induced effects of the amniocentesis. The fact that significant increases were nevertheless 
observed emphasizes the strong impact of this naturalistic stressor. Salivary 11β-HSD activity 
varies substantially across the day as well. The F/E ratio appears to be highest in the morning 
hours (6:00-8:00) and then gradually decreases (Lee et al., 2010; Morineau et al., 1997). 
A major strength of the present study results is that the stress reactivity of pregnant 
woman was measured under standardized conditions but using a naturalistic and pregnancy-
relevant stress situation. Furthermore, a wide variety of stress markers of both the HPA axis 
and the ANS including parameters of the SNS and PSNS were investigated and observed over 
the entire course of the stress response. No study to date has reported the psychobiological 
stress response of the SalE/(E+F) ratio and very little is known about the stress response of 
sAA and HRV during pregnancy. No study to date has compared the maternal HPA axis and 
ANS stress response with amniotic fluid parameters. Glover et al. (2009) have investigated to 
what extent maternal anxiety moderates the relationship between maternal plasma F and 
amniotic fluid F and found a stronger relationship between these parameters in the most 
anxious quartile of pregnant women (Glover et al., 2009). No significant association was 
detectable in the least anxious women and the authors attributed these findings to the activity 
of 11β-HSD. While these findings have strongly contributed to a better understanding of the 
impact of prenatal stress, Glover and colleagues (2009) did not measure the stress response in 
the pregnant women and did not assess the E/(E+F) ratio nor the F/E ratio in the amniotic 
fluid.  
 
11. Outlook  
The investigation of prenatal stress during pregnancy has wide implications for 
maternal physical and psychological wellbeing as well as for that of the offspring. Prenatal 
maternal stress and anxiety have for example been related to: 
 Increased maternal plasma CRH levels (Mancuso et al., 2004) 
 Elevated maternal plasma ACTH levels (Wadhwa, Porto, Garite, Chicz-DeMet, & 
Sandman, 1998) 
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 Augmented maternal evening salivary cortisol levels (Obel et al., 2005) 
 Heightened cortisol concentration in the maternal hair (Kalra et al., 2007) 
 Lower 24 hour HRV and faster HR during the sleeping period (Shea et al., 2008) 
 Maternal postpartum depression (Nierop, Bratsikas, Zimmermann et al., 2006b; 
Robertson, Grace, Wallington, & Stewart, 2004)  
 Greater amniotic fluid F (Glover et al., 2009)  
 pregnancy loss (Arck et al., 2001) 
 Infant preterm birth and low birth weight (Dunkel Schetter, 2011; Dunkel Schetter 
& Glynn, 2011) 
 Increased serum F reactivity to the TSST in young adult offspring (Entringer et al., 
2009) 
 Shorter telomere length25 in young adult offspring (Entringer, Epel et al., 2011) 
 
Our findings suggest that similar to rodents, human placental 11β-HSD2 activity may 
offer an explanation of how maternal stress is transmitted to the foetus. Subsequently, the 
question arises whether amniotic fluid E/(E+F) ratio is associated with gestational length and 
foetal birth weight. Therefore, the birth parameters of the foetuses from this study need to be 
subject of further investigation by taking the E/(E+F) ratio as an indirect marker of placental 
11β-HSD2 activity into account. Moreover, examining the amniotic fluid E/(E+F) ratio with 
regard to maternal psychological risk factors, such as perinatal depression or in relation to 
psychological resources like social support and relationship quality, opens doors for future 
research. Likewise, psychological influences on the SalE/(E+F) ratio need to be examined as 
well.  
The present findings may also have important implications for pregnancy prevention 
programs. Recently, studies have begun to analyse the protective impact of psychosocial 
resources, such as self-efficacy, daily uplifts (Nierop et al., 2008), and relaxation (DiPietro et 
al., 2008; Fink et al., 2011; Teixeira et al., 2005) on the maternal and foetal HPA axis and 
ANS stress response. In a very simple study intervention, pregnant women were asked to 
eliminate factors that caused stress in everyday life and seek out activities that increased 
                                                          
25
  Telomeres are DNA-protein complexes that cover the end of chromosomes. Shorter telomere length is related 
with aging and disease (Entringer et al., 2011).  
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relaxation (Urizar et al., 2004). Consequently, nine days later the pregnant women reported 
less stress, less symptoms of depression and negative mood and lower levels of morning SalF 
compared to baseline. 
As mentioned in the introduction section of this thesis, prenatal stress appears to 
have foetal programming effects (Drake et al., 2007; Glover et al., 2010). However, in 
rodents, it seems that these adverse effects of prenatal stress can be reversed by positive 
postnatal nurturing of the offspring (Maccari et al., 1995; Wakshlak & Weinstock, 1990). A 
recent study in humans reports similar findings (Bergman, Sarkar, Glover, & O'Connor, 
2010). A significant association between levels of amniotic fluid F and impaired cognitive 
ability in infants after birth at an average age of 17 months was present in insecurely attached 
children but not in securely attached children. These results are encouraging, as stress during 
pregnancy cannot always be avoided. The findings by Bergman et al. (2010) indicate that the 
adverse effects of prenatal stress do not necessarily have long-lasting and irreversible effects 
but can indeed be compensated by the positive relationship between mother and child.  
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